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Abstract 
 
The ability to synthesize and modify short DNA sequences has helped to advance 
numerous research fields such as genomics, molecular biology, molecular engineering and 
nanobiotechnology. DNA has ceased to be used only as a genetic code carrier, but became also 
an important structural and functional element for the assembly of nanostructures, in design of 
the antisense therapeutics and for development of the microarray and biosensors technology. 
Various strategies with different extent of success have been used to introduce number of 
functional groups to DNA and in such way, enable both the further biomolecular studies and 
the surface immobilization.  
Within this thesis, covalent coupling strategies, namely light-induced Diels-Alder 
cycloaddition and nitrile imine-mediated tetrazole-ene cycloaddition (NITEC) were employed 
for attachment of DNA to different molecules and surfaces in a temporally and spatially 
controlled manner. The functionalization of DNA with photo-activatable groups; 2,5-
dimethylbenzophenone derivative (PE1), 2-methoxy-6-methylbenzaldehyde derivative (PE2) 
for Diels-Alder cycloaddition, and tetrazole derivative (Tz) for NITEC was achieved utilizing 
phosphoramidite, H-phosphonate and amide coupling methodologies. In order to determine the 
suitability of the light-induced reactions for further DNA modification, detailed kinetic studies 
using functionalized DNAs were performed, indicating that photoenol containing DNA (PE2-
DNA) is the most efficient reacting agent for further applications in protein conjugation and 
surface structuring. This was additionally confirmed by successful light-induced conjugation 
of PE2-DNA to horseradish peroxidase (HRP), which resulted in HRP-DNA conjugate with 
preserved inherent functions of both the DNA and protein.  
Finally, light-induced immobilization of DNA onto glass surface was performed in 
order to establish mild, simple and easily controllable route to DNA surface structuring. To 
achieve that, two different strategies, which differ in the level of resolution and versatility of 
the achieved pattern, were employed for DNA patterning: one based on the use of the shadow 
mask and the other on Direct Laser Writing (DLW). DLW enabled design of the DNA line 
pattern with resolution of 600 nm, surpassing other commercially available strategies and also 
allowing for fast and simple structuring of multiple DNA sequences and subsequent 
immobilization of complementary DNA and DNA-protein conjugates for future protein array 
applications.  
  
This was the first demonstration of the use of light-induced chemistry and direct laser 
writing for precise patterning of DNA sequences on the surface, paving the way for advanced 
applications in design of biomolecular arrays and new functional materials.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
Zusammenfassung 
 
Die Fähigkeit kurze DNA Sequenzen zu synthetisieren und zu modifizieren, hat 
entscheidende Weiterentwicklungen in Forschungsbereichen wie der Genomik, 
Molekularbiologie, Molekulartechnik und Nanobiotechnologie ermöglicht. Die DNA ist nicht 
mehr nur ein Träger der Erbinformation, sondern ist zu einem wichtigen struktur- und 
funktionsgebenden Element für die Nanostrukturierung, die Entwicklung der 
Antisense-Therapeutika und DNA Chip-Technologie sowie der Biosensorik geworden. Diverse 
Strategien wurden mit unterschiedlichem Erfolg zur Einführung zahlreicher funktioneller 
Gruppen verwendet, um weitere biomolekulare Studien und Oberflächenimmobilisierung zu 
ermöglichen. 
Im Rahmen dieser Arbeit wurden kovalente Kupplungsstrategien wie die lichtinduzierte 
Diels-Alder Cycloaddition und die lichtinduzierte Nitrilimin-vermittelte Tetrazol-En 
Cycloaddition (NITEC) verwendet, um DNA zeitlich und räumlich kontrolliert an verschiedene 
Moleküle und Oberflächen anzubinden. Die DNA-Funktionalisierung mit lichtaktivierbaren 
Molekülen wie den 2,5-Dimethylbenzophenon- (PE1) und 2-Methoxy-6-methylbenzaldehyd- 
(PE2) Derivaten für die Diels-Alder-Reaktion und dem Tetrazol-Derivat (Tz) für die NITEC 
wurde mittels Phosphoramidit- und H-Phosphonat-Methoden sowie der Amidkupplung 
realisiert. Um die Eignung der lichtinduzierten Reaktionen für die weitere DNA-Modifikation 
zu überprüfen, wurden detaillierte kinetische Untersuchungen von Reaktionen 
funktionalisierter DNA durchgeführt und es konnte festgestellt werden, dass PE2-modifizierte 
DNA den effizientesten Reaktionspartner für weitere Anwendungen wie die 
Proteinkonjugation oder die Oberflächenstrukturierung darstellt. Dies wurde zusätzlich durch 
erfolgreiche lichtinduzierte Konjugation von PE2-DNA mit der Meerrettichperoxidase (HRP) 
bestätigt. Die natürlichen Funktionen der DNA und des Enzyms blieben in dem gebildeten 
HRP-DNA-Konjugat erhalten.  
Im letzten Teil der Arbeit wurde die lichtinduzierte Immobilisierung von DNA auf 
Silizium- und Glasoberflächen durchgeführt, um somit eine milde, einfache und leicht-
kontrollierbare Route zur DNA-Oberflächenstrukturierung zu etablieren. Hierzu wurden zwei 
verschiedene Strategien verfolgt, die zum einen auf dem Einsatz einer Schattenmaske, zum 
anderen auf dem Direkten Laserschreiben (DLW) basieren. Die beiden Methoden 
unterscheiden sich hinsichtlich des Auflösungsvermögens und der Vielseitigkeit der 
erreichbaren Muster. Mittels DLW konnte ein Linienmuster mit einer Auflösung von 600 nm 
  
geschrieben werden, was andere kommerziell erhältliche Strategien übertrifft. Somit konnte 
eine schnelle und einfache Strukturierung der Oberfläche mit mehreren DNA-Sequenzen sowie 
die anschließende Immobilisierung der komplementären DNA und von Protein-DNA 
Konjugaten erreicht werden, was in der Zukunft in der Protein-Chip-Technologie Anwendung 
finden könnte.  
Zum ersten Mal wurde die Anwendung der lichtinduzierten Diels-Alder Reaktion in 
Verbindung mit direktem Laserschreiben für eine präzise Strukturierung von DNA-Sequenzen 
auf der Oberfläche demonstriert und somit der Weg für weitere Anwendungen im Bereich der 
Entwicklung biomolekularer Chips und neuer funktionaler Materialien geebnet.  
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1 Introduction 
 
1.1 DNA Synthesis and Modification 
Deoxyribonucleic acid (DNA) is a biopolymer of crucial importance for the genetic 
information transfer, and the discovery of its structure and mode of action[1] has initiated 
remarkable developments in molecular biology and genetics,[2] but also opened the route for 
DNA to become an important element in nanostructuring,[3] biosensing and optoelectronic 
device design.[4] DNA is a polymeric species with remarkable self-assembling ability, which 
leads to the formation of the double helix structure (Figure 1.1). The structure consists of four 
different monomers, the deoxyribonucleotides, composed of a deoxyribose sugar, one of four 
nitrogen-containing nucleobases; adenine (A), guanine (G), cytosine (C) and thymine (T) 
bound to the sugar at the 1'-position through 1-N-β-glycosidic bond, and a phosphate group at 
the 5'-position of the sugar. The binding of nucleotides within the single strand is enabled by a 
covalent phosphodiester bond between the sugar of one nucleotide and the phosphate of the 
next one, resulting in an alternating 5'-3'-phosphate-sugar backbone (Figure 1.1).  
 
 
 
Figure 1.1: Space model of the DNA double helix (left), structure of the single DNA strand (middle) 
and the principle of the base pairing (right), R = phosphate-sugar backbone. 
As first described by Watson and Crick,[1f] two anti-parallel polynucleotide strands pair 
to each other as a result of the hydrogen bond formation between nucleobases, and form a right-
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handed double helix (B-DNA), the most common form found within most living organisms. 
Several other forms of DNA are known, which differ in the level of stacking and hydration of 
the double helix backbone (A-DNA and Z-DNA). However, the pairing within all forms is 
highly specific and it results in formation of the base pairs between adenine and thymine (A-T) 
and guanine and cytosine (G-C). The double helix is additionally stabilized by hydration of the 
phosphate groups and hydrophobic interactions between the aromatic ring systems that results 
in stacking of the bases (π−π interaction). Double helix structure has exceptional stability and 
flexibility, which is crucial for both the packing and the transfer of genetic material, and there 
is a complex machinery composed of numerous proteins involved in DNA repair, unwinding 
and copying.  
Interestingly, due to the high specificity of the base pairing and the robust structure, 
DNA is also an advantageous building block for applications in bionanotechnology. In early 
1980s, Ned Seeman demonstrated the use of the DNA as a structural element for the 
construction of three-dimensional networks.[5] The concept of DNA self-organization was 
elaborated and expanded to the scaffold-strand technique known as DNA origami, first 
described by Yan et al.[6] and Shih et al.[7] and further developed by Rothemund.[8] The most 
important feature used in DNA assembly and structuring is the ability of the single stranded 
DNA to bind to its complementary strand with high specificity. This ability has particularly 
been useful in enabling the immobilization of various species onto different surfaces, in the 
process referred to as DNA directed immobilization (DDI).[9] Advantages of the DDI compared 
to other methods of immobilization are its biocompatibility (it proceeds in aqueous solutions) 
and binding reversibility. Namely, double stranded DNA can be unfolded (dehybridized) using 
either heat or various chemical agents allowing for a control of immobilization and the release 
of immobilized species.[10] In such way, platforms for biosensing[11] and drug delivery 
systems[12] could be designed. Short chemically synthesized DNA strands (10-25 bp) are 
commonly used for such applications as they are readily available and reversibility of the 
binding processes can be easily estimated and controlled.  
DNA origami technology also employs DDI as a mean of immobilization and 
structuring, but uses longer DNA (usually around 7 000 bp) from natural sources such as 
viruses, to build the platform, which can vary in shape and size, and to which different DNA 
modified species can be immobilized.[13] In such way the distances between immobilized 
species can be precisely controlled aiding the design of new materials for biosensing.  
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Recently, natural nucleic acids, those extracted directly from the cells of various 
organisms, have also been used in material science.[4a, 14] In one such application, DNA was 
employed as a template for growth of nanoparticles. Hung et al. used a salmon sperm 
DNA−surfactant complex and light-induced reduction of gold salt precursor to prepare a 
complex anisotropic gold crystalline structure.[15] Moreover, natural DNA has been shown to 
be remarkably interesting material for preparation of optoelectronic devices[16] and organic 
catalysts.[17] An overview of the different applications of natural DNA is given in the extensive 
review by Hung and co-workers.[14c]  
As mentioned earlier, short DNA strands, usually employed in DNA structuring and 
immobilization, are prepared by automated chemical synthesis. A range of the possible nucleic 
acid applications can additionally be extended by introduction of various chemical 
modifications to basic DNA structure. Synthetic oligonucleotides became particularly 
interesting after 1977 when Paterson et al. showed that gene expression can be modified by 
addition of exogenous, short nucleic acids.[18] A year later, Zamecnik and Stephenson 
demonstrated that a short oligodeoxyribonucleotide (13-mer) could inhibit the translation of 
proteins specified by Rous sarcoma virus 35S RNA in the wheat embryo cell-free system.[19] 
These discoveries led to the development of technologies, which enabled the gene expression 
manipulation within the living cells by employing synthetic oligonucleotides. Such 
oligonucleotide therapeutics have already shown promise in the treatment of viral diseases and 
cancer.[20] Best investigated route is the antisense mechanism, in which the complementary 
oligonucleotide is hybridized to mRNA of the targeted gene and in such way that it selectively 
inhibits the gene expression.[21],[22] However, years of research resulted in only a small number 
of nucleic acid therapeutics being used for the human disease treatment. For example, 
Pegaptanib, a pegylated anti-vascular endothelial growth factor (VEGF) aptamer, was 
approved for the treatment of age-related macular degeneration, a disease, which causes 
damage to the macula, a small spot near the center of a retina and is crucial for sharp, central 
vision, allowing people to see objects that are straight ahead.[23] The major issues with the 
therapeutic use of oligonucleotides are their instability in biological fluids (degradation by 
nucleases), poor cell penetration and inefficient tissue-specific delivery. However, in recent 
years some of these issues were addressed by introduction of DNA backbone modifications,[24] 
conjugation to biomolecules[25] or the use of viral and synthetic vectors for systemic delivery.[26] 
In general, oligonucleotide applications in both the biomedicine (either as diagnostic or 
therapeutic agents) or nanotechnology (i. e. surface modification and structuring) require use 
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of oligonucleotides, which contain a variety of functional groups to enable their further 
modification and conjugation.[27] Most of the modifications are introduced during the 
oligonucleotide synthesis and the following section will give an overview of the chemical 
strategies used for preparation of synthetic oligonucleotides.  
 
1.2 Oligonucleotide Synthesis  
Oligonucleotides can be prepared by chemical synthesis using three main methods: 
phosphate triester, phosphoramidite (phosphite triester) and H-phosphonate method with 
phosphoramidite being the most common one.  
 
1.2.1 Phosphoramidite (phosphite triester) Method 
The ground for the chemical synthesis of oligonucleotides was laid in 1955 when 
A. M. Michelson and A. R. Todd prepared a di-thymidine dinucleotide for the first time.[28] 
Further significant contribution was given by Har Gobind Khorana and his team, who 
introduced a phosphodiester method for the preparation of dinucleotide segments in 1956. 
Following such success, but almost two decades later, the segments were combined to afford 
77 units of double stranded DNA corresponding to the gene for alanine transfer ribonucleic acid 
(tRNA) from yeast.[29] It should be noted that Korana and colleagues have also developed the 
orthogonal protection/deprotection scheme, which is still used today (Figure 1. 2).[30]  
 
 
 
Figure 1.2: Common protecting groups (red) used in the oligonucleotide synthesis developed by Korana 
et al.[30-31]  
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For the protection of 5'-OH group of sugar 4,4'-dimethoxytrityl, (DMT) protecting 
group was used.[32] The exocyclic amino groups of nucleobases were protected by isobutyryl 
(iBu) for guanine and benzoyl (Bz) for adenine and cytosine.[30, 33] The next important step in 
oligonucleotide synthesis was made by Letsinger et al.[34] They, at the same time as 
Merrifield,[35] applied solid phase synthesis, developed for peptide preparation, to the 
preparation of oligonucleotides. Styrene-divinylbezene polymer was employed as a solid 
support, but this posed a significant synthetic challenge as the polymer swelled in some 
commonly used solvents and also absorbed the reagents limiting the efficiency of the 
synthesis.[36] The method was further optimized in the 1980s by Caruthers and colleagues,[37] 
who improved upon the Letsinger method and introduced the phosphoramidite monomer 
building blocks,[38] which are still used today in an automated standard oligonucleotide 
synthesis. For the protection of reactive P(III) phosphite group they used β-cyanoethyl group, 
and employed dialkylamino group as a leaving group, providing an ideal balance between the 
stability during phosphoramidite preparation and the ease of activation during oligonucleotide 
synthesis.[39] This resulted in a stable phosphitylating reagents, phosphoramidite nucleosides, 
which could be stored until they were needed making this method commercially viable. In the 
coupling reaction, phosphoramidite monomer is first activated by addition of a weak acid 
tetrazole and the resulting phosphite triester is oxidized to a phosphate in an additional step. 
Polymeric solid support was replaced by HPLC-grade silica, known as a controlled pore glass 
(CPG), due to its excellent properties such as ease of derivatization, straightforward removal of 
solvents and reagents, chemical inertness to reagents used for the synthesis, robustness and non-
swelling in common organic solvents. Depending on the scale of the synthesis, CPG can also 
be packed in columns of different dimensions, which can range from 0.05 mL to several liters 
and by varying the glass pore size from 500 to 3000 Å, different lengths of oligonucleotides 
(50-200 bases) can be prepared. For the automated synthesis, CPG is usually functionalized 
with 40 nmol to 1 µmol of the starting base. To achieve this, CPG is first activated with 
(3-aminopropyl)triethoxysilane (APTES) 1 and then treated with succinic anhydride 2 in order 
to generate the carboxylic groups, which are subsequently condensed with 3'-hydroxy groups 
of the starting nucleoside 3 in the presence of N,N'-dicyclohexylcarbodiimide (DCC) 
(Scheme 1.1).[40] In the course of optimization of the synthetic protocols, it has been shown that 
a spacer length and the nature of the bond between the CPG matrix and the lead nucleoside 
were important for the overall yield and the product purity.[41] In order to avoid the folded 
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conformation of the spacer due to the hydrogen bonding, dipole-dipole or π-π-interactions, 
spacers with more than 25 atoms were recommended and are still used today.[42] 
 
 
 
Scheme 1.1: Functionalization of CPG with APTES 1 and succinic anhydride 2 and a subsequent 
condensation with the lead nucleoside 3 (thymidine).  
The preparation of nucleoside phosphoramidite building blocks is performed in three 
steps: protection of exocyclic amino groups, tritylation and phosphitylation[31, 43] and typical 
oligonucleotide synthesis cycle within the automated systems is depicted in Scheme 1.2. 
 
 
 
Scheme 1.2: Oligonucleotide synthesis cycle based on the phosphoramidite method; 
B, B' = nucleobases, DMT = 4,4'-dimethoxytrityl protecting group.[30-31] 
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The reaction cycle involves: 
a) deblocking of the 5'-hydroxyl group by treatment with dichloroacetic acid 4  (usually 3% in 
dichloromethane); 
b) activation with a tetrazole 5 solution  
c) coupling of the nucleoside phosphoramidite 6 to a 3'-growing oligonucleotide still bound on 
the support. The chain elongation occurs in 3' → 5' direction; the phosphoramidites are usually 
used in the 1.5 - 20-fold excess and due to their high reactivity, should be handled exclusively 
under inert reaction conditions; 
d) masking of the non-reacted 5'-OH groups (capping) by treatment with acetic anhydride and 
N-methylimidazole in order to avoid the formation of undesired sequences; 
e) oxidation of the tri-coordinated phosphite triester linkage to tetra-coordinated phosphate by 
treatment with iodine and water in the presence of bases such as pyridine. 
The nucleotide chain is grown by reaction with the next nucleoside phosphoramidite 
after the detritylation step and when the desired length is achieved, cleaved from the solid 
support by treatment with 25% ammonia hydroxide solution at increased temperatures (usually 
within 5 hours at 55° C). During the cleavage step, all protective groups of exocyclic amines 
and the β-cyanoethyl group are removed. Depending on further application, DMT protecting 
group can be kept on or removed with dichloroacetic acid prior to the cleavage procedure. Since 
condensation does not proceed in quantitative yields (the yield per chain elongation step is 
mostly around 99%), short-chain oligonucleotides are present in addition to desired longer 
sequence within the final product. Therefore, the purification of synthesized oligonucleotides 
is required and this can be achieved either by reversed phase high performance liquid 
chromatography (HPLC) or by gel electrophoresis. 
 
1.2.2 H-phosphonate Method for Oligonucleotide Synthesis 
Though the first synthesis of oligonucleotide dimer using H-phosphonate chemistry was 
described by Hall, Todd and Webb in 1957,[44] its use in the solid phase synthesis was only 
demonstrated three decades later by Garegg et al.[45] and Froehler and Matteucci.[46] 
H-phosphonates are mono- or diesters of phosphonic acid and can be prepared by activation of 
phosphonic acid with trimethylacetyl chloride 7 in pyridine and subsequent transesterification 
with a hydroxy terminated molecule 8 (Scheme 1.3)[47] or employing other synthetic 
pathways.[48] In solution, H-phosphonates exist as an equilibrium mixture of two tautomeric 
forms: a tetra-coordinated phosphonate 9 and a tri-coordinated phosphite 10 (Scheme 1.3).[49]  
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Scheme 1.3 Synthesis and two tautomeric forms of the H-phosphonate, tetra-coordinated phosphonate 
9 and tri- coordinated phosphite 10.[49] 
Although the oxidation state of phosphorus atom in both forms is +3, the chemical 
reactivity is fundamentally different. Tri-coordinated species 10 reacts fast with various 
electrophiles, due to the presence of the lone electron pair at a phosphorus atom. In contrast, 
tetra-coordinated phosphonate 9 lacks a lone electron pair, which leads to a decreased reactivity 
towards electrophiles and consequently, to the improved stability and resistance to spontaneous 
oxidation. The chemistry of the phosphonate 9 is dominated by formation of a phosphoryl group 
(P=O), which is often a driving force of the reaction.[48] The tautomeric equilibrium of both 
forms is almost completely shifted towards the tetra-coordinated H-phosphonate form 9, 
permitting the synthesis of the phosphorus compounds without use of the protecting groups.[49] 
At the same time, upon activation with appropriate activating reagents, such as trimethylacetyl 
chloride or 1-adamantanecarbonyl chloride, H-phosphonate monoesters 9 can efficiently 
undergo a nucleophilic substitution. The general synthetic cycle for the preparation of 
oligonucleotides by H-phosphonate method is depicted in Scheme 1.4.[40] 
 
 
 
Scheme 1.4: Schematic illustration of the oligonucleotide synthesis cycle using H-phosphonate method; 
B, B' = nucleobases, DMT = 4,4'-dimethoxytrityl protecting group; a) condensation, b) detritylation, c) 
chain elongation, d) oxidation. 
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Following the detritylation step using dichloroacetic acid  4, condensation is performed 
by addition of an appropriate nucleoside H-phosphonate  11 and an activating reagent 
trimethylacetyl chloride 7, which results in the H-phosphonate diester 12. Due to the stability 
of the H-phosphonate compound, oxidation at every cycle is not necessary and can be 
performed at the end of synthesis by treatment with an aqueous iodine in the presence of 
pyridine.[40] Alternatively, the oxidation step can be performed under non-aqueous conditions 
providing modified oligonucleotides such as phosphoramidates,[50] phosphorothioates,[51] or 
phosphoroselenoates.[52] By employing the solution of aqueous ammonia (25%), protecting 
groups of exocyclic amino groups are removed and the oligonucleotide is cleaved from the 
solid support. Despite the advantages of H-phosphonate method such as stability of nucleoside 
H-phosphonates, one-step oxidation and the ability to provide the backbone modified 
oligonucleotides, phosphoramidite method continues to be the most widely used due to its 
higher yields and fewer side products. However, the main appeal of the H-phosphonate 
approach lies in the stability of the coupling elements, which is advantageous when sensitive 
groups need to be introduced to the oligonucleotide.  
  
1.2.3 Phosphate Triester Method for Oligonucleotide Synthesis 
This method was first used in the 1970s to synthesize oligonucleotides using appropriate 
building blocks in solution, but can also be employed for the solid-phase synthesis.[53] To 
achieve this, a protected nucleoside phosphodiester derivative 14 is allowed to react with the 
5'-end of a support-bound nucleoside 13 to give a neutral phosphotriester (Scheme 1.5).[54]  
 
 
Scheme 1.5: Principle of the phosphate triester method for oligonucleotide synthesis using 
phosphodiester derivative 13 bound to the solid support and DMT protected phosphodieser 14 to give 
neutral dinucleotide 16.    
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Different condensing agents such as mesitylene sulfonylnitrotriazole (MSNT) 15 or others,[53b, 
55] can be employed. However, due to long reaction times and large number of side reactions, 
the method is not used for the synthesis of oligonucleotides any longer. 
Further developments of the oligonucleotide chemistry have largely been application 
driven. The more demanding applications required advanced modification strategies and 
sometimes, presence of multiple modifications within a single oligonucleotide. Novel, elegant 
chemistry solutions were developed in order to reduce the time and the costs of the synthesis. 
Structural modifications of the backbone, bases or sugars,[24] but also conjugation with various 
compounds were performed on solid support or in the solution.[56] However, it was soon clear 
that depending on the intended purpose, modified oligonucleotides need to be carefully 
designed in order to prevent the loss of their inherent biological and structural properties  
 
1.3 Modification of Oligonucleotides with Various Functional 
Moieties  
 
1.3.1 Oligonucleotide Modification on the Solid Support 
Modification of oligonucleotides is mainly based on the phosphoramidite chemistry, 
which is utilized in commercial DNA synthesis. For the incorporation of modified 
phosphoramidites, but also in certain cases H-phosphonates derivatives (when the functional 
group, which needs to be added is not compatible with the phosphoramidite chemistry),[47] 
during the automated synthesis, the nucleosidic or non-nucleosidic building blocks are 
synthesized, protected, and phosphitylated. As mentioned earlier, the phosphoramidite coupling 
reaction is water and oxygen sensitive requiring inert reaction conditions. When a modification 
of the nucleotide is required, this can be achieved by addition of the desired functional group 
either at the two ends (3'- and/or 5'-end) or within the sequences. In such way, various 
oligonucleotides were synthesized containing large number of functional moieties such as 
polyalkyl chains, cholesterol, azide, alkyne, dendrons and many others.[57] Due to the 
availability of modified oligonucleotides containing optical tags such as fluorophores, 
significant advances could be made in DNA sequencing[58] and in vivo gene detection.[59] It will 
also be shown later within this thesis, how commercially available cyanine dye (Cy Dye) 
labeled oligonucleotides, prepared using cyanine phosphoramidites, can be employed for 
molecular recognition experiments.  
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One of the major advantages of the solid support synthesis, besides the ease of 
purification, is that organic solvents can be used, enabling in such way a functionalization of 
hydrophilic oligonucleotides with hydrophobic groups.[60] The solvent used in commercial 
synthesizer is anhydrous acetonitrile, therefore to be applied in an automated DNA synthesizer, 
the modifier phosphoramidites should have good solubility in acetonitrile. For molecules, 
which do not, the functionalization has to be handled manually and post-synthetically by 
employing the appropriate solvents.[57a, 61]  
Besides the reaction solvent, size of the modifier molecule has to be taken into account 
while planning the synthetic strategy, as the big molecules such as polymers can be sterically 
hindered, which makes active centers less accessible, resulting in low yields of coupling.[61] 
Another disadvantage of the modification on the solid support is the challenging synthesis of 
desired modifiers, as not every conceivable phosphoramidite can be prepared using organic 
chemistry strategies or is commercially available. It should be noted that the solid support 
modification of oligonucleotides and addition of various functional groups, extends beyond the 
phosphoramidite or H-phosphonate chemistry. For example, amino- or aldehyde- terminated 
oligonucleotides, which are still bound to the solid support, can further be reacted with 
additional functional units such as activated carboxylic acid or amino terminated 
compounds.[62] Finally, once the modification is achieved, modified DNA can be cleaved from 
the solid support by use of various reagents depending on the sensitivity of the modifier group.  
 
1.3.2 In-solution Modification of Oligonucleotides 
Another modification strategy, the in-solution coupling, involves pre-synthesis on the 
solid support and the purification of oligonucleotides, which usually contain smaller functional 
groups, and further modification using non-covalent or covalent strategies. As DNA is stable 
and fully functional in aqueous solutions, the disadvantage of this strategy is the limited number 
of modification methods, which can be performed in water. Furthermore, the in-solution 
conjugation usually requires an excess of the reagents and extensive purification, which is 
associated with product loss. However, the in-solution strategies are particularly suitable for 
conjugation with hydrophilic molecules such as various biomolecules (proteins, peptides), 
which are not compatible with organic solvents.[11c] Table 1.1. summarizes the most employed 
approaches for chemical linkage of modified oligonucleotides in solution. 
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Table 1.1: Commonly employed linkages/reactions for in-the solution oligonucleotide conjugation. 
Adapted with permission from [56].[56] 
Entry 1: Amide 
 
 
Entry 2: Thiourea 
 
Entry 3: Reductive amination via imine 
 
Entry 4: Hydrazone 
 
Entry 5: Oxime 
 
 
Entry 6: Glyoxylic-oxime 
 
Entry 7: Disulfide 
 
 
 
Entry 8: Thioether 
 
Entry 9: Diels-Alder cycloaddition 
 
 
Entry 10: Huisgen 1,3-dipolar cycloaddition 
 
Entry 11: Staudinger ligation 
 
 
   
 
Amide bond formation is one of the most widely used synthetic strategies for post 
synthetic DNA modification. A standard procedure for the amide coupling involves the in situ 
activation of the carboxylic acid using activating reagents 1-ethyl-3-(3-
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dimethylaminopropyl)carbodiimide (EDC) or N-hydroxysuccinimid (NHS) and subsequent 
coupling to amino-terminated DNA. Using such strategy, Lapiene et al. derivatized amino-
modified oligonucleotide with a maleimide moiety using a heterobispecific cross linker 
sulfoSMCC (sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate). The 
maleimide functionalized oligonucleotide could then be employed in further conjugation 
reactions with different fluorescent proteins.[63] The drawback of the amide coupling reaction 
is that the nucleophilic nature of the amino group depends on the pH, meaning that at lower pH 
the amino group is protonated, which reduces the reactivity towards electrophiles.  
Other widely used linkage method is the nucleophilic addition between thiol modified 
oligonucleotide and maleimide containing molecules. This strategy has extensively been used 
for the preparation of semisynthetic protein-DNA conjugates, in which the maleimide moiety 
is first introduced to the protein and subsequently conjugated with thiol modified 
oligonucleotides.[64] In addition to maleimide-thiol coupling, other click-chemistry strategies, 
such as the Cu[I]-catalyzed azides-alkyne Huisgen cycloaddition (CuAAC), which is high-
yielding, bioorthogonal and does not result in side products, has been employed for DNA 
modification.[65] The effect of the cytotoxic copper catalysts, which limits the in vivo 
applications of CuAAC, can be minimized by use of Cu[I]-stabilizing ligands such as 
tris(benzyltriazolylmethyl)amine (TBTA) and tris(3-hydroxypropyltriazolylmethyl)amine 
(THPTA).[66] Further developments in the azide-alkyne cycloaddition strategies also resulted in 
a copper-free strain-promoted alkyne-azide cycloaddition (SPAAC), which employs strained 
cyclooctynes and their derivatives.[67] Cu-free reaction conditions allowed for Huisgen click 
reactions to be used in vivo with cultured cells, live zebrafish and mice. In the last decade, 
several excellent reviews were published concerning the application of click chemistry 
reactions for DNA modification, which shows their extraordinary applicability and 
versatility.[68] Recently, Bauer and coworkers prepared a small library of bi-functional linkers, 
which allowed for protein-DNA conjugation employing CuAAC and SPAAC.[9c] CuAAC 
reaction was also utilized by Isobe et al. for the synthesis of DNA analogues, in which the 
backbone phosphates were replaced by triazole moieties.[69] Observed increase in double helix 
melting temperature demonstrated, that the prepared artificial oligonucleotide analogues have 
higher stability.[69] Finally, Timper and colleagues also used click chemistry for the 
immobilization of alkyne functionalized DNA onto the azide modified silica surface to allow 
for preparation of the metal wires by gold deposition, enabling new developments in the use of 
DNA nanotechnology for design of electronic devices.[70]  
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Besides azide-alkyne cycloaddition, Diels-Alder reaction between an electron-donating 
diene and the electron-withdrawing dienophile groups as well as Staudinger ligation between 
an azide and phosphane group were employed for the DNA conjugation. Generally, due to their 
stability, dienes are usually incorporated into oligonucleotides during the automated DNA 
synthesis and subsequently reacted with a range of dienophiles. In such way, Fruk and 
colleagues used Diels-Alder cycloaddition to label furan DNA with a spectroscopic reporter, 
benzotriazole dye containing a maleimide dienophile, to allow for detection of DNA at very 
low, femtomolar concentration.[71] Highly selective and efficient labeling of DNA with 
fluorophores was also achieved by Wang et al. employing Staudinger ligation in which azido 
labeled DNA was reacted with fluorescein derivatized phosphane affording modified DNA in 
90% yield.[72] The advantage of using described cycloaddition reactions and Staudinger ligation 
is not only their high efficiency, absence of the side products and mild reactions conditions, but 
also their bioorthogonality as the employed reactive moieties are not present in the 
biomolecules (if not introduced on purpose). Therefore, DNA labeling or conjugation reactions 
using unprotected oligonucleotides can also be achieved in complex biological environments 
and in vivo.[73]  
For modification of oligonucleotides that are longer than those accessible by chemical 
synthesis (>100 bases), enzyme facilitated reactions such as enzymatic ligation or polymerase 
chain reaction (PCR) can be applied. These strategies are also useful for ligation of short native 
or modified oligonucleotides to other macromolecules such as proteins, polymers, fatty acids 
or another oligonucleotides, for which traditional routes of covalent modification fail due to the 
low yields. In one such application, Kjems and colleagues used terminal deoxynucleotidyl 
transferase (TdT) enzyme for direct enzymatic ligation of native DNA to nucleotide 
triphosphates coupled to peptides, proteins, dendrimers and PEGs.[74] Furthermore, the same 
strategy was used for covalent attachment of nucleotide triphosphate activated streptavidin and 
G3.5 PAMAM dendrimer to a DNA origami platform.[74] 
As described above, a range of versatile strategies for modification of nucleic acids has 
been developed. The ability to synthesize, characterize and manipulate DNA opened many 
novel routes to applications in genomics, molecular biology, molecular engineering and 
nanobiotechnology. Especially for the latter two fields, DNA is widely used as a structural and 
functional element for the assembly of nanostructures, in design of antisense therapeutics and 
for development of microarray and biosensors technology. In order to use DNA for a specific 
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application, it needs to be modified taking into account the goal of the application and available 
resources.  
Within this thesis DNA was functionalized with light activatable functional groups to 
enable the temporally and spatially resolved conjugation of DNA to various surfaces such as 
metallic nanoparticles and silicon wafers, which could further be employed both for 
development of new hybrid materials or biosensors. Following chapter will explore the 
importance of DNA coated surfaces and different strategies to achieve their design. 
 
1.4 DNA Coated Surfaces 
Functionalization of different surfaces with DNA has become significantly important 
due to its applications in diagnosis of infectious or genetic diseases, gene expression analysis, 
single nucleotide polymorphism (SNP) detection and mutation analysis, drug discovery, DNA 
sequencing, forensic science and sensing.[75] Due to its physicochemical stability and ability to 
introduce different modifications to the backbone, DNA was immobilized on various surfaces 
such as gold, glass, silicon, polymer and other materials.[76] A number of DNA microarray 
devices,[77] new hybrid materials such as DNA-nanoparticle conjugates,[78] but also various 
biological sensors[76b] was developed in the past decades. The applications are commonly based 
on DNA directed immobilization (DDI): after immobilization of the specific oligonucleotides 
on the surface, hybridization of the complementary strands can be used to attach the whole 
range of functional molecules. Commonly used immobilization methods to prepare DNA 
coated surfaces are physisorption, chemisorption and covalent attachment and they will be 
addressed in the following sections.  
 
1.4.1 Physisorption of DNA onto Charged Surfaces 
Physisorption, as a method of surface modification with oligonucleotides, takes an 
advantage of the negatively charged DNA backbone, which can be adsorbed onto positively 
charged surfaces. Deposited oligonucleotides are randomly oriented due to their unspecific 
interaction with the surface at several points along the backbone (Figure 1.3.). 
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Figure 1.3: Physical adsorption of the negatively charged single stranded DNA onto the positively 
charged amino-functionalized glass substrate.[79]  
 
This is considered as the main disadvantage as it results in a weak interaction and a high 
background signal due to a highly unspecific adsorption. Still, such approach has been used in 
certain applications. For example, Xu and colleagues designed an electrochemical DNA sensor 
by immobilizing a single-stranded DNA (ssDNA) onto a chitosan-modified platinum electrode 
by physical adsorption.[80] The ability of the sequence-specific DNA detection was confirmed 
by successful hybridization with the complementary strand. Wongkaew and colleagues 
demonstrated an effective DNA based voltammetric electrochemical detection method for a 
verification of the specific pathogenic infection within plants such as destructive crop disease, 
the sugarcane white leaf (SCWL).[81] The SCWL-ssDNA, immobilized by electrostatic 
interactions on a chitosan modified glassy carbon electrode, could be used for identification of 
different DNA sequences from SCWL plants, mosaic virus infected sugarcane and healthy 
sugarcane plants. The successful hybridization of immobilized SCWL-ssDNA with a 
complementary strand from the infected plant probe was confirmed by cyclic and differential 
pulse voltammetry.  
However, although this strategy does not involve any prior modification of the oligonucleotide, 
but only an introduction of charged moieties to the surface, it provides random orientation and 
only weak attachment of DNA, which can be easily removed by washing steps or by use of 
detergents.  
 
1.4.2 Chemisorption of Modified DNA  
Chemisorption is the substrate selective bonding of atoms or molecules to the solid 
surface.[82] For example, sulfur containing substances including thiols, dialkylsulfides and 
dialkyldisulfides are known to be chemisorbed with high affinity onto gold.[83] Therefore, gold 
surfaces can be coated with DNA by introduction of sulfur containing moieties into 
oligonucleotides. Furthermore, due to the absence of the sulfur atoms in natural DNA, this 
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approach was shown to be highly selective for the site-specific attachment of oligonucleotides 
onto surfaces. In 1996, Mirkin and colleagues showed for the first time that thiol-terminated 
DNA can be attached to gold nanoparticles (NPs) and subsequent aggregation of the particles 
can be induced by addition of the complementary strand.[84] The prepared NP-DNA conjugates 
were highly stable at ambient conditions and could be stored and used over the prolonged period 
of time. However, when heated above 60 °C or treated with competing thiol reagents such as 
dithiothreitol (DTT) or β-mercaptoethanol, bound thiol oligonucleotide dissociated from NP 
surface. To overcome this problem, Letsinger and colleagues developed dithiane 
phosphoramidites and introduced them to oligonucleotides.[85] Dithiane containing 
oligonucleotides form two gold-sulfur bonds with NP surface resulting in the more stable 
conjugates. In the meanwhile, DNA-NP conjugates have been used for the alternative DNA 
delivery in gene silencing applications[86] and in the design of biosensors and bioelectronic 
devices.[87]  
Strong interactions between gold surface and thiol terminated oligonucleotides were also 
employed in fabrication of DNA nanostructures i.e. by AFM-based lithography.[88] Applying 
the higher shear force on the AFM tip, the alkanethiol molecules within a self-assembled 
monolayer on the planar gold surfaces are displaced allowing for the thiol terminated 
oligonucleotides to adsorb onto the exposed gold area. This principle is called AFM 
nanografting and can result in DNA lines as narrow as 10 nm.[88] The grafting approach was 
recently used by Castronovo and colleagues for the investigation of enzyme/DNA interactions 
within nanografted DNA patches of different density, demonstrating that the enzymatic activity 
is inhibited when the DNA density is higher than a certain threshold density.[89] The AFM based 
methodology can be particularly interesting for preparation of biosensors and in one such 
approach, Bano and colleagues utilized nanografted DNA patterns for DNA directed 
immobilization of proteins to afford protein arrays for further sensing applications.[90] 
Chemisorption approach is a useful DNA immobilization strategy, however for some 
applications, in particular for a design of DNA microarrays, a covalent binding of molecules is 
preferred due to the stronger attachment. In addition, for many applications, the use of gold 
surfaces is not cost effective. 
 
1.4.3 Covalent Attachment of DNA onto Various Surfaces 
Covalent attachment is widely used strategy for the DNA immobilization onto surfaces 
as it relies on the conjugation of the chemically modified DNA to the activated surface by 
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formation of the stable covalent bonds. This allows a single point attachment of 
oligonucleotides in a region-selective manner with good surface coverage. Moreover, the 
oligonucleotide-surface bond remains stable towards high temperature and high salt 
concentration, which are often required in subsequent washing procedures or applications. 
Various strategies for the covalent attachment of oligonucleotides were developed, and many 
are overlapping with the DNA modification strategies summarized in Table 1.1. For the choice 
of the right surface chemistry, several aspects should be considered: a) the linkage between 
surface and oligonucleotide should be chemically stable, b) selected linker should ensure 
efficient hybridization and minimize the steric interference with the surface, c) non-specific 
interaction of oligonucleotides with surface should be minimized or eliminated and d) the 
reaction should be compatible with aqueous conditions.  
In order to choose the right modification strategy, firstly, the application requirements 
should be considered. For microarray technology, glass slides are usually employed to prepare 
chips, while biosensors often require immobilization of DNA onto surface of various 
nanoparticles (gold, silver, magnetic or semiconducting) or noble metal electrodes. Self-
assembly of larger devices might require use of both metals and polymers. The chemistry 
employed to coat such surfaces with DNA will depend largely on the surface material.  
Glass and silicon surfaces, which are employed for microarray fabrication can be 
functionalized by use of organosilanes, which have been shown to be a very efficient reagents 
to introduce various functional groups to the glass surface.[91] Different organosilane derivatives 
have been developed to date and the most widely used are shown in Figure 1.4. 
 
 
Figure 1.4: Most commonly used organosilane reagents for functionalization of glass and silicon 
surfaces. APTES = (3-aminopropyl)triehoxysilane, MPTS = (3-mercapto-propyl)trimethoxysilane, 
GOPTS = (3-glycidoxypropyl)triethoxysilane, TPICC = N-(3-triethoxysilylpropyl)-4-(isothiocyanato-
methyl)cyclohexane-1-carboxamide. 
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(3-Aminopropyl)triethoxysilane (APTES) is widely used for the introduction of amino groups 
on glass and silicon surfaces.[92] APTES has also been shown to form covalently attached self-
assembled monolayer (SAM) on aluminium oxide and gold surfaces.[93] Recently, hydroxy 
functionalized multi-walled carbon nanotubes were silanized using APTES in order to improve 
the dispersion and interfacial interaction in composites.[94] Once introduced to the surface, 
amine groups can further be derivatized with appropriately modified oligonucleotides.[95] Using 
N-(3-triethoxysilylpropyl)-4-(isothiocyanatomethyl) cyclohexane-1-carboxamide (TPICC), 
Misra et al. introduced isothiocyanate moieties onto the glass surface to allow for the 
immobilization of self-quenched amino modified DNA hairpin, which fluorescence is restored 
upon hybridization with the complementary DNA.[96] In a study by Sethi and colleagues, 
aminoalkyl, mercaptoalkyl and phosphorylated ssDNA were first reacted with (3-
glycidoxypropyl) trimethoxysilane (GOPTS) using nucleophilic epoxide ring opening, and the 
resulting conjugates were subsequently immobilized onto the glass surface employing the 
silanization strategy to obtain DNA microarray.[97] Fabricated microarray showed high 
immobilization efficiency (36-40%), high signal-to-noise ratio (98) and high hybridization 
ability. Silanization procedure was also utilized for the functionalization of glass with the 
maleimide moiety. Such surfaces can further react with thiolated DNA by thioether linkage[98] 
as well as with the diene functionalized DNA via Diels-Alder cycloaddition.[99] In addition, 
Rozkiewitcz and colleagues reported a straightforward method to immobilize acetylene-
modified oligonucleotides onto the azide terminated glass substrate employing click chemistry 
and microcontact printing.[100] Glass slides were first silanized with 11-
bromoundecyltrichlorosilane and subsequently treated with saturated sodium azide solution in 
order to replace bromide groups with azide. In the next step, acetylene modified 
oligonucleotides were physisorbed onto the dendrimer functionalized PDMS stamps and 
immobilized to the azide substrate by click reaction induced by microcontact printing.  
Activation of various surfaces by silanization was also used for the fabrication of DNA 
biosensors. For example, an indium tin oxide glass (ITO) electrode was silanized with APTES 
and then reacted with the aldehyde modified complementary oligonucleotide by Schiff base 
formation.[101] To obtain such electrodes, amide bond formation was also employed whereas 
the ITO surface was first functionalized with carboxyl moieties using 3-phosphonopropionic 
acid and subsequently reacted with amino terminated oligonucleotides by EDC/NHS 
coupling.[102] Strategy employing amide coupling was also successfully used to immobilize 
amino terminated oligonucleotides onto a polycarbonate-gold nanoelectrodes[103] and onto 
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carboxyl group coated CdSe/ZnS quantum dots (QD).[104] To design DNA biosensors, Chen 
and colleagues recently utilized Diel-Alder cycloaddition reaction by first adding the maleimide 
dienophile to silver NPs and subsequently reacting them with diene modified DNA strands.[105]  
In general, covalent attachment represents a powerful tool for the immobilization of 
oligonucleotides onto various surfaces, enabling not only fabrication of the stable functional 
constructs, but also covering the wide range of surfaces and available functional groups. 
However, this strategy requires the activation of the reaction partners by different reagents, 
which can affect the yields and the subsequent hybridization of the complementary strands. 
Within this thesis, we have investigated sub-group of covalent strategies, namely 
photochemical reactions for attachment of DNA to various surfaces. Photochemical reactions 
are particularly interesting as they enable spatial and temporal control over the immobilization 
by use of light. Next section will give an overview of the mechanism and types of 
photochemical reactions further described in Results and Discussion. 
 
1.4.4 Photochemical Reactions for the DNA Immobilization 
Photochemical reactions are chemical reactions, caused by absorption of ultraviolet, 
visible or infrared irradiation.[106] According to the first law of photochemistry the light of a 
particular wavelength must be absorbed for photochemical process to occur. After absorption 
of light, the molecule is promoted from its ground state (S0) to a higher energy state (S1), which 
in turn can undergo different physical and chemical processes. These are summarized in 
Jablonski diagram shown in (Figure 1.5).[107]  
 
 
 
 
Figure 1.5: Schematic depiction of the Jablonski diagram including electronic excitation via absorption, 
radiative relaxation processes such as fluorescence and phosphorescence, and non-radiative processes 
such as internal conversion, intersystem crossing and vibration relaxation. 
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According to Frank-Condon-Principle, the excited molecule interacts with the 
surrounding molecules under energy loss and eventually reaches the vibrational ground state 
S1. Further loss of excess energy can happen through several physical routes including 
fluorescence, internal conversion, phosphorescence and energy transfer to another molecule. 
Internal conversion of excited states to lower energy states of the same multiplicity (S1→S0) 
takes place fast with loss of heat energy. Alternatively, the transition to the ground state can 
take place under light emission (fluorescence). The transition from excited single state S1 to a 
lower energy triplet state T1 is termed intersystem crossing. After relaxation to the ground T1 
state the radiative decay (phosphorescence) can occur including the transition from T1 to S0.  
Importantly, the excited state energy can also initiate a chemical reaction such as elimination, 
cyclization, addition, electron transfer, cleavage, isomerization or rearrangement. 
Photochemical reactions can allow for the constructions of thermodynamically disfavored 
products like small rings, overcoming large activation barriers. Moreover, since the chemical 
reaction takes place exclusively after interaction with light, it can be controlled in a temporal 
and spatial manner. This poses a significant advantage for application of DNA as a structural 
or functional building material, in catalysis, for gene regulation and molecular diagnostics 
(DNA microarrays).  
To guide the immobilization of oligonucleotides or affect their properties with light, 
different strategies have been developed. Generally, they can be divided into photoswitching 
and photocaging strategies and the use of photo-activatable groups.[108] Photoswitching is based 
on the ability of molecules to undergo isomerization reactions upon light irradiation and in such 
way enabling structural changes of the systems they are coupled to. The most prominent 
molecule used for the photoswitching studies is azobenzene, which undergoes photochemically 
induced and a wavelength controlled cis/trans isomerization of the N=N bond. Once introduced 
to the oligonucleotides, it can affect the hybridization ability. Asanuma and colleagues found 
that trans-azobenzene units intercalate into duplex DNA structures through π-π interactions, 
leading to cooperative stabilization of the DNA duplex.[109] On the other hand, cis-azobenzene 
lacks such affinity and therefore leads to helix destabilization. In the meanwhile, different 
approaches based on azobenzene switches have been developed.[108a] Yan and colleagues 
employed visible-light-stimulated stabilization of duplex DNA by trans-azobenzene and 
duplex separation by UV-stimulated photoisomerization of trans-benzene to cis-benzene for 
the photoregulation of gold nanoparticles aggregation.[110] 
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In case of photocaging, the regulation of the molecular processes with light is achieved 
by introduction of the photolabile protecting groups, either on the nucleobases, which affects 
the Watson-Crick base pairing, or on the ribose, the phosphodiester backbone, or internally.[108a] 
To achieve that, a plethora of the photocleavable groups has been developed.[111] For example, 
Deiters and colleagues added 6-nitropiperonyloxymethyl-caged thymidine to phosphorothioate 
oligonucleotides, antisense agents, which hybridize sequence specifically to mRNAs inhibiting 
translation and potentially leading to mRNA degradation through RNAse H. Addition of the 
caging group decreases the antisense activity, which can be restored by its removal upon 
irradiation with UV light at 365 nm.[112]  
Light activation and photocaging have been used for the first to allow in situ preparation 
of DNA microarrays at the beginning of 1990s.[113] Design procedure is based on the 
conventional phosphoramidite synthesis of oligonucleotides but employs light to activate each 
consecutive step in the oligonucleotide synthesis. First, hydroxyl derivatized glass substrate is 
reacted with the base, protected with a photocleavable protecting group at the 5'-end 
(Figure 1.6).  
 
 
Figure 1.6: Scheme of the in situ photolithographic preparation of the oligonucleotides directly on the 
surface. Based on [79].[79] 
Subsequently, light is allowed to pass through a photolithographic mask with a high 
spatial resolution to enable photodeprotection to which another 5'-protected building block is 
added. In the following step, a new mask is used for site specific irradiation to generate next 
pattern of hydroxyl groups and the chemical cycle is repeated. In this way, the oligonucleotide 
chains of desired sequence and length are prepared. This method has revolutionized microarray 
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methodology as it enables the generation of small microarrays of high density (106 
sequences/cm2).[79] The success of this strategy depends on several factors such as efficiency 
of photocleavage procedure, the accuracy of mask alignment and the yields of phosphoramidite 
coupling steps. However, the method is burdened with some drawbacks, namely, low coupling 
yields, no quality and purification control of the generated arrays, long fabrication time, 
requirement for the expensive photo-masks and sophisticated instrumentation. In order to 
improve efficiency of the photocleavage procedure various photolabile protecting groups such 
as benzoyl-2-(2-nitrophenyl)-propoxycarbonyl and 
thiophenyl-2-(2-nitrophenyl)-propoxycarbonyl were introduced.[114] In addition, the elaborate 
masks were replaced by a light projection from a digitally controlled array of micromirrors.[115] 
Recently, Sack and colleagues presented an optimized photolithographic microarray fabrication 
procedure, using very photosensitive protecting group thiophenyl-NPPOC, which shortened the 
photodeprotection and coupling time resulting in a six-fold reduction in array fabrication 
time.[116]  
Another approach makes use of the chemical reactions in which photo-activatable 
moiety is attached to the DNA and allowed to react with various functional groups on surfaces. 
In such way, Koch and colleagues immobilized anthraquinone modified oligonucleotides on 
microtiter wells.[117] In its excited state, anthraquinone is highly reactive towards C-H 
containing substrate and could be attached to various surfaces such as polystyrene, 
polycarbonate, polypropylene, Teflon and silylated glass. In another approach, formation of the 
light activated thioether linkage was used to immobilize thiol-DNA onto epoxy-functionalized 
silicon-substrate via UV irradiation (365 nm).[118] The spatial control was achieved by 
employing the shadow mask. Additionally, light-induced thiol-ene and thiol-yne reactions were 
utilized by the same group for the immobilization of the thiolated DNA on alkene or alkyne 
functionalized silicon surface.[119]  
Within this thesis, light-induced Diels-Alder reaction and light-induced nitrile imine 
mediated tetrazole-ene cycloaddition were employed to control the reactions by light, and both 
reactions are discussed in the following section.  
 
1.4.4.1 Light-induced Diels-Alder Cycloaddition 
Light-induced Diels-Alder reaction is a [4+2] cycloaddition reaction between 
light-activated dienols, photoenols, which are formed via tautomerization of 
o-alkylphenylketones or o-alkylbenzaldehydes under UV irradiation, and dienophiles. 
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Photoenolization, the light-induced dienol formation, was first reported by Yang and Rivas in 
1961.[120] They obtained dienol 18 of the ortho substituted benzophenone (o-dimethyl 
benzophenone) 17 instead of expected photochemical reduction product benzopinacol in the 
presence of hydrogen donors. Such dienol readily reacted with dimethyl acethylenedicarboxylat 
to give Diels-Alder cycloadduct in excellent yields.[120] After extensive flash photolysis 
investigations, Porter and Tchir proposed a photoenolization mechanism for this reaction, 
which is presented in Scheme 1.6.[121]  
 
Scheme 1.6: Photoenolization mechanism of 2,4-dimethylbenzophenone 17. After absorption of light, 
excited singlet state is formed, which undergoes intersystem conversion (ISC) to the corresponding 
triplet state. After the internal 1,5-H-transfer di-radical species is formed followed by formation of E 
and Z dienol isomers 18 and 18'. Both isomers can undergo the 1,5-rearrangement (also termed 
reketonization) yielding the starting ketone. Additionally, E-isomer can undergo Diels-Alder 
cycloaddition or electrocyclization reactions. The figure was adapted with permission from [121].[121] 
The initial nπ* singlet state, which is formed after a photon absorption by 
2,4-dimethylbenzophenone 17, is extremely short-lived (lifetime τ < 10 ns) and undergoes 
intersystem crossing to the corresponding triplet state, which exhibits a lifetime of τ < 40 ns. 
The triplet state decays to a transient di-radical species (τ = 70 ns) under 1,5-hydrogen transfer, 
which then undergo the recombination with delocalised  π-electrons of the aromatic ring and 
result in formation of E- and Z-isomeric dienols 18 and 18’. E-dienol 18 exhibits longer lifetime 
(250 s) due to the unfavored internal tautomerization to starting ketone in aprotic solvents 
(1,5-hydrogen rearrangement) and can therefore, be employed for subsequent reactions such as 
Diels-Alder cycloaddition or electrocyclization.[121-122] The general reaction scheme for the 
light-induced Diels-Alder cycloaddition is depicted in Scheme 1.7. 
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Scheme 1.7: General reaction scheme for the light-induced Diels-Alder cycloaddition of o-methyl 
benzaldehyde/benzophenone with an electron deficient dienophile; R = H, Ph; EWG = electron 
withdrawing group. 
After the light absorption, reactive dienol is formed, which readily undergoes cycloaddition 
reactions with electron-deficient dienophiles, such as maleimide, the driving force of the 
reaction being the restored aromaticity. Although the photoenolization of o-methyl/phenyl 
ketones and aldehydes has been employed in organic chemistry for a long time,[122-123] it was 
only recently applied in polymer chemistry and wider by group of Barner-Kowollik.[124] In their 
initial study, two polymers each containing either o-methyl benzophenone or maleimide group 
have been conjugated via light-induced cycloaddition reaction under irradiation with a compact 
fluorescence lamp (36 W, λmax = 320 nm) in toluene.[124] Inspired by the success and high 
efficiency of the block copolymer formation, the same strategy was applied to the preparation 
of the tri-block polymers and wider.[125] Further numerous studies led to the synthesis of the 
more reactive photoenol precursor, 2-formyl-3-methylphenoxy (FMP) derivative, which could 
undergo a cycloaddition with less electron deficient acrylates.[126] Moreover, due to its 
biocompatibility, FMP has also been applied to coupling of biomolecules. In one such example, 
maleimide functionalized peptide could successfully be immobilized to FMP modified silicon 
wafer in a spatially controlled manner, utilizing a shadow mask.[126a] Furthermore, Bauer and 
colleagues recently employed FMP derivative for the light-induced conjugation of DNA with 
maleimide functionalized myoglobin.[127]  
 
1.4.4.2 Nitrile Imine-Mediated Tetrazole-Ene Cycloaddition (NITEC) 
Another light-induced conjugation strategy used within this thesis and further described 
in Results and Discussion, employs tetrazoles as photo-activatable compounds. Photochemical 
reactions of tetrazole moiety have been studied extensively for the last 50 years and it was first 
reported by Huisgen and colleagues in 1967 employing 2,5-diphenyl tetrazole and methyl 
crotonate as reagents.[128] Upon UV irradiation, 2,5-diphenyl tetrazole undergoes facile 
cycloreversion and generates a nitrile imine dipole in situ, which spontaneously reacts with 
methyl crotonate to afford fluorescent pyrazoline as a cycloproduct. Nitrile imine, unlike other 
dipoles, readily undergoes reaction with water, resulting in hydrozides, which is the reason for 
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its in situ formation.[129] General reaction scheme between the tetrazole 19 and dienophile 20 to 
afford fluorescent pyrazoline 21 is given in Scheme 1.8. 
 
 
Scheme 1.8: General reaction scheme for the light-induced NITEC between 2,5-diaryl tetrazole 19 and 
alkene dipolarophile 20 to afford fluorescent pyrazoline 21. 
For a long time, tetrazoles were mostly used for the synthesis of heterocycles and 
polymers,[130] but in 2007, Lin et al. reported the use of tetrazole for synthetic and biological 
applications.[131] Since then, his group has extensively studied the photo-induced chemistry of 
tetrazoles and reported on various tetrazole derivatives in order to achieve highly biocompatible 
systems.[132] Recently, the tetrazole-based cycloaddition (often referred to as NITEC for nitrile 
imine-mediated tetrazole-ene cycloaddition) has successfully been employed to selectively 
functionalize an alkene encoded protein in vivo under irradiation (λmax = 302 nm) and the 
reaction could be monitored in real time by following the formation of the fluorescent 
pyrazoline cycloadduct (λEx =438/24 nm, λEm = 483/32 nm).[133] Furthermore, Lin and 
colleagues also prepared a panel of oligothiophene-based tetrazoles in order to shift the 
activation wavelength towards visible (405 nm) region. Such water soluble tetrazole was then 
employed for the real-time spatially controlled fluorescence imaging (λEx =458 nm, 
λEm = 531−623 nm) of microtubules in live mammalian cells.[134] NITEC strategy was also used 
for polymer grafting onto tetrazole functionalized silicon wafers and cellulose,[135] and for 
conjugation of the antifouling polymers to polydopamine surface.[136] Recently, our group 
showed that maleimide modified oligonucleotides can be attached to the surface of the tetrazole 
coated gold nanorods and the coupling quantified by fluorescence measurement of the resulting 
product.[137]  
Such recent applications of both light triggered reactions prompted us to try to employ 
them for structuring of DNA on various surfaces and inspired the use of simpler, more efficient 
strategy for surface patterning based on precise delivery of light by means of laser writing. 
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1.5 Methods for DNA Surface Structuring 
The physical and chemical character of DNA immobilization to various surfaces has 
been reviewed in previous sections However, for biosensing and diagnostic application, precise 
structuring of the surfaces is often needed to allow for the immobilization of pre-programmed 
sequences in a controllable spatial manner. This can be achieved by careful choice of the 
oligonucleotide structuring/surface delivery methods. The most common techniques to enable 
design of DNA structured surfaces were summarized in an extensive review by Meyer and 
colleagues and are shown in Table 1.2.[11d]  
 
Table 1.2: Overview of different techniques used for surface structuring of oligonucleotides. Adapted 
with permission from [11d].[11d] 
Method Patterning 
modea 
Transfer 
modeb 
Multiplexingc Minimal 
feature 
sized 
Process 
time/speede 
Feature 
generationf 
Dip-pen 
Nanolithography 
 
Direct Direct Sequential 100 nm 1 s/feature Serial 
Nanografting 
 
Direct Self-
assembly 
Sequential 10 - 100 nm 800 nm/s Serial 
Microcontact 
Printing 
 
Replicative Direct By spotting of 
stamp 
5 - 50 µm 20 min/stamping Parallel 
Inkjet printing 
 
Direct Direct Sequential 50 - 200 µm n.a.g Serial 
Nano-pipetting 
 
Direct Direct Sequential 800 nm 10 s/feature Serial 
Microfluidic 
patterning 
 
Replicative Self-
assembly 
Sequential 10 - 100 µm 4 h/chip Parallel 
Photolithographic 
in situ synthesis 
 
Replicative In situ 
synthesis 
Massive 1 µm 60 - 360 s/frame 
 
Parallel 
aPattern is generated directly or by intermediate structures like masks or molds (replicative) 
bDirect feature transfer of ssDNA , by self-assembly or in situ synthesis 
cArray with different sequences possible 
dSpot diameter or line width 
eFeature fabrication duration 
fParallel or serial (one after another) feature generation 
gNo values specified 
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Important parameters to guide the choice of the structuring methods are the size and the 
number of features which can be generated, as well as the multiplexing ability of the method, 
that is, the ability of producing patterns of different sequences. One of the approaches, the 
photolithographic in situ synthesis, which is characterized by high multiplexing ability was 
described in Section 1.4.4 (Figure 1.6). However, this method is highly demanding in terms of 
instrumental equipment.[138] Another photolithographic processes such as immobilization of 
pre-synthesized oligonucleotides via photo-activatable linker uses shadow masks to introduce 
desired pattern. Such an approach has the advantage of the simultaneous exposure, but for every 
desired pattern a specific mask must be fabricated, the method is not capable of multiplexing 
and the resolution is restricted to several tens of micrometers. For conventional applications in 
bioanalytics, such as gene expression profiling, inkjet printing has been the method of choice 
to afford the fabrication of oligonucleotide microarrays bearing spots of ≥ 100 µm diameter. 
Within this method, sample droplets are delivered to pre-programmed sites. However, for the 
applications of microarrays for single cell studies, more elaborate array constructions with 
smaller feature sizes are required. Only few methods are capable of structuring the features 
smaller than 10 µm diameter and these include high resolution methods such as dip-pen 
nanolithography[139], AFM nanografting (Section 1.4.2),[90] nano-pipetting[140] or microcontact 
printing (Section 1.4.3).[141] However, these methods are often time consuming and either lack 
in multiplexing ability (nanografting) or patterning variety (microcontact printing).  
To overcome some of the drawbacks of existing DNA structuring methods and enable 
one-step fabrication of arrays with various patterns using light-induced reactions, we employed 
a multi-photon strategy referred to as direct laser writing (DLW), which is based on 
multi-photon absorption by photopolymers and allows fabrication of computer-designed 
mm-sized 3D structures with sub-100 nm spatial resolution.[142]  
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Figure 1.7: General experimental direct laser writing (DLW) setup. The inset shows the principle of 
drawing by a moving laser beam, which is focused onto the photoresist material. Adapted with 
permission from [143].[143] 
Figure 1.7 depicts a general experimental DLW setup. The beam of a femtosecond 
titanium sapphire oscillator is tightly focused inside the volume of transparent photopolymer 
solution, which is usually deposited on a supporting glass substrate. The laser light is absorbed 
via multi-photon absorption process at the focus, leading to a photo-polymerization within the 
absorbing material. By translating the focal spot inside the sample, arbitrary 3D structures can 
be fabricated. The translation can be achieved by using the high-accuracy translation stages 
controlled by piezo transducers or by moving the laser beam. Combination of the different 
light-induced chemical processes with the multi-photon absorption makes DLW technique 
highly suitable for various applications. Employing photo-polymerizable compounds, such as 
acrylates, but also organic-inorganic hybrid materials a number of components and devices has 
been fabricated such as photonic crystals,[144] micromechanical and microfluidic 
devices,[145]biomedical micro-devices and cell culture scaffolds.[146] Recently, methacrylate 
modified polylactide was employed to fabricate high-resolution 3D structure to grow 
neuroblastoma cells, which preserved their viability and proliferation, indicating a good 
biocompatibility of the written structure, opening new routes for the use of such structures in 
the preparation of neuronal implants.[147] 
In addition to 3D fabrication, DLW can also be employed for the precise spatially 
resolved patterning on different surfaces. In this manner spatially controlled surface 
immobilization of functional polymers[148] and gold nanoparticles,[149] and as shown within this 
thesis DNA patterning could be performed. 
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2 Research Objectives 
 
The aim of this thesis is to establish light-induced conjugation strategies to allow for 
DNA protein conjugation and surface immobilization in a controllable manner. DNA is a 
biopolymer, with the main role of being the genetic code carrier, and as with any other 
biomolecule, the chemical methods for its modification need to be mild (no temperature or pH 
extremes, no catalysts, or harsh reagents), proceed readily in aqueous solutions and be 
bioorthogonal. Besides its major role in genetics, DNA double helix formation between two 
DNA strands has been shown to be remarkably efficient way for immobilization of various 
moieties onto different surfaces, a process known as DNA directed immobilization. This 
requires an attachment of single stranded short DNA onto the desired surface, and a subsequent 
hybridization with the complementary strand. To achieve that, besides above requirements, 
chosen chemical strategy also needs to allow for the formation of a stable, covalent surface 
linkage in a controllable and reproducible way.     
Within this thesis, two conjugation strategies should be employed, the light-induced 
Diels-Alder cycloaddition and the nitrile imine-mediated tetrazole-ene cycloaddition 
(NITEC). They were selected because they are bioothogonal, do not require harsh conditions 
or catalysts, proceed well in aqueous media, although with different level of efficiently and can 
be triggered “on-demand” by light. To respond to irradiation, DNA needs to bear a light-
activatable groups, which should be added to a short single stranded oligonucleotide using 
different modification approaches such as phosphoramidite, H-phosphonate or amide coupling 
to select for the most efficient. Two different photo-activatable photoenol moieties 2,5-
dimethylbenzophenone and 2-methoxy-6-methylbenzaldehyde as well as 2,5-diphenyl 
tetrazole should first be derivatized with appropriate functional group and subsequently 
incorporated at 5’-end of oligonucleotides. The ability of the modified oligonucleotides to 
undergo light-induced reactions should then be investigated by kinetic studies, employing a 
model, small ene-containing molecule, to select for the most suitable light-induced reaction to 
be used for preparation of DNA-protein conjugates and DNA coated surfaces employing 
direct laser writing strategy.  
 
 
 
  
32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results and Discussion 
33 
 
3 Results and Discussion 
 
3.1 Synthesis of the Photo-Activatable Oligonucleotides 
Various strategies have been employed for the light-induced regulation of 
oligonucleotide synthesis and reaction, although they could be grouped into three distinct 
approaches.[108] One involves the use of the light sensitive protecting groups within the key 
locations such as nucleobases, ribose or phosphodiester as well as 5'- and 3'-end. The introduced 
modification blocks the inherent function of these groups by use of protecting functional groups 
(photo-caging), which can then be restored by use of light. This process is inherently 
irreversible. The other involves introduction of the light activatable molecular species to 
oligonucleotide, which undergo reversible isomerization reactions of double bonds or 
unimolecular pericyclic reactions upon irradiation (photo-switching).[108a] The incorporated 
molecules change their conformation affecting the hybridization ability of the oligonucleotide 
and the process is reversible (switchable). Third approach employs light to control 
oligonucleotides and other biomolecules within the cells, typically neurons, which have been 
genetically modified in order to express light-sensitive ion channels.[108a] 
Within this thesis, new strategy was explored in which the advantages of first two 
approaches were employed. The isomerizable moiety was incorporated within oligonucleotides 
not for its steric effects, but for the reactive isomer formed upon irradiation to be further 
employed in modification reactions with various molecular species. As such, a photo-
activatable 2-methoxy-6-methylbenzaldehyde 22 and 2,5-dimethylbenzophenone 
derivative 23, which form reactive dienols, photoenols (PE) described in Section 1.4.4.1, were 
utilized. The generated reactive dienols can be trapped by electron deficient dienophiles in a 
Diels-Alder cycloaddition reaction. Resembling the photo-caging strategy, individual building 
elements of oligonucleotide were not protected, but rather protected reactive moiety was added 
to the oligonucleotide. The caging group can be removed by irradiation affording reactive group 
to further engage in coupling reactions. For this approach, tetrazole derivative 24, which 
generates nitrile imine species upon photolysis and nitrogen release, was employed. Nitrile 
imines are reactive intermediates and undergo 1,3-dipolar cycloaddition reactions with various 
dipolarophiles. Both photoenol and tetrazole strategies can be, as it is shown further in the 
thesis, be used to link the oligonucleotides with other molecules in controllable manner using 
light as a trigger.  
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For the incorporation of these photo-activatable groups standard phosphoramidite and 
H-phosphonate methods, but also amide coupling via N-hydroxysuccinimide (NHS) ester were 
employed. The following section describes the synthesis of novel photo-activatable 
oligonucleotide building blocks, and their introduction to oligonucleotides by solid phase 
synthesis. 
 
3.1.1 Phosphoramidite Method 
As described in Section 1.4.4.1, photoenolization combined with subsequent Diels-
Alder trapping, represents an effective method for the light controlled molecule association. 
Diverse photoenol precursors at different reaction conditions were screened by group of Prof. 
Barner-Kowollik for their applicability in a light-induced Diels-Alder cycloaddition reaction 
and are described elsewhere.[150] In these studies, 2-methoxy-6-methylbenzaldehyde 22 and 
2,5-dimethylbenzophenone 23  were found to give highest yields and fastest rate of reaction 
under mild reaction conditions.[150] Photoenol 25 which is generated by irradiation of 
2-methoxy-6-methylbenzaldehyde 22 is stabilized by internal hydrogen bonds and therefore 
less unstable in his activated state and longer available for further reactions, resulting in better 
product yields as shown in the case of the Diels-Alder cycloaddition with maleimide 26. In case 
of 2,5-dimethylbenzophenone 23 the stabilization of the photoenol species 28 results from a 
double bond conjugation (Scheme 3.1).  
 
 
Scheme 3.1: Light-induced photoenol formation and its subsequent DielsAlder cycloaddition reaction 
with maleimide moiety using a) 2-methoxy-6-methylbenzaldehyde 22 and b) 
2,5-dimethylbenzophenone 23 as a photoenol precursor. 
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The photoenols,1 especially 22, which was found to be the most efficient, were used for 
various applications including polymer-polymer conjugations,[126b, 151] immobilization onto 
different surfaces[126a, 149, 152] and the design of 3D micro scaffolds.[153] In addition, the 
light-induced conjugation strategy based on Diels-Alder cycloaddition of photoenols has been 
shown to be biocompatible, since it can be performed in aqueous media at ambient temperature. 
In one such study, maleimide functionalized peptide was covalently bound to photoenol coated 
silicon surfaces in a patterned way using a shadow mask.[126a] In addition, biosurfaces such as 
hyaluronan film and cellulose were functionalized with photoenol moiety and patterned with 
maleimido-poly(trifluoroethyl methacrylate) and maleimido-peptide.[154] Following this ground 
breaking work of Prof. Barner-Kowollik et al., we explored the use of the photoenol based 
conjugation strategy to DNA functionalization and structuring.  
Initially, Bauer et al. derivatized an oligonucleotide with 4((2-formyl-3-
methylphenoxy)methyl)benzoic acid 30 through amide coupling using HBTU/HOBt as 
coupling reagents onto amino terminated oligonucleotide.[126a, 127] The photoenol modified 
DNA was then conjugated to a protein myoglobin containing maleimide groups by light-
induced Diels-Alder cycloaddition resulting in the functional protein-DNA conjugate. 
However, this approach resulted in the low yields of PE modified DNA, so we decided to 
explore another, more convenient strategy based on the use of phosphoramidites.  
Phosphoramidite approach, described in Section 1.2.1, was employed for tethering the 
photoenol moiety to a 5'-end of oligonucleotide using automated solid phase synthesis, 
commonly employed for preparation of modified oligonucleotides. This method allows the 
direct introduction of photoenol moiety to various non-modified sequences during the 
automated process using DNA synthesizer. The procedure employs phosphoramidite building 
blocks containing desirable functional groups together with the range of reagents in a sequence 
of reactions, which result in DNA synthesis and desired modification.[43]  
 
 
 
Scheme 3.2: Synthesis of photoenol PE1 31; a) NaOH, CH3I, THF, 50 °C, 16 h; H2O, 88%; b) AlCl3, 
benzoyl chloride, 0 °C - RT, CH2Cl2, 60h, 10%. 
 
                                                 
1For the sake of convenience 2,5-dimethylbenzophenone 23 and 2-methoxy-6-methylbenzaldehyde 22 are called 
photoenols, PE1 and PE2, in the following text. 
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To achieve this with photo-activatable groups, phosphoramidites bearing photoenol moiety 
need to be synthesized and the first step was the preparation of photoenols PE1 31 
(Scheme 3.2)[155] and PE2 37 (Scheme 3.5) adapting the literature procedures. Firstly, 
2,5-dimethylphenol 32 was etherified using methyl iodide as reported by Paptchikhine and co-
workers,[155] which was then followed by Friedel-Crafts acylation and methyl ether cleavage 
using AlCl3 as a catalyst.
[126a] In order to improve the solubility and to allow for more steric 
freedom for further ligation reactions, the prepared photoenol PE1 31 was derivatized with a 
three-membered glycol unit in a nucleophilic substitution of tosylated triethylene glycol 35 
(Scheme 3.3).[156] This resulted in modified photoenol 36 obtained in 87% yield. [126a] 
 
 
 
Scheme 3.3: Synthesis of triethylene glycol derivatized PE1 36; a) 4-methylbenzenesulfonyl chloride, 
CH2Cl2, 0 °C - RT, 16 h, 21%; b) K2CO3, LiBr, 18-crown-6, MeCN, reflux, 24 h, 87%. 
The second photoenol 30, that contained carboxylic acid functional group was 
synthesized according to the literature procedure in four steps (Scheme 3.4).[126a] 
 
 
 
Scheme 3.4: Synthesis of 4-((2-formyl-3-methylphenoxy)methyl)benzoic acid 30 (PE2); a) K2S2O8, 
CuSO4, MeCN/H2O (1:1, v/v), 100 °C, 30 min, 51%; b) AlCl3, CH2Cl2, 0 °C, RT, 16 h, 48%; c) K2CO3, 
methyl 4-(bromomethyl)benzoate 41, 18-crown-6, acetone, 40 °C, 16 h, quantitative; d) NaOH, 
CH2Cl2/MeOH (5:1, v/v), RT, 16 h, 85%. 
 
For the preparation of phosphoramidite, a hydroxyl group is required to bind to the phosphorus 
atom. Hydroxyl group is already introduced to PE1 31 through triethylene glycol, while it was 
added to PE2 30 through amide coupling with the bifunctional linker containing amine and 
hydroxyl group 44 (Scheme 3.5).[9c] The amide coupling was performed using 
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1-hydroxybenzotriazole (HOBt), N,N'-dicyclohexylcarbodiimide (DCC) and N-
hydroxysuccinimide (NHS) as coupling reagents resulting the product 37 with a yield of 
47%.[157] 
 
 
Scheme 3.5: Synthesis of triethylene glycol derivatized PE2 37; a) methanesulfonyl chloride, THF, 
0 °C - RT, 16 h, NaN3, EtOH, reflux, 24 h, 26%; b) Pd(OH)2/C, H2, EtOAc, RT, 16 h, 94%; c) HOBt, 
DCC, NHS, DMF, RT, 24 h, 47%. 
En route to phosphoramidite, synthesized bifunctional photoenol precursors PE1 36 and 
PE2 37 were phosphitylated using 2-cyanoethyl N,N-diisopropylchlorophosphor-
amidite reagent 45 following the reported literature procedure.[158] The crude  PE1 
phosphoramidite 46 was characterized by 31P-NMR and mass spectrometry and used in the next 
step without further purification. The reaction of PE2 37 with the phosphitylating reagent 45 
was not successful even after several attempts. Although a small phosphoramidite 47, peak was 
observed in 31P-NMR spectrum, mass analysis using Electron Ionization Mass Spectrometry 
(EI-MS) showed  that only an oxidized species [(47+O+2H)+] is present.  
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Scheme 3.6: Synthesis of photoenol-phosphoramidites 47 (left) and 46 (right); DIPEA, CH2Cl2, 
0 °C - RT, 2 h.  
To afford modified DNA, PE1-phosphoramidite 46 was dissolved in an anhydrous 
acetonitrile, mounted onto a DNA synthesizer following by the standard synthesis protocol with 
prolonged coupling time of 560 s (standard coupling time 96 s). The photoenol modified 
oligonucleotide PE1-DNA1 48 (Scheme 3.7) was obtained after high-performance liquid 
chromatography (HPLC) purification with a yield of 38%. The identity of the product was a 
confirmed by Matrix-Assisted Laser Desorption Ionization - Time of Flight mass spectrometry 
(MALDI-TOF) (Table 5.10).  
 
 
Scheme 3.7: Solid phase synthesis of the oligonucleotide PE1-DNA1 48 containing photo-activatable 
5'-end employing DNA synthesizer. 
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Due to the general instability of phosphoramidite and inability to obtain photoenol 
phosphoramidite PE2 47 in applicable yields, another DNA incorporation strategy using 
H-phosphonate derivative (details on the methodology are given in Section 1.2.2) was explored. 
  
3.1.2 H-Phosphonate Strategy for PE-DNA Preparation 
In order to circumvent the observed oxidation of phosphorus during the synthesis of 
PE2-phosphoramidite 47, another more stable phosphorus containing DNA building block, 
namely H-phosphonate photoenol 49 was prepared. As described in Section 1.2.2, 
H-phosphonates are mono- or diesters of phosphonic acid. These trivalent P(III) compounds 
with a tetrahedral geometry contain a phosphoryl group (P=O) and a hydrogen atom bonded to 
the phosphorus atom. Due to the lack of the lone electron pair on the phosphor center, 
H-phosphonates are more resistant towards oxidation than most P(III) compound and therefore 
easier to handle, in particular during the purification steps. At the same time, upon activation, 
for example with trimethylacetyl chloride 50, H-phosphonates monoesters can undergo 
nucleophilic substitution with hydroxyl containing molecules, such as nucleosides or another 
hydroxyl containing compound, to give the desired nucleoside H-phosphonate.[40, 49] 
To afford PE2 H-phosphonate 49, the triethylene glycol derivatized photoenol 37 was 
used as a precursor. First, the procedure described by Froehler and co-workers, employing PCl3, 
N-methyl morpholine and triazole as an activating reagent was used for the synthesis 49, but 
was not successful in our hands.[159] However, the desired product 49 could be obtained using 
the synthetic procedure reported by Dougan and colleagues, which involved the reaction with 
phosphonic acid.[47] 
 
 
Scheme 3.8: Synthesis of the photoenol-H-phosphonates 49 and 51; phosphonic acid, pyridine, 
trimethylacetyl chloride 50, RT, 2 h; triethylammonium bicarbonate buffer. 
Results and Discussion 
40 
 
Phosphonic acid was dissolved in anhydrous pyridine and added under inert atmosphere 
to 37 and after a complete dissolution, trimethylacetyl chloride 50 was added and the mixture 
stirred for two hours at ambient temperature. After quenching with triethylammonium 
bicarbonate buffer the solvents were removed and the product 49 was obtained as a 
triethylammonium salt with a yield of 68% (Scheme 3.8). Same procedure was employed to 
obtain PE1-H-phosphonate 51 (Scheme 3.8). 
The introduction of the photoenol-H-phosphonates 49 and 51 to DNA was performed 
manually by direct coupling to commercially available CPG-bound oligonucleotides DNA1 
and DNA2. Different reaction conditions were tested in order to improve the product yield and 
these are summarized in Table 3.1. 
 
Table 3.1: Overview of different reaction conditions for the coupling of H-phosphonate 51 to DNA1.  
Nr. H-
phosphonate/ 
eq. 
Trimethylacetyl 
chloride/ 
eq. 
Adamantyl 
chloride/ 
eq. 
Reaction 
time, 
temp. 
 
Yield 
 
1 29.0 13.0 - 
30 min 
RT 
2% 
2 185 20.0 - 
3 h 
RT 
3% 
3 52.0 - 58.0 
30 min 
RT 
- 
4 365 143 - 
16 h 
39 °C 
36% 
 
The best results were achieved employing the procedure 4, which involved heating at 39 °C for 
16 h. The reaction was performed by addition of PE H-phosphonate 51 to the CPG-bound 
oligonucleotide in a mixture of anhydrous acetonitrile/pyridine (1:1, v/v) followed by addition 
of trimethylacetyl chloride 50 solution (0.100 M) and stirring at elevated temperature. After the 
washing steps, resulting PE1-DNA1 48 was treated with standard oxidizing solution containing 
0.02 M iodine in THF/pyridine/water (7:2:1) (10 min), washed with acetonitrile and cleaved 
from the solid support by incubation in 25% aqueous ammonia solution. After HPLC 
purification, the photoenol modified oligonucleotide PE1-DNA1 48 was obtained with 36% 
yield. Additionally, another sequence, DNA2, was functionalized with PE1 36 using the same 
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procedure and obtained with 41% yield. The products were analyzed by MALDI-TOF mass 
spectrometry (Table 5.10). The syntheses of PE2-DNA1 53 and PE2-DNA2 54 were performed 
using the optimized reaction conditions described above, however the oxidation time needed to 
be decreased (3min instead of 10 min) to avoid the oxidation of aldehyde moiety of PE2. 
 
 
 
Scheme 3.9: H-phosphonate method for the synthesis of the photoenol modified oligonucleotides a) 
PE2-DNA1 53 or PE2-DNA2 54 and b) PE1-DNA1 48 or PE1-DNA2 52; solid phase synthesis.  
PE2-DNA1 53 and PE2-DNA2 54 were purified by HPLC in 43% and 38% yield respectively. 
The analysis was performed by MALDI-TOF mass spectrometry (Table 5.10). 
To explore, if the yields of reaction can be improved as well as to find the most suitable 
modification procedure for range of different DNA sequences, amide coupling of photoenol 
NHS derivative to amino modified DNA1 and DNA2 was performed. Amide coupling was an 
important strategy also to enable coupling of another photo-activatable species, tetrazole (Tz), 
as the preparation of tetrazole phosphoramidite or H-phosphonate derivatives would involve 
the complex synthetic procedure, so simpler alternatives were of huge advantages. 
 
3.1.3 Amide Coupling Strategy for the Preparation of PE- and Tz-DNA. 
Amide bond, one of the most common covalent linkages present in a wide variety of 
synthetic and natural compounds,[160] is formally a product of the condensation reaction 
between a carboxylic acid and an amino group.[161] However, the amidation reaction does not 
occur spontaneously as the elimination of water requires high temperature (> 200 °C),[162] 
which is not compatible with many substances. Therefore, the activation of the precursor, 
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namely carboxylic acid, is a necessary step. The common procedure to achieve that includes 
the conversion of OH group of a carboxylic acid into a good leaving group prior to its reaction 
with amino functionality. In the past decades, enzymatic catalysis has also been explored and 
used as an alternative to the traditional organic synthesis procedures, although enzymes are not 
suitable for the wide use, as they require mild reaction condition and controllable environment 
consisting, of aqueous solutions.[163] 
However, a plethora of activation methods and coupling strategies has been developed 
over the time, to be used in variety of synthetic procedures.[161, 164] One of them, used in this 
thesis, is the activation of the acid functionality by treatment with DCC and NHS, the 
procedure, first applied for the peptide synthesis by Anderson and co-workers.[165] In short, 
photoenol  is derivatized to NHS ester by DCC/NHS activation in THF at ambient temperature, 
purified by column chromatography and subsequently employed in reaction with amino 
terminated oligonucleotide (Scheme 3.10), bound to the solid support (CPG-DNA), as we have 
found out previously, that yields can be improved if CPG bound DNA is used in amide 
coupling.[166] The solid support strategy was the method of choice as the coupling reaction in 
solution was low yielding, due to the bad solubility of prepared NHS esters of PE2 and Tz in 
aqueous solutions. The solubility could be improved by introduction of ethylene glycol units to 
the photo-activatable compounds. However, the solid support strategy provided good yields 
and therefore was employed for the preparation of PE2 and Tz modified oligonucleotides. 
 
 
 
Scheme 3.10: Synthesis of PE2-NHS ester 55 and amide coupling to NH2-DNA2/DNA3; a) NHS, DCC, 
THF, 0 °C - RT, 16 h, quantitative; b) DIPEA, DMF, 40 °C, 2 h; c) 25% NH3, 55 °C, 5 h.  
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 The yields of the coupling reaction could be improved when the reaction was performed 
at 40 °C, instead at ambient temperature. PE2 modified sequences DNA2 and DNA3 were 
deprotected and cleaved from the solid support using the 25% aqueous ammonia solution and 
obtained in yields of 35% and 40% respectively after HPLC purification. 
The amide coupling strategy via NHS ester was also used for the modification of 
oligonucleotides with photo-activatable tetrazole moiety (please refer to Section 1.4.4.2 for 
more details). Photo-induced reaction of tetrazole, namely 2,5-diphenyltetrazole, was for the 
first time reported in 1967 by Huisgen and co-workers. They described a cycloaddition reaction 
between 2,5-diphenyltetrazole and methyl crotonate upon UV irradiation.[128] The proposed 
mechanism involved a cycloreversion of 2,5-diphenyltetrazole upon irradiation, resulting in the 
release of nitrogen and the formation of intermediate nitrile imine dipole, which subsequently 
reacted with an alkene dipolarophile to afford the pyrazoline cycloadduct (Scheme 3.11). 
 
Scheme 3.11: Principle of the ight-induced nitrile imine-mediated tetrazole-ene cycloaddition (NITEC) 
between 2,5-substituted tetrazole 19 and alkene dipolarophile 20. 
This reaction was initially done in benzene. Decades later, Lin and co-workers further 
developed the nitrile imine-mediated tetrazole-ene cycloaddition (NITEC), which can be 
performed in aqueous solution,[131] and could be used for "stapling" of the peptide side 
chains,[167] for fast (≤1 min) and selective protein modification in biological media,[168] and 
investigation of the protein dynamics and function in live cells.[169] Recently, Arndt and 
co-workers prepared tetrazole modified DNA by phosphoramidite procedure and performed 
subsequent "photoclick" reaction with maleimide functionalized Cy®3 dye.[170] They introduced 
the photo-activatable tetrazole moiety at an internal oligonucleotide position by modifying 
nucleotides, which led to low yields of obtained cycloadducts, a result of the poor accessibility 
of the photo-reactive group. For our applications such approach is not suitable, as we aimed at 
designing surface immobilized DNA and require fast and high yielding reaction strategy. At 
the same time, we require 3’ or 5’ modification, for which amide coupling of amino terminated 
DNA is particularly suitable. To obtain tetrazole modified DNA, 4-(2-(4-methoxyphenyl)-2H-
tetrazol-5-yl)benzoic acid 24, which was shown to decrease the activation energy and allows 
the activation using UVA (≈ 320 nm) light, advantageous for biological applications, due to its 
lower damaging effect, was first synthesized.[136] The synthesis was performed using optimized 
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literature procedure in three steps resulting the tetrazole carboxylic acid 24 with 51% overall 
yield (Scheme 3.12).  
 
 
Scheme 3.12: Synthesis of tetrazole carboxylic acid 24; a) EtOH, reflux, 30 min, 81%; b) HCl, NaNO2, 
0 °C, H2O/EtOH (1:1, v/v); c) pyridine, -10 °C, 30 min, RT, 16 h, 62% (51% overall). 
The acid moiety was subsequently converted to NHS ester employing the DCC/NHS procedure 
and coupled with amino-terminated oligonucleotide bound to CPG (Scheme 3.13).  
 
 
 
Scheme 3.13: Synthesis of Tz-NHS ester 62 and amide coupling to NH2-DNA2; a) NHS, DCC, THF, 
0 °C - RT, 16 h, quantitative; b) DIPEA, DMF, RT, 2 h; c) 25% NH3, 55 °C, 5 h. 
After the cleavage and purification, tetrazole modified oligonucleotide 63 was obtained with 
yield of 44% and the product identity verified by MALDI-TOF mass spectrometry (Table 5.11). 
In conclusion, three different approaches were developed for the introduction of photo-
activatable moieties to DNA on solid support. First, phosphoramidite photoenol building 
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elements were synthesized, employing novel triethylene glycol bifunctional linker containing 
OH group to enable the photoenol modification. As phosphoramidite preparation was not 
successful for all photoenol precursors, due to the sensitivity of the reaction to oxidation during 
the purification steps, another more robust strategy employing H-phosphonates was explored, 
which resulted in preparation of the H-phosphonate photoenol derivative, successfully used to 
obtain photoenol modified oligonucleotide in high yield. Finally, to extend the toolbox of 
available methodologies and enable addition of wider variety of photo-activatable molecules, 
NHS esters of both photoenol and tetrazole were synthesized for modification of solid phase 
bound DNA through amide coupling. All three strategies have their advantages and 
disadvantages and could be used as complementary methods to apply to different moieties 
depending on the application and availability of the starting materials. Photoenol and tetrazole 
containing oligonucleotides were successful prepared and conditions and kinetics of the 
photo-induced cycloaddition will be discussed in the following section. 
  
3.2 Kinetic Study of Light-Induced Cycloaddition Reactions 
In order to investigate the ability and conditions, under which light-induced 
cycloaddition reaction can be used in future applications of DNA conjugation to biological 
molecules or surface structuring, it is important to thoroughly study the test reactions with 
smaller dienophiles. Reactions involving oligonucleotides require mild conditions in aqueous 
medium and therefore need to be carefully optimized. Protic solvents, such as water reduce the 
lifetime of reactive photoenol species, required for successful light-induced cycloaddition 
reaction.[122] However, Pauloehrl and co-workers reported the successful cycloaddition reaction 
between photoenol 30 and maleimide modified peptide in aqueous acetonitrile (phosphate 
buffer/acetonitrile (1:3), v/v) indicating that the reaction can be optimized by adjusting the ratio 
of aprotic to protic solvents and by allowing for a longer reaction time (2 h for water/acetonitrile 
mixture as compared to 15 min for pure acetonitrile).[126a] Another issue, which needs to be 
taken into account and might pose the critical obstacle is the use of UV irradiation 
(λmax = 317 nm) required for enolization process. Namely, UV light can be detrimental to the 
DNA.[171] In general, exposure to UV irradiation can damage DNA either by direct DNA 
excitation or indirect mechanisms involving excitation of other chromophores present in the 
DNA environment (for example chromophores such as quinone, flavin or porphyrin within the 
cells).[172] The direct excitation leads to the formation of cyclobutane pyrimidine dimers and 
other photoproducts, which are implicated in cytotoxic, carcinogenic and mutagenic effects of 
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UV-C and UV-B radiation.[173] The radiation at longer wavelengths (UV-A or visible light), 
which will not be significantly absorbed by DNA, can generate excited photosensitizers within 
the biological medium, which can in turn cause oxidation or breakage of the DNA strands either 
directly or through the intermediates such as singlet oxygen or other reactive oxygen 
species.[174] To minimize such effects, it is necessary to investigate the effect of irradiation on 
DNA, employed in presented studies. This was indeed done in Fruk group by irradiation of 
amino modified oligonucleotides by UV light (λmax = 320 nm) commonly used for 
photoactivation of o-methylbenzaldehyde.[127] Results obtained from gel electrophoresis and 
HPLC studies have shown that there is no significant damaging effect to short oligonucleotides 
used in our applications upon prolonged irradiation (up to 16 hours). In their study of UV 
damaging effect, Schreier and co-workers explored dimerization process for all-thymine (T) 
oligonucleotides by a femtosecond time-resolved infrared spectroscopy and could ascertain that 
the ultrafast photoreaction between two thymines (~1 picosecond) takes place if the bases are 
properly oriented at the time of light absorption.[175] However, oligonucleotides used in our 
work contain varied base sequence, ensuring the stability under UV irradiation. To make sure 
that significant amount of oxygen is removed from the solution, to minimize the possible 
generation of reactive species,[176] all of the reaction samples were deoxygenated by purging 
with argon prior to irradiation. The deoxygenation was also performed to avoid the reaction of 
photoenol intermediate 25 with oxygen and production of cyclic peroxide.[177] 
To confirm the previous results obtained in the group and ensure that there are no 
damaging effects of UV radiation, studies on non-modified and photoenol and tetrazole 
modified oligonucleotides were performed. In addition, kinetic studies of light-induced 
cycloaddition reaction between photoenol or tetrazole modified oligonucleotides and 
maleimide containing molecules were performed by HPLC, gel electrophoresis and ESI-MS. 
 
3.2.1 Light-Induced Cycloaddition of PE-DNA with the Model Maleimide 
To assess the reactivity of synthesized photoenol or tetrazole modified oligonucleotides, 
model reactions with dopamine maleimide Do-TEG-Mal 64, synthesized by Dr. Ishtiaq Ahmed, 
were performed. A solution of 1.00 eq. PE1-DNA1 48 and 4.00 eq. Do-TEG-Mal 64 in a 
mixture of water/acetonitrile (1:1, v/v) was deoxygenated with argon for 15 min and 
subsequently irradiated using a 320 nm light source for 16 hours (Scheme 3.14). 
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Scheme 3.14: Model photoreaction between PE1-DNA1 48 (1.00 eq.) and Do-TEG-Mal 64 (4.00 eq.); 
water/acetonitrile (1:1, v/v), 320 nm, RT, 16 h. 
Excess of 64 was removed by gel filtration. After reduction of solvent in vacuum, the reaction 
mixture was analyzed by HPLC (Figure 3.1). 
 
Figure 3.1: Overlay of HPLC chromatograms of PE1-DNA1 48 and photoreaction between 
PE1-DNA1 48 and Do-TEG-Mal 64.  
No cycloadduct was obtained, but new shoulder peaks were observed in irradiated 
samples. As their intensity or retention time did not change after prolonged irradiation (46h) 
and changed conditions, they were not investigated further. The reaction was also performed at 
different reaction conditions including decreased and increased amounts of maleimide 64 
(0.25 eq., 4.00 eq. and 50.0 eq.) and different solvent systems, such as water/DMSO (1:1) or 
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DMF, but no cycloadduct was detected. We attribute this to the effect of the protic solvent on 
the enolization process of PE1 derivative. However, when we used PE2 30, previously 
employed for modification of peptides,[126a] desired cycloadduct was identified. Using two 
different DNA sequences, PE2-DNA1 53 and PE2-DNA2 54 for light-induced addition of Do-
TEG-Mal 64 in water/acetonitrile (1:1, v/v) (λmax = 320 nm) respective cycloadducts 
(Scheme 3.15) could be obtained and characterized using MALDI-TOF and gel electrophoresis 
(Figure 3.2). 
 
 
 
Scheme 3.15: Model reaction between PE2-DNA1 53 or PE2-DNA2 54 and Do-TEG-Mal 64; 1.00 eq. 
PE2-DNA1 or PE2-DNA2, 1.00 eq. Do-TEG-Mal, water/acetonitrile (1:1, v/v), 320 nm, RT, 16 h.  
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Figure 3.2: Analysis of photoreaction between PE2-DNA2 54 and 64; a) HPLC chromatograms of 
PE2-DNA2 (P1) and photoreaction (P2); b) native PAGE analysis of photoreaction, DM: 10 bp DNA 
marker, I: DNA2 , II: PE2-DNA2 , III: cycloadduct 67; gel conditions: 21% polyacrylamide, 100 V, 2 h, 
running buffer: 1×TBE, SYBR Gold staining. 
As it can be seen from the overlay of HPLC chromatograms (Figure 3.2a), new peak at 
the retention time of 25.7 (P 2, 35%) can be detected, which was assigned to cycloadduct 67 by 
MALDI-TOF mass spectrometry (Table 5.12). The chromatogram section between 16 and 
25 min contains residues of starting PE2-DNA2 54 and new additional peaks, which were not 
present in the control reactions with non-modified oligonucleotide (Figure 3.3a, II) or when 
reaction is performed in dark (Figure 3.3a, IV). 
 
 
Figure 3.3: HPLC chromatograms of control  reactions; a) I: DNA2 only; II: DNA2 irradiated with 
Do-TEG-Mal 64 at 320 nm for 16 h; III: PE2-DNA2 54 only; IV: PE2-DNA2 54 incubated with Do-
TEG-Mal  for 16 h in the dark; b) I: PE2-DNA2 54 without irradiation , II: PE2-DNA2 54 after 
irradiation with 320 nm light for 16 h.   
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However, upon irradiation of PE2-DNA2 54 in the absence of any other reagents (Figure 3.3b, 
II), additional peaks, indicating the presence of side products, can clearly be observed. We 
attribute these side products to the intramolecular interactions most probably between 
photoenol moiety and double bonds within nucleobases, although due to the time constrains the 
side reactions have not been further investigated at this point. Gel electrophoresis analysis of 
cycloadduct in comparison to non modified DNA2 and PE2-DNA2 54 was additionally 
performed. As it can be seen in Figure 3.2b, the electrophoretic mobility of oligonucleotides 
decreases for cycloadduct (lane III) in comparison with DNA2 (I) and PE2-DNA2 54 (II) due 
to the change in molecular weight. Additional band with decreased electrophoretic mobility can 
be observed in lanes II and III, which can be attributed to a dimer formation (ca. 50 bp), a 
common effect observed in short DNA sequences cleaved from the solid support. It should be 
noted that the dimer band is also present in the lane I corresponding to a commercial, 
unmodified DNA, although at much lower intensity due to the extensive purification. As an 
additional confirmation of the dimer hypothesis, the electrophoretic mobility of this band 
remains same in all samples indicating that there is no hindering functional group present, 
which could impair the reaction.  
To investigate whether the change of the DNA sequence influence the outcome of the 
reactions, PE2-DNA1 53 was allowed to react with model maleimide under the same conditions 
and the results are shown in Figure 3.4.  
 
 
Figure 3.4: Analysis of photoreaction between PE2-DNA1 53 and 64; a) HPLC chromatograms of 
PE2-DNA1 (P1) and of photoreaction (P2); b) native PAGE analysis of photoreaction, DM: 10 bp DNA 
marker, I: cycloadduct 66, II: PE2-DNA1, III: DNA1; gel conditions: 21% polyacrylamide, 100 V, 
1.5 h, running buffer: 1×TBE, SYBR Gold staining. 
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As it can be seen, cycloaddition proceeds with high yield of product formation (P2, 93%) and 
negligible amount (7%) of side products (region between 15−25 min). Control reactions 
(Figure 3.5) show trends similar to PE2-DNA2 54 reaction. Larger amount of side product is 
formed upon irradiation of PE2-DNA1 53 without the presence of maleimide, indicating the 
intramolecular reaction.  
 
Figure 3.5: HPLC chromatograms of control reactions; a) I: DNA1 only; II: DNA1 and Do-TEG-Mal 64 
irradiated at 320 nm for 16 h, III: PE2-DNA1 53 only, IV: PE2-DNA1 53  incubated with Do-TEG-
Mal 64  for 16 h in the dark; b) I: PE2-DNA1 53 only, II: PE2-DNA1 53 irradiated at 320 nm for 16 h. 
Gel electrophoresis (Figure 3.4b) confirms the presence of cycloadduct of higher molecular 
weight (low mobility, lane I) after irradiation. Unlike for DNA2, additional peak, which can be 
attributed to a dimer, is present only in the lane containing PE2-DNA1 53 (lane 2), most 
probably due to the limitation of the HPLC purification of shorter oligonucleotides (DNA1 
contains 12 bases as compared to DNA2 with 22 bases). 
 
3.2.2 Photoenol- vs. Tetrazole-DNA Photoreaction with Model Maleimide 
In order to assess the rate of reaction as well as the suitability of light-induced 
cycloadditions for DNA modification and conjugation, model reactions with maleimide were 
performed under same conditions using both PE2-DNA2 56 and 64 and Tz-DNA2 63 and 64 
(Scheme 3.16). In such way, direct comparison of the kinetic parameters and yields could be 
obtained and most suitable reaction employed in further applications.  Photo-induced 
cycloadditions were performed using equimolar quantities of reagents in water/DMSO mixture 
(3:2, v/v) under irradiation with a 320 nm light source for 2 h. DMSO was employed for the 
photoreactions instead of acetonitrile, as it has a lower vapor pressure and thus, ensures a slower 
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evaporation under irradiation of small volumes, which is an important requirement for DNA 
structuring applications where small volumes of reagents are required.  
 
 
Scheme 3.16: Model photoreaction between a) PE2-DNA2 56 or b) Tz-DNA2 63 and Do-TEG-Mal 64 
studied to obtain kinetic parameters. 1.00 eq. 56 or 63 and 1.00 eq. 64 respectively, solvent: 
water/DMSO (3:2, v/v), irradiation at 320 nm, RT, 2 h. 
The reaction mixtures were worked up as described in previous section and purified by 
HPLC. PE2-DNA2 cycloadduct 68 was obtained and characterized as discussed in 
Section 3.2.1. The HPLC chromatogram of the photoreaction of tetrazole modified DNA2 63 
and maleimide is shown in Figure 3.6. Several distinct peaks can be observed. Peak P4 with 
retention time of 26.1 min (22% yield) was assigned to the expected cycloadduct 69 by 
MALDI-TOF mass spectrometry (Table 5.13).  
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Figure 3.6: HPLC chromatogram of Tz-DNA2 63 (1.00 eq.) and model reaction with maleimide 64 
(1.00 eq). 
Peaks P1 (16.2 min), P2 (around 17.4) and P3 (20.4) correspond to the side products of 
irradiation of Tz-DNA2 63 with UV light. Attempt was made to decipher the possible products, 
however the analysis of the peaks P1 and P2 by MALDI-TOF has shown that a species with 
m/z ratio of 7218 g/mol is present which does not correspond to the starting material 63 
(m/z = 7349) nor any literature deduced side product and due to the time constrains was not 
analyzed further. However, the reaction conditions were optimized to minimize or fully remove 
the occurrence of the side products. To achieve that photoreactions were tested using different 
amounts of maleimide and different irradiation times. First, 15.0 eq. of maleimide 
dienophile 64 were added to the solution of PE2-DNA2 56 and Tz-DNA2 63 and irradiated 
with 320 nm light source for 3 hours and the reaction mixtures ware analyzed by HPLC and gel 
electrophoresis (Figure 3.7). 
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Figure 3.7: Photoreaction of PE2-DNA2 56 (a, c) and Tz-DNA2 63 (b, d) with 15.0 eq. of 
Do-TEG-Mal 64 under 320 nm irradiation for 3 h. HPLC chromatograms of PE2-DNA2 (a) and 
Tz-DNA2 (b) show I: PE2-DNA2 or Tz-DNA2 only; II: photoreaction; III: photoreaction after 3 h 
incubation in the dark; IV: irradiation of PE2-DNA2 and Tz-DNA2 without maleimide; c) and d) 
correspond to the gel electrophoretic analysis of the PE2-DNA2 and Tz-DNA2 photoreactions 
respectively. DM: 10 bp DNA marker, gel conditions: 21% polyacrylamide, 100 V, 2 h, running buffer: 
1×TBE, SYBR Gold staining. 
HPLC chromatograms of both photoreactions in the presence of 15.0 eq. of 
maleimide 64 as well as the control reactions show trends, already described for equimolar 
reactions. However, it can be observed that use of larger amount of dienophile minimizes the 
appearance of the side products (16−25 min region, see Figure 3.2 in Section 3.2.1), indicating 
that the photoreaction is strongly preferred in the presence of an excess of dienophile 64. 
Controls, incubated in the dark, do not show any cycloadduct presence, while the irradiation of 
DNA, containing photo-activatable groups, indicates the presence of internal cycloaddition 
products discussed previously. Two peaks (Figure 3.7b, II) and corresponding two bands 
(Figure 3.7d, II) are observed in HPLC and gels respectively, after photoreaction of 
Tz-DNA2 63 with excess maleimide 64. In addition to the cycloadduct 69, the band II contains 
a band with higher electrophoretic mobility also present in lane IV corresponding to the side 
product of Tz-DNA2 63 irradiation. This indicates that both maleimide cycloaddition and 
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internal photo-induced side reaction occur within the irradiated reagent mixture. No reaction 
takes place when the reaction mixture is kept in dark confirming that the presence of the light 
source is a crucial requirement.  
In order to determine the optimal dienophile amount and irradiation time, the kinetic 
studies of PE2-DNA2 56 and Tz-DNA2 63 reactions with 5.00 eq. and 15.0 eq. dienophile 64 
were performed. The solutions were mixed and the analysis of the reaction mixture performed 
after specific intervals of irradiation (0 min, 15 min, 30 min ,1 h and 3 h). Comparison of HPLC 
chromatograms (Figure 3.8a, b) of reactions with different amounts of dienophile shows that in 
both cases the reactions are completed after 15 min irradiation, though around 16% reactant 
remained non-reacted. The reaction mixtures were additionally analyzed by ESI mass 
spectrometry, resulting in spectra of 4-, 5-, 6- and 7-fold charged ions assigned to reactant 56, 
and photoadduct 68. The abundance ratios of the ions confirms the results obtained by HPLC 
analysis. The amount of non-reacted PE2-DNA2 56 is approximately 16% in both reactions 
and does not decrease with prolonged irradiation time. 
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Figure 3.8: Kinetic study of the photoreaction between PE2-DNA2 56 and Do-TEG-Mal 64. HPLC 
chromatograms and ESI-MS data for 5.00 eq. (a, c) and 15.0 eq. (b, d) Do-TEG-Mal 64. Irradiation was 
performed with a 320 nm light sources for 0 min, 15 min, 30 min, 1 h and 3 h. 
Increasing the amount of dienophile to 100 eq. did not further improve the reaction yield, as 
confirmed by HPLC analysis (Figure 3.9).  
 
 
Figure 3.9: HPLC chromatograms of PE2-DNA2 56 (P1) and photoreaction between 56 and 100 eq. 
Do-TEG-Mal 64 (P2). 
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To get more insight into the kinetics of the photoenol-DNA reaction, more detailed study was 
performed using ESI-MS (Figure 3.10). 
 
 
Figure 3.10: ESI-MS spectra (top) and the kinetic plots derived from the integration of the 
corresponding mass spectra (bottom) for photoreaction of PE2-DNA2 56 with a) 5.00 eq. and b) 15.0 eq. 
of Do-TEG-Mal 64 at different irradiation times with 320 nm light.   
The mass spectra in Figure 3.10 (top) show 5-fold and 6-fold charged ions of reactant 
with m/z = 1467.2625 and m/z = 1222.5521, and of photoadduct with m/z = 1567.0983 and 
m/z = 1301.9206 (determined by the most abundant isotopes of the isotopic patterns). 
indicating that the reaction is completed by 10 min irradiation. Approximately 16% of 
non-reacted 56 is still present after the reaction and this does not change with the time of 
irradiation, as already observed in HPLC. Kinetic plots (Figure 3.10, bottom), obtained by 
integration of the mass spectra peaks and plotting the percentage values as a function of time, 
indicate excellent agreement of the experimental data points with an exponential fit for both 
5.00 eq. or 15.0 eq. reactions pointing out towards pseudo first-order kinetics. 
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Figure 3.11: Expansion of the ESI mass spectrum region (bottom) and comparison between 
experimental and simulated data (top) for a) reactant 56 (m/z range: 1221.9 - 1224.0) and b) 
photoadduct 68 (m/z range: 1301.50 - 1303.0).   
In addition, detailed analysis of the isotopic pattern of the most abundant isotopes of 
reactant and of the product and the comparison to their simulated isotopic pattern (Figure 3.11) 
provides unambiguous evidence for the successful generation of the desired cycloadduct. 
Furthermore, experimentally obtained m/z values of the reactant 56 and photoadduct 68 and 
their sodium adducts are in excellent agreement with the theoretically calculated, expected 
exact mass values (∆ m/z < 0.0100, Table 3.2). 
 
Table 3.2: Peak assignment of the ESI mass spectra of reactant 56 from m/z = 1218.0 to m/z = 1263.0 
(a−e) and photoadduct 68 from m/z = 1297.0 to m/z = 1328.0 (a'−e'). Peak labels correspond to the 
spectra shown in Figure 3.11. Both experimental and theoretical m/z values and their differences (∆m/z) 
are shown.   
Ion assignment Sum formula m/zexpt m/ztheor ∆ m/z 
a [C240H289N95O133P22]
6+ 1218.8905 1218.8841 0.0064 
b [C240H288NaN95O133P22]
6+ 1222.5521 1222.5477 0.0044 
c [C240H287Na2N95O133P22]
6+ 1226.2140 1226.2114 0.0026 
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d [C240H286Na3N95O133P22]
6+ 1229.8765 1229.8750 0.0015 
e [C240H285Na4N95O133P22]
6+ 1233.5382 1233.5387 0.0005 
a' [C264H321N97O141P22]
6+ 1298.2589 1298.2534 0.0055 
b' [C264H320NaN97O141P22]
6+ 1301.9206 1301.9171 0.0035 
c' [C264H320Na2N97O141P22]
6+ 1305.7491 1305.7487 0.0004 
d' [C264H319Na3N97O141P22]
6+ 1309.4111 1309.4123 0.0012 
e' [C264H318Na4N97O141P22]
6+ 1313.0731 1313.0760 0.0029 
 
Kinetic study of the photoreaction between Tz-DNA2 63 and Do-TEG-Mal 64 was 
performed in a same manner as described above using 5.00 eq. or 15.0 eq. of dienophile 64 in 
water/DMSO (3:2, v/v) and irradiation for 0 min, 15 min, 30 min, 1 h and 6 h or 3 h, followed 
by purification by HPLC and MS characterization (Figure 3.12a-d).  
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Figure 3.12: Kinetic study of the photoreaction between Tz-DNA2 63 and 5.00 eq. (a, c) and 15.0 eq. 
(b, d) of Do-TEG-Mal 64  using HPLC (top) and ESI-MS mass spectrometry (bottom) at different 
irradiation time.   
The HPLC analysis of the photoreaction (Figure 3.12a, b) indicates that the reaction is 
completed after 30 min for both 5.00 eq. and 15.0 eq. dienophile 64, which is longer than in the 
case of PE2-DNA2 56. However, when 5.00 eq. of dienophile is added, side products (SP) 
(70%), represented by the fractions with a retention times of 15.5 min and 16.7 min, were 
mainly detected with merely 14% photoadduct 69 (the fraction at t = 26.0 min). With the 
increase of the dienophile amount to 15.0 eq. more photoadduct is obtained (80%) as compared 
to 17% of the side products, indicating the product promoting effect of the increased equivalents 
of dienophile. The reactions were also analyzed by ESI mass spectrometry, resulting in mass 
spectra (Figure 3.12c and d) with 4-, 5-, 6- and 7-fold charged ions, assigned to reactant 63, 
photoadduct 69 and additional unidentified species, most probably the side products, which 
prevail in reaction mixture, containing 5.00 eq. of dienophile 64 and are considerably reduced 
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for 15.0 eq. 64. Attempt was made to decrease the amount of the side products and the amount 
of dienophile increased to 100 eq., but this did not change the overall outcome (Figure 3.13). 
 
 
Figure 3.13: HPLC chromatograms of the reaction between Tz-DNA2 63 and 100 eq. dienophile 64 
after 0 min, 5 h and 24 h irradiation. 
When irradiation time was increased to 24 h (Figure 3.13), it was observed that 
prolonged irradiation resulted in appearance of additional side products (t = 14.4 min and 
22.8 min), probably stemming from the UV caused damage or species present in the reactions 
mixture. As such long irradiation times will not be used for further applications, but the 
experiment was performed out of scientific curiosity, these newly formed side products were 
not investigated further.  
Detailed kinetic analysis by ESI-MS (Figure 3.14, top) showed the same trend as 
observed above, namely that the amount of side product is significantly increased when smaller 
amounts of dienophile is present (17% for 5.00 eq.), but only 5% is present for 15.0 or more 
equivalents, indicating that the larger amounts of dienophiles should be used in case of 
Tz-DNA2 63. This is unlike PE2-DNA2 56 reaction where there is no significant increase in 
the cycloadduct yield upon the addition of 15.0 eq. of dienophile 64 and no side products are 
present in significant amount. Previous photoreaction of Tz-DNA2 63 with 5.00 eq. 
dienophile 64 resulted almost exclusively side product, as determined by peak integration of 
HPLC spectra. In this case, however, the integration of undefined peaks from ESI mass spectra 
resulted a value of 17%. The difference can be attributed to the inaccuracy in the preparation 
of dienophile solution (caused by weighing), which was always freshly prepared in small 
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amounts. However, it should be noted, that for the dienophile amount ≥ 15.0 eq. the 
photoreaction is strongly preferred.  
 
 
Figure 3.14: ESI-MS spectra (top) and the kinetic plots derived from the integration of the 
corresponding mass spectra (bottom) for photoreaction of Tz-DNA2 63 with a) 5.00 eq. and b) 15.0 eq. 
of Do-TEG-Mal 64 at different irradiation times with 320 nm light.   
Figure 3.14 (bottom) shows the plots of integrated MS peak values as a function of 
irradiation time, indicating the reaction completions after 30 min. The experimental data points 
show an excellent agreement with an exponential fit for both reactions with 5.00 eq. or 15.0 eq. 
dienophile 64. 
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Figure 3.15: Expansion of the ESI mass spectrum region (bottom) and comparison between 
experimental and simulated data (top) for a) Tz-DNA2 63 (m/z range: 1226.3 - 1228.3) and b) 
photoadduct 69 (m/z range: 1301.0 - 1303.0).   
The detailed analysis of the isotopic pattern (Figure 3.15, bottom) of the most abundant 
isotopes of Tz-DNA2 63 (m/z range of 1222.5 - 1256.0) and photoadduct 69 (m/z range of 
1296.0 - 1331.0) and the comparison to their simulated isotopic pattern (Figure 3.15, top) 
provides evidence for the successful generation of the desired cycloadduct. Furthermore, 
experimentally obtained m/z values of the reactant 63 and photoadduct 69 and their sodium 
adducts are in excellent agreement with the theoretically calculated, expected exact mass values 
(∆ m/z < 0.0100, Table 3.3). 
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Table 3.3: Peak assignment of the ESI mass spectra of reactant 63 from m/z = 1222.5 to m/z = 1235.5 
(a - d) and photoadduct 69 from m/z = 1296.0 to m/z = 1311.0 (a' - d'). Peak labels correspond to the 
spectra shown in Figure 3.15. Both experimental and theoretical m/z values and their differences (∆m/z) 
are shown.  
Ion assignment Sum formula m/zexpt m/ztheor ∆ m/z 
a [C239H287N99O132P22]
6+ 1223.2224 1223.2177 0.0047 
b [C239H286NaN99O132P22]
6+ 1226.8839 1226.8813 0.0026 
c [C239H285Na2N99O132P22]
6+ 1230.5456 1230.5450 0.0006 
d [C239H284Na3N99O132P22]
6+ 1234.2080 1234.2086 0.0006 
a' [C263H319N99O140P22]
6+ 1297.9250 1297.9193 0.0057 
b' [C263H318NaN99O140P22]
6+ 1301.5863 1301.5830 0.0033 
c' [C263H317Na2N99O140P22]
6+ 1305.2482 1305.2466 0.0016 
d' [C263H316Na3N99O140P22]
6+ 1308.9107 1308.9103 0.0004 
 
Photoreactions of oligonucleotides labeled with two photo-activatable groups 
(PE2-DNA2 56 and Tz-DNA2 63) were thoroughly studied using HPLC chromatography, gel 
electrophoresis and ESI-MS to optimize the reactions conditions, explore existence of the side 
products and get insight into the kinetics, in particular the most suitable equivalents of reagents 
and reaction time to obtain desired cycloadduct. Reactions using PE1 derivative were not 
successful due to the disfavored photoenolization process in aqueous (protic) media and this 
derivative was not further explored. Photoreactions employing PE2 modified oligonucleotides 
resulted in photoadducts obtained in good yields (35% for 1.00 eq. of dienophile), and the yields 
could be additionally improved by increasing the dienophile amount to 5.00 eq. (84%). Side 
products were observed only when starting PE2-DNA2 is irradiated by UV light in absence of 
dienophile, indicating a possible intramolecular cyclization. However, side product is not 
present in the significant amount when dienophile is added, indicating the preference for the 
photocyclization reaction. In contrast, side products can be detected when photoreaction with 
Tz-DNA2 is performed, although the amount decreases with addition of more dienophile (more 
than 15.0 eq.). Detailed ESI-MS and HPLC study also showed that photoenol reaction is faster 
(completion at 10 min) as compared to tetrazole (completion at 30 min), in which the side 
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products are not eliminated by either the addition of dienophile excess or prolonged irradiation 
time. According to the insights, gained from this study, PE2 modified oligonucleotide 56 
represent the most appropriate reagent for the light-induced cycloaddition reactions, as 
confirmed by its use in different applications, such as light triggered DNA conjugation 
presented in the following chapter.  
 
3.3 Photoenol Modified Oligonucleotides in DNA Bioconjugation 
and Structuring 
 
3.3.1 Light-Induced Conjugation of PE2-DNA2 54 to Horseradish 
Peroxidase (HRP) 
Conjugation of artificial oligonucleotides with proteins provides multifunctional 
constructs for the applications in bionanotechnology. Such construct have both the intrinsic 
functions of proteins, which can vary from catalysis[178] and signaling and small molecule 
transfer[179] to structuring[180] and highly specific structural addressability of DNA, due to the 
Watson-Crick base pairing. Variety of synthetic strategies were developed for the covalent and 
non-covalent conjugation of the nucleic acids and proteins.[11c] This section presents the use of 
previously described light-induced conjugation for oligonucleotides, which was for the first 
time demonstrated by our group by two independent studies employing different proteins, 
myoglobin and horseradish peroxidase, presented herewith.[127] 
Horseradish peroxidase (HRP, Figure 3.17a) is biotechnologically very important 
protein and one of the most potent peroxidases, used in various assays and biosensing 
applications.[181] Taking into account its significance, it is not surprising that various methods 
have been published to enable its conjugation and we have attempted to extend the chemical 
toolbox by exploring light-induced cycloaddition methodology. Although it was shown, that 
the irradiation with UV light, necessary to cause the light-induced coupling, does not affect the 
structure and function of DNA, native structure of proteins has been reported to be more 
sensitive.[182] Therefore, prior to light-induced coupling of PE2-DNA2 54, the study of HRP 
under UV light irradiation was performed. A solution of HRP in PBS/acetonitrile (3:2, v/v) was 
deoxygenated by purging with argon and irradiated under UV lamp (λmax = 320 nm) at ambient 
temperature for 16 hours. After buffer exchange by gel filtration columns, solution was 
analyzed by denaturing polyacrylamide gel electrophoresis (sodium dodecyl sulfate 
polyacrylamide gel electrophoresis, SDS-PAGE) shown in Figure 3.16. 
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Figure 3.16: SDS-PAGE characterization of irradiated horseradish peroxidase HRP* in comparison to 
non-irradiated HRP. Conditions: 12% SDS-PAGE; Running buffer: 1xSDS-running buffer; Voltage: 
30 min at 80 V, 1 h at 100 V; Staining: silver staining; Loading: 25.0 pmol; PM: protein marker 
(Precision Plus Protein Dual Xtra Standards, BioRad). 
Both samples (irradiated HRP* and non-irradiated HRP) show the same electrophoretic 
mobility (bands between 37 kDa and 50 kDa) and no additional bands for irradiated HRP* 
could be detected, indicating that there is no significant structural damage of the protein under 
used irradiation conditions. Consequently, HRP could be employed in the light-induced 
cycloaddition reaction. HRP, like any other native protein, does not contain natural dienophile 
groups and to enable [4+2] photocycloaddition reaction with PE2-DNA2 54, must first be 
modified with dienophile moiety. This can be achieved using heterobifunctional linker 
sulfosuccinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate 70 (sSMCC) 
(Figure 3.17b), which selectively reacts with lysine residues on the protein surface.[183] 
 
 
Figure 3.17: a) HRP structure with lysine moieties (black sticks); graphics was created using a software 
UCSF Chimera 1.11rc and 1W4W data from the protein data bank; b) modification of lysine moieties 
of HRP with sSMCC 70. 
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To achieve the amide coupling, 33.2 nmol HRP in PBS buffer (pH = 6.0) were 
incubated with 2.00 mg sSMCC in DMF for 1 hour at ambient temperature. Excess sSMCC 
removed by gel filtration and the maleimide functionalized HRP was directly employed in a 
light-induced conjugation with PE2-DNA2 54 (Scheme 3.17). 
 
Scheme 3.17: Light-induced conjugation of PE2-DNA2 54 and maleimide functionalized HRP 
(HRP-Mal); PBS/acetonitrile (3:2, v/v), λmax = 320 nm, 16 h, RT. 
For the photoreaction a mixture of 2.00 nmol PE2-DNA2 54 and 2.20 nmol of fresh 
prepared HRP-Mal in 500 µL of PBS/CH3CN solution (3:2, v/v) was deoxygenated by purging 
with argon for 15 minutes and subsequently irradiated under UV lamp (λmax = 320 nm) at 
ambient temperature, followed by chromatographic purification using fast protein liquid 
chromatography (FPLC). The collected fractions F1 and F2 exhibit the absorption at 260 nm 
and 403 nm, which are characteristic of DNA and HRP respectively (Figure 3.18a).[184] Fraction 
F3, which contains several peaks, shows absorption exclusively at 260 nm, which is typically 
for DNA[185] and most probably represents non-reacted PE2-DNA2 54 and related side 
products. Characterization of the collected fractions was performed by native PAGE (12.5% 
PA gel, 30 min at 80 V, 90 min at 100 V in tris/glycin running buffer, Figure 3.18 b) using 
SYBRGold® staining for oligonucleotides and silver staining for HRP. Bands responding 
positively to both staining strategies contain HRP-DNA2 conjugates.  
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Figure 3.18: a) FPLC chromatogram of HRP-DNA2 conjugate purification; absorption detection at 
260 nm (black curve) and 403 nm (red curve); b) native PAGE characterization of the FPLC fractions 
F1, F2 and F3 in comparison to PE2-DNA2 54, HRP and HRP-Mal; DM: 10 bp DNA marker; 
oligonucleotide and protein band visualization by SYBRGold® and silver staining respectively. 
As it can be seen in Figure 3.18b, F1 fraction contains only HPR moiety and has the 
same electrophoretic mobility as HRP-Mal indicating that non reacted HRP-Mal is present in 
this fraction. Band F2 was assigned to HRP-DNA2 conjugate, as it shows the higher 
electrophoretic mobility in comparison to non-modified HRP or HRP-Mal, due to the increased 
negative charge after the coupling to PE2-DNA2 54. Additionally, it could be stained by both 
SYBRGold® and silver staining methods, confirming the presence of both DNA and protein. 
Beside the main product additional band with a lower electrophoretic mobility, similar to 
HRP-Mal, was detected in F2, indicating that small amount of residual HRP-Mal, which could 
not be separated from the main product, due to the chosen conditions is isolated together with 
the main product. Choice of different purification conditions could allow for better separation 
of both fractions. However, this was not an important requirement for this study and the product 
was used, as obtained from single FPLC purification. Band F3 shows the same electrophoretic 
mobility as PE2-DNA2 54 and could be visualized exclusively by SYBRGold®, therefore it can 
be assigned to the non-reacted PE2-DNA2 54. 
In order to explore the selectivity of the photoreaction, a number of control reactions 
was performed, such as the incubation of PE2-DNA2 54 and HRP-Mal in the dark 
(Figure 3.19 a), irradiation of PE2-DNA2 54 and non-modified HRP (Figure 3.19 b) alone, 
irradiation of non-modified DNA2 and HRP-Mal (Figure 3.19 c) and irradiation of non-
modified DNA2 and non-modified HRP (Figure 3.19 d). The reactions were performed at the 
same reaction conditions as those used in previously described photoreaction (Scheme 3.17). 
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Figure 3.19: FPLC chromatograms of control reactions: a) incubation of PE2-DNA2 54  and HRP-Mal 
for 16 h in the dark; b) irradiation of PE2-DNA2 54 and HRP for 16 h at 320 nm; c) irradiation of DNA2 
and HRP-Mal for 16 h at 320 nm; d) irradiation of DNA2 and HRP for 16 h at 320 nm. The black curve 
represents the absorption at 260 nm (DNA) and the red curve the absorption at 403 nm (HRP). 
In case of the irradiation of non-modified HRP with PE2-DNA2 54, an insignificant 
amount of conjugate HRP-DNA2 was obtained, indicating, that a low yielding side reaction 
occurs between a photoenol moiety and amino acids of the protein. Recently, Siti and 
colleagues described the formation of the conjugation product when PEG-tetrazole is irradiated 
with native HRP and other proteins.[186] Further investigations revealed that the light-induced 
cycloaddition reaction occurs exclusively with proteins/peptides containing tryptophan residue. 
Presumably, the side product in our case results from the reaction between tryptophan residue 
of HRP and photoenol moiety of PE2-DNA2 54. Due to very low amounts of side product 
(Figure 3.19b), isolation was not possible to enable instrumental analysis at this point and it 
was not further investigated.  
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Figure 3.20: FPLC chromatograms of HRP-DNA2 obtained in the photoreaction between 
PE2-DNA2 54 and HRP-Mal (black curve) and of the side product obtained after irradiation of 
PE2-DNA2 54 and HRP (red curve). 
The absence of HRP-DNA2 conjugate in other control reactions indicates the high 
specificity of the light-induced cycloaddition reaction between photoenol and maleimide 
modified biomolecules.   
In order to explore if the inherent functions of DNA and HRP are preserved in the 
HRP-DNA2 conjugate, the hybridization ability of DNA, which is crucial for the DNA directed 
immobilization (DDI), as well as catalytic activity of HRP were tested. For the hybridization 
ability tests, purified HRP-DNA2 conjugate was incubated with a 10-fold excess of 
complementary oligonucleotide cDNA2 and, additionally, with a fluorescein labeled 
complementary strand 6-FAM-cDNA2 in a tris/EDTA/NaCl hybridization buffer. The reaction 
was performed for 16 hours at ambient temperature and subsequently analyzed by 12.5% 
polyacrylamide gel electrophoresis (Figure 3.21). 
 
 
Figure 3.21: Native PAGE analysis of hybridization of HRP-DNA2 with complementary strands 
cDNA2 and 6-FAM-cDNA2, DM: 1kb DNA-marker, I: native HRP; II: control reaction 
(HRP+DNA2+cDNA2), III: HRP-DNA2 conjugate, IV: HRP-DNA2+cDNA2, V: control reaction 
(HRP+DNA2+6-FAM-cDNA2), VI: HRP-DNA2+6-FAM-cDNA2; Conditions: 12.5% PAGE; 
Running buffer: tris/glycine; Voltage: 30 min at 80 V, 90 min at 100 V; Loading: 25.0 pmol; DM: 1kb 
DNA marker; Visualization: UV irradiation, ethidium bromide and silver staining. 
Results and Discussion 
71 
 
For the visualization of bands, UV irradiation, ethidium bromide and silver staining 
were performed. For the control reactions non-modified HRP was incubated with 
PE2-DNA2 54 and cDNA2 or 6-FAM-cDNA2. The resulted gel was first analyzed under UV 
irradiation, which allows the detection of 6-FAM-cDNA2. Subsequently, the gel was stained 
with ethidium bromide in order to visualize the hybridized strands and finally silver staining 
was performed for the protein staining. As it can be seen in Figure 3.21, only the bands in 
lane IV and VI, which were loaded with hybridized samples, could be visualized with all three 
methods confirming the successful hybridization of HRP-DNA2 conjugate and preservation of 
the inherent DNA function.  
In order to assess the peroxidase activity of the HRP-DNA2 conjugate, Amplex®Red 
assay was employed. Amplex®Red assay relies on HRP mediated transformation of colorless 
non-fluorescent Amplex Red (N-acetyl-3,7-dihydroxyphenoxazine) to pink, highly fluorescent 
resorufin (λex = 530 nm, λem = 590 nm) in presence of H2O2 (Figure 3.22 a). 
 
 
Figure 3.22: a) Principle of the peroxidase activity assay using Amplex Red and HRP in the presence 
of H2O2; b) the average of fluorescence intensity as a function of time after 0 min, 30 min and 60 min 
reaction duration obtained by Amplex®Red assay using native HRP (blue bar) or HRP-DNA2 conjugate 
(red bar). 
The fluorescence signal intensity of the product was measured as a function of time and 
used as the confirmation of HRP activity, as the reaction does not proceed without the presence 
of the protein. Five measurements were performed for each sample of non-modified HRP and 
HRP-DNA2 conjugate over a period of one hour. The fluorescence intensity obtained in the 
presence of native HRP (blue bar) and HRP-DNA2 conjugate (red bar) is shown in 
Figure 3.22b. There is no difference in the intensity when both species are compared, indicating 
the high peroxidase activity of the conjugate, which is not affected by presence of conjugated 
DNA.  
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In conclusion, the light-induced conjugation strategy could successfully be applied for 
the conjugation of the photoenol modified oligonucleotide to a maleimide containing proteins 
such as horseradish peroxidase. After conjugation, the inherent functions of both DNA 
(hybridization ability) and HPR (enzymatic activity) were preserved, as shown by hybridization 
tests and Amplex®Red peroxidase activity assay. Successful conjugation of photoenol modified 
oligonucleotides to HRP inspired us to employ this mild and easily controllable reaction for 
modification of another class of catalysts, namely inorganic nanoparticles, which are playing 
increasing role in various applications beyond material design. Following section addresses the 
use of the light-induced reaction for the conjugation of maleimide functionalized copper 
nanoparticles with PE2-DNA2 54. 
 
3.3.2 Light-Induced Biofunctionalization of Maleimide Coated Copper 
Nanoparticles 
Functionalization of nanoparticles with biomolecules such as DNA, allows for the use 
of such composites in variety of applications. They can be employed as building blocks for 
nano-assembly or drug delivery vectors, structure design and the development of sensors and 
nanodevices[187] as they possess both the recognition property of DNA and the unique optical, 
magnetic, electronic, mechanical and chemical properties of nanomaterials.[188] Among DNA 
conjugated nanomaterials, gold nanoparticles (Au NPs) are best characterized and most widely 
used for various applications.[189] In contrast, DNA conjugates with copper nanoparticles (Cu 
NPs) have not been yet reported, although Cu NPs have a range of highly desirable electronic 
and catalytic properties. Recently, double stranded DNA was utilized as a template for the 
synthesis of Cu- NPs,[190] but the surface of Cu NPs has rarely been functionalized, most 
probably due to the inherent instability of Cu under ambient conditions and its oxidation, which 
changes the properties of nanomaterials. In the last decades, Cu NPs became more attractive to 
the science community because of their fascinating properties such as high catalytic activity, 
high conductivity and optical properties,[191] but also because of the high natural abundance and 
low costs of copper. Till now, Cu NPs have been shown to be able to generate reactive oxygen 
species (ROS), which can be employed for the activation of HRP, [192] and have shown a 
potential in design of catalysts,[193] antibacterial materials,[194] electronic materials[195] and 
sensors.[196] All of these prompted researchers to develop methods for the preparation of stable 
Cu and Cu-based nanomaterials.[193] However, there is still a lack of synthetic procedures for 
modification of Cu NP surface, in particular attachment of biomolecular species such as 
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oligonucleotides, which could be, for instance, used for assembly of novel catalytic or 
optoelectronic platforms. Within this section, the use of light-induced cycloaddition reaction in 
design of DNA-Cu NPs is presented and discussed. 
Originally, a strategy was developed within our group (by Dr. Cheng Chen) to prepare 
stable maleimide functionalized Cu NPs by employing catechol containing dopamine-based 
linkers.[192] Using dopamine based linkers, several different dopamine derivatives were 
employed in addition to dopamine-maleimide. Of those, we have decided to use 
dopamine/maleimide, containing triethylene glycol group (Do-TEG-Mal 71, prepared by Dr. 
Ishtiaq Ahmed) to minimize the steric hindrance on the surface, for the preparation of CuNPs. 
To further increase the access of the maleimide group for cycloaddition by minimizing surface 
crowding effect, a 1:10 ratio of maleimide containing to inert (without maleimide) dopamine 
linker was used for one-pot synthetic procedure (Scheme 3.18). As reported by Susumu et al. a 
combination of reactive and inert linker generally improves the colloidal stability and enable 
control over the density of reactive groups.[197] 
 
 
Scheme 3.18: Schematic illustration for the synthesis of maleimide functionalized copper nanoparticles; 
water/acetonitrile (1:1, v/v), 80 °C, 8 h. 
Procedure, published by Chen et al., was used to prepare and characterize stable Cu 
NPs.[192] To test if the maleimide capped Cu NPs can undergo the light-induced reaction with 
photoenol modified DNA, they were mixed with a solution of PE2-DNA2 54 in 
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water/acetonitrile (1:1, v/v), deoxygenated by purging with argon for 15 min and irradiated 
under UV lamp (λmax = 320 nm) for 16 hours at ambient temperature (Scheme 3.19). 
 
 
Scheme 3.19: Light-induced cycloaddition reaction between PE2-DNA2 54 and maleimide 
functionalized copper nanoparticles and subsequent hybridization with a complementary 
oligonucleotide cDNA2; a) water/acetonitrile (1:1, v/v), λmax = 320 nm, 16 h; b) 20 mm MgCl2, 16h, 
RT.  
In addition, a control reaction was performed by incubating PE2-DNA2 54 with 
maleimide containing CuNPs for 16 h at ambient temperature without irradiation. After 
purification by centrifugation, hybridization test for both reactions was performed by 
incubation of Cu NPs with a 10-fold excess of complementary cDNA2 in a 20 mM MgCl2 
solution at ambient temperature for 16 h. All reaction mixtures were subsequently analyzed by 
0.8% agarose gel electrophoresis (Figure 3.23). 
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Figure 3.23: Agarose gel (0.8%) electrophoresis study of photoreaction between PE2-DNA2 54 and 
maleimide Cu NPs nanoparticles at 320 nm. Visualization of bands was afforded by use of the visible 
and UV light after SYBRGold® staining of DNA. Gels were exposed to 100 V for 15 min in 0.5xTBE 
buffer. 
As seen from Figure 3.23, the electrophoretic mobility can be observed in all bands, 
containing Cu NPs, and the slight change is noticeable for bands corresponding to photoreaction 
(lane II) and that for control reaction (lane IV), performed in the dark. SYBRGold® staining is 
positive indicating that PE2-DNA2 54 is present in both bands and DNA is interacting with Cu 
NPs unselectively. After addition of cDNA2 to explore the hybridization ability of bound DNA, 
a change in the mobility of the bands is observed (III and V) confirming the successful 
hybridization. However, there is no noticeable difference between the reaction and the control 
indicating that PE2-DNA2 54 interacts with Cu NP in a non-specific way, most probably due 
to the electrostatic interaction of positively charged Cu NPs surface (zeta 
potential = 10.2 ± 1.18 mV)[192] and negatively charged oligonucleotide backbone. There is 
also a possibility that PE group reacts as an anchor for Cu ions on the surface of NPs, however 
this hypothesis was not tested.  
In order to remove any nonspecifically bound DNA, different washing steps were 
performed including wash steps with water at ambient temperature and at 40 °C, multiple 
washing steps with 20 mM and 200 mM NaCl solutions both at ambient temperature and 60 °C. 
Additionally, the photoreactions were performed in 20 mM, 40 mM and 200 mM 
NaClaq/acetonitrile (1:1, v/v) solutions in order to minimize the electrostatic interactions. 
However, the photoreaction was not successful using this particular system. Therefore, another 
Cu NP anchoring linker was explored to afford stable Cu NPs with surface attached maleimide 
groups, which could further be used for photoreactions.  
Carboxylic acid groups and polyols have strong affinities for the metal surface and 
different synthetic methods, employing L-ascorbic acid,[198] citric acid,[199] oleic acid[200] and 
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other[201] have been used as a stabilizing agents for Cu NPs. Recently, nitrilotriacetic acid has 
been employed as a chelator for the extracellular synthesis of copper nanoparticles by 
thermoanaerobic bacteria.[202] Combining strong affinity to copper with availability (derivatives 
were synthesized in the group) and simple modification route, nitrilotriacetic acid derivative 81 
has been employed for the synthesis of Cu NPs.  
For the initial experiments derivative 75 was prepared using synthetic procedure 
described by Liu et al.[203] 
 
 
Scheme 3.20: Synthesis of the nitrilotriacetic acid derivative 75 for CuNP coating; NaOH, 0 °C - RT, 
16 h; 50 °C, 2 h, 50%. 
In a nucleophilic substitution reaction a lysine derivative 73 was reacted with a 
bromoacetic acid 74 yielding 50% nitrilotriacetic acid derivative 75 (NTA) as a white solid 
(Scheme 3.20). Subsequently, the product 75 was employed for the Cu NPs synthesis using the 
modified procedure described by Kind and co-workers.[199] CuCl2∙2H2O, dissolved in 
diethylene glycol, was reduced with NaBH4 in the presence of 75 at 100 °C under inert 
atmosphere. Different ratios of copper salt, NaBH4 and 75 were used to prepare batches of NTA 
coated Cu NPs (Figure 3.24a). After the addition of reducing agent, the color of the reaction 
solution turned from blue to black, indicating the formation of NPs, which were washed with 
an isopropanol/ethanol mixture (1:1, v/v) by centrifugation and resuspended in DMSO. 
 
 
Figure 3.24: Tested reactant ratios a) for the synthesis of Cu-NTA nanoparticles and b) UV-Vis 
characterization of the obtained Cu-NTA nanoparticles. 
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Since Cu0 nanoparticles exhibit a characteristic localized surface plasmon resonance in 
the visible spectral range,[204] the presence of Cu NPs can be confirmed by UV-Vis 
spectroscopy. Therefore, the UV-Vis spectra of copper suspensions in DMSO were recorded 
(Figure 3.24b) and the obtained spectra for the reactions with 0.100 eq. and 0.200 eq. NTA 
linker 75 showed absorption bands with λmax= 628 nm and 607 nm, confirming the presence of 
Cu NPs.[199, 204] NPs prepared using 0.200 eq. of NTA 75 showed higher stability than those 
prepared with 0.100 eq., which precipitated on the bottom of the vial after 2 hours.  
In order to employ the light induced cycloaddition for DNA modification of Cu NPs, 
they need be derivatized with dienophile groups. To afford that, NTA derivative containing 
maleimide group was prepared. In the first step amino group of the NTA derivative 76, 
synthesized by Dr. Ishtiaq Ahmed, was deprotected by palladium catalyzed hydrogenolysis.[203] 
Then 4-maleimidobutyric acid 77, was derivatized to acid chloride by refluxing with thionyl 
chloride.[205] Obtained substances 78 and 79 were coupled by amidation reaction[205] and finally 
the desired maleimide functionalized nitrilotriacetic acid 81 (NTA-Mal) was obtained after the 
deprotection of carboxylic groups by treatment with trifluoroacetic acid (Scheme 3.21a - d).[206] 
 
 
 
Scheme 3.21: Synthesis of NTA-Mal 81; a) Pd/C, H2, MeOH, 5 h, RT, 95%; b) benzene, 70 °C, 2 h, 
99%; c) trietylamine, CH2Cl2, inert atmosphere, 0 °C - RT, 16 h, 84%; d) TFA, CH2Cl2, 0 °C, 2 h at RT, 
98%. 
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The obtained NTA-Mal 81 (98% in the last step) was subsequently employed for 
synthesis of Cu NPs. To prepare maleimide functionalized Cu NPs, 1.00 eq. CuCl2∙2H2O in 
diethylene glycol was reduced with NaBH4 (8.00 eq.) in the presence of 0.200 eq. NTA-Mal 81 
at 100 °C. The color change from blue to black confirmed the formation of Cu NPs, which were 
subsequently characterized by UV-Vis spectroscopy (Figure 3.25). 
 
 
Figure 3.25: UV-Vis characterization of Cu-NTA-Mal immediately after the synthesis (black curve) 
and after 24 h of storage (red curve). 
As seen in Figure 3.25, the UV-Vis spectra showed plasmon band at 623 nm 
characteristic for Cu NPs. Upon storage the band broadens and undergoes the red shift 
indicating the formation of Cu2O layer on the NP surface.
[204] Due to the time constrains and 
experimental study of DNA surface structuring, further attempts to stabilize the NPs and study 
the photoreactions were not undertaken.  
In conclusion, maleimide coated Cu NPs were prepared using both dopamine maleimide 
and nitrilotriacetic acid (NTA) maleimide anchoring strategies. Although initial results on 
photoreaction with PE2-DNA2 54 were promising in case of dopamine Cu NPs, control 
reactions indicated that there is a strong, but non-specific binding of DNA to the NP surface, 
due to the electrostatic interactions between positively charged Cu NPs and negatively charged 
DNA backbone. To avoid the non-specific binding and afford stable maleimide coated Cu NPs, 
novel linker, based on NTA moiety, was employed to prepare Cu NPs, however they were not 
stable enough to perform further experiments. Additional studies were not conducted, due to 
the time constraints but, research student starting in Fruk group in 2016 will continue and build 
upon this initial, promising work and optimize the system for future applications.  
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Final section discusses one of the main focuses of this thesis, namely use of light-induced 
reactions for surface structuring with DNA.  
 
3.3.3 Light-Induced Reactions for Spatially Controlled Immobilization of 
DNA  
DNA has found numerous applications as a structural and functional element in design 
of biological assays,[207] biosensors,[208] nanomotors and optoelectronic devices.[4a, 4b, 209] 
Different attachment strategies have been developed in order to obtain DNA functionalized 
surfaces, with different types of covalent binding, being most widely used. In general, such 
binding can be achieved by use of oligonucleotides, modified with a terminal functional group, 
which can selectively bind to the surface of interest.[210] Using different structuring techniques 
such as dip-pen nanolithography,[139] photolithography[138] or in situ DNA chemical 
synthesis,[138] single or many DNA sequences can be immobilized to design functional 
surfaces.[113, 211] Among the developed structuring techniques, photolithography is nowadays 
considered as a routine tool in research laboratories,[212] due to the relative ease of control over 
the structural features and positions of the molecules by use of the shadow mask.[213] This is 
particularly important for design of biosensors and there is an ongoing search for covalent 
strategies that would ease the fabrications process.[119a, 214] Due to advantages such as 
orthogonality and the ability to selectively pattern surfaces simply by UV irradiation, light-
induced Diels-Alder cycloaddition is an excellent candidate for a surface modification 
strategy.[126a, 149, 151b, 152] As discussed in previous sections, the reaction proceed under mild 
reaction conditions and provides quantitative or near-quantitative yields. Although it was 
mainly used for surface structuring of polymers, it was also shown that it can be employed as 
an elegant and facile method for the anchoring of biomolecules, such as peptides, onto different 
surfaces.[126a, 154] Herewith we also, for the first time, show that this type of photoreaction can 
be employed for the covalent attachment of photoenol modified oligonucleotide PE2-DNA2 54 
onto a maleimide functionalized silicon surface. For this purpose silicon wafers were first 
functionalized with a maleimide moiety in a two step procedure employing 
(3-aminopropyl)triethoxysilane (APTES) 1 and 4-maleimidopropanoyl chloride 82 
(Scheme 3.22).[215] 
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Scheme 3.22: Maleimide functionalization of silicon wafer using a two step approach employing 
(3-aminopropyl)triethoxysilane (APTES) 1 and 4-maleimidopropanoyl chloride 82. 
To enable a spatial control, a shadow mask with a wave patterns, as shown in 
Figure 3.26, was employed. 
 
 
 
Figure 3.26: Photograph of the sample holder (1), silicon wafer (2) and shadow mask with a wave 
pattern (3), employed for the spatially controlled immobilization of PE2-DNA2 54. 
Maleimide functionalized silicon wafer was covered with a mask, mounted in a sample 
holder, placed into the 1.75 µM PE2-DNA2 54 solution (PBS/acetonitrile, 1:1, v/v), 
deoxygenated by purging with argon for 15 min and subsequently irradiated in a photoreactor. 
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Figure 3.27: Schematic illustration of the spatially controlled light-induced immobilization of 
PE2-DNA2 54 on maleimide functionalized silicon wafer. 
Successful light-induced immobilization of PE2-DNA2 54 was confirmed by 
Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS). Figure 3.28a depicts the 
ToF-SIMS image resulting from the sum of characteristic species assigned to nucleic acid 
(m/z = 96.95 (H2PO4
-), m/z = 150.01 (G-, guanine), m/z = 125.02 (T-, thymine), m/z = 134.03 
(A-, adenine) and m/z = 110.01 (C-, cytosine)). The mass fragments corresponding to the DNA 
could only be found in the irradiated area thus confirming the site-specific immobilization of 
PE2-DNA2 54. In order to verify that DNA was not attached by non-specific interactions, 
control reaction was performed by irradiation of non-modified DNA2 at the same reaction 
conditions. The DNA characteristic mass fragments could not be found by ToF-SIMS analysis 
indicating that DNA was not attached to the surface (Figure 3.28b). 
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Figure 3.28: ToF-SIMS imaging of photo-patterned PE2-DNA2 54 a) derived from the sum of the 
signals detected at 96.95 (H2PO4-), 150.01 (G-), 125.02 (T-), 134.03 (A-) and 110.01 (C-) and ToF-SIMS 
imaging of photo-patterned non-modified DNA2 b) derived from the sum of the signals detected at 
96.97 (H2PO4-), 150.03 (G-), 125.04 (T-), 134.04 (A-) and 110.03 (C-) assigned to fragments of the 
corresponding oligonucleotides. Adapted with permission from [216].[216] 
To explore if the inherent function of the surface immobilized oligonucleotide was 
preserved, the PE2-DNA2 54 containing surface was incubated with a complementary 
oligonucleotide cDNA2 (Figure 3.29a), labeled with a commercially available fluorophore 
Cy®3 (λex = 550 nm, λem = 570 nm). In addition, a control reaction was performed by 
incubation of PE2-DNA2 54 modified silicon wafer with a non-complementary Cy®3 labeled 
oligonucleotide Cy®3-DNA4 and both samples were studied using fluorescence microscopy. 
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Figure 3.29: a) Schematic illustration of the hybridization of the PE2-DNA2 54 modified silicon surface 
with a Cy®3 labeled complementary oligonucleotide Cy®3-cDNA2; b) fluorescence image of hybridized 
Cy®3-cDNA2; c) fluorescence image of the control hybridization with a non-complementary Cy®3 
labeled oligonucleotide Cy®3-cDNA4. Adapted with permission from [216]. 
As shown in Figure 3.29b the surface incubated with a complementary strand indicates 
a clear fluorescence pattern in the areas containing immobilized PE2-DNA2 54, as opposed to 
the lack of the pattern observed in the control sample (Figure 3.29c). Due to the overnight 
hybridization in high concentration of Cy®3-cDNA2 and Cy®3-DNA4 solutions (50.0 µM), 
DNA aggregates, seen as a small circular fluorescent deposits, were detected on both (reaction 
and control) surfaces. Further optimization of the hybridization conditions such as lower 
concentration of a complementary oligonucleotide or shorter hybridization times and additional 
washing steps as well as other hybridization buffer should be employed in future experiment in 
order to avoid the DNA aggregates formation.  
However, successful spatially controlled immobilization of PE2-DNA2 54 on 
maleimide functionalized silicon wafers, confirmed by ToF-SIMS analysis, was demonstrated. 
The preservation of inherent functions of immobilized oligonucleotides was confirmed by 
selective hybridization with a complementary strand. This allows for further applications of 
such surfaces for the immobilization of different species such as nanoparticles or proteins by 
DNA directed immobilization. 
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As proof-of-concept study was successful, light-induced immobilization strategy has further 
been employed for the more precisely patterning technique, which does not involve the use of 
mask but involves direct patterning by Direct Laser Writing (DLW). 
 
3.3.4 Photo-Encoding of Maleimide Surfaces with DNA by Direct Laser 
Writing  
Some bioanalytical applications, such as studies of the single cells or protein-protein 
interactions, require precise positioning of these species and for DNA directed immobilization 
to be used for these applications, DNA anchoring arrays are required features size smaller than 
10 µm. As mentioned in previous section, various DNA patterning techniques including dip-
pen nanolithography,[139] nanografting,[217] nano-pipetting[218] or microcontact printing[141] have 
been developed in last decades for the fabrication of precise DNA structures smaller than 1 µm, 
but they all have their advantages and disadvantages depending on a particular application. 
Direct Laser Writing (DLW) by multiphoton polymerization has emerged as a powerful 
printing technology, which allows fabrication of 3D structures with sub-100 nm resolution.[142c, 
219] DLW is based on multi-photon absorption by photopolymers.[142] The beam of a 
femtosecond titanium sapphire oscillator is tightly focused inside the volume of transparent 
photopolymer solution, causing it to polymerize at specific positions by multiphoton 
absorption. By moving the laser beam or the substrate, depending on the desired pattern design, 
one can fabricate large variety of different patterns. The home-built direct laser writing setup, 
employed in this study (Figure 3.30), is based on a tunable titanium sapphire oscillator, 
delivering 150 fs pulses at a center wavelength of 700 nm. The beam intensity is controlled by 
an acousto-optical modulator (AOM) and is focused through an oil immersion objective lens 
with an numerical aperture of 1.4. The sample is held by a 3D piezo stage, that allows for its 
relative translation with respect to the laser beam focus. An additional CCD camera is used for 
monitoring the writing process and sample alignment. 
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Figure 3.30: The home-built DLW setup for multiphoton microfabrication. 
The used photoresist consists of at least two components: a monomer or a mixture of 
monomers, which polymerize to provide the final polymer, and a photoinitiator, which absorbs 
the laser light and induces the polymerization. There are two types of photoinitiators which are 
employed for DLW: the cationic photoinitiators (used for the polymerization of epoxides or 
vinyl ethers)[220] and most commonly used radical photoinitiators, such as benzophenone and 
its derivatives, employed for the polymerization of acrylates and vinyl ethers.[221] The 
photoresists can be divided in positive-tone photoresist[222] (the structures are fabricated by 
focusing a laser beam into a solid resist, thereby dissolving the exposed regions) and 
negative-tone photoresist (the polymer structure is solidified from a solution in an exposed 
volume).[223] The mostly employed negative photoresists are acrylate materials,[142a, 224] the 
epoxy-based photoresist SU-8,[143] hybrid materials[225] and hydrogels.[226] Furthermore, 
biological material including bovine serum albumin (BSA), fibrogen, fibronectin and collagen 
have been employed for the multiphoton polymerization.[227] For example, Sun and colleagues 
used BSA as a building block for the fabrication of a novel soft diffractive optic, so called 
microscale kinoform phase-type lens, which might find applications in preparation of flexible 
and stretchable photonics and optics or bioimplantable devices.[228] In addition, Melissinaki and 
colleagues employed methacrylate modified polylactide to fabricate high-resolution 3D 
structure and grown neuroblastoma cells, which preserved their viability and proliferation, 
indicating a good biocompatibility of the written structure, opening new routes to the use of 
such structures for preparation of neuronal implants.[147] Recently, Richter and colleagues 
employed Diels-Alder photopolymerization and DLW for the immobilization of biotin or 
benzylguanine containing molecules, which were then used for the binding of streptavidin or 
SNAP-GFP in a high-precisely manner.[153a] The multiphoton-induced cycloaddition reaction 
was also employed for the fabrication of woodpile photonic crystals, [229] immobilization of 
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functionalized gold nanoparticles,[149] for the coating of preformed 3D polymeric 
microstructures,[230] for the wavelength selective polymer network formation of end-functional 
star polymers[148a] and others.[231] However, DLW by multiphoton-induced Diels-Alder 
cycloaddition for DNA structuring is for the first time demonstrated within this thesis.  
 
3.3.4.1 DNA Array Prepared by DLW Using Single DNA Sequence 
For the immobilization of oligonucleotides onto maleimide functionalized glass surface 
via Direct Laser Writing (DLW), photoenol modified PE2-DNA2 56, was employed. As 
described in Section 3.2.2, the kinetic studies of this light-induced cycloaddition showed that 
the reactions is fast, proceeds in high yields and can be performed in water/DMSO solution 
(3/2. v/v). This is an important fact, as solvents employed in DLW should have low volatility 
to avoid the concentration changes and reactant precipitation (or salt precipitation, if the buffer 
needs to be used) during the sample exposure, and water/DMSO mixture represents an 
appropriate solvent mixture, due to the low vapor pressure of both solvents.[232] The home-built 
DLW setup2 we have used, employs a laser tuned to 700 nm center wavelength for targeted 
two-photon excitation. An absorption maximum for PE2 moiety is at λmax = 317 nm. Previously 
described photoreactions were successfully performed using UV irradiation from compact 
low-pressure fluorescent lamp with λmax = 320 nm ± 30 nm and therefore, selected laser 
wavelength ensures the efficient multiphoton absorption, required for the photoreaction. 
To fabricate the DNA microstructures by DLW,3 a droplet of 10.0 µM 56, dissolved in 
a mixture of 1.00 mM NaClaq/DMSO (3:2, v/v), was placed on a glass surface (Figure 3.31a), 
previously cleaned, activated and functionalized with 4-maleimidobutyroyl chloride 78. For the 
initial experiments, simple square pattern consisting of ten squares (50×50 µm) was written by 
exposing PE2-DNA2 56 solution to the excitation laser. The squares were written at different 
laser powers (20, 18, 16, 14, 12, 10, 8, 6, 4 and 2 mW) with four passes per square and a writing 
speed of 100 µm s-1.  
                                                 
2The home-built DLW setup was assembled by Dr. Joachim Fischer, Institute of Nanotechnology, Karlsruhe 
Institute of Technology (KIT).  
3DLW procedure was performed by Patrick Müller, Institute of Applied Physics, and Dr. Alexander Quick, 
Institute for Technical Chemistry and Polymer Chemistry, Karlsruhe Institute of Technology (KIT). 
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Figure 3.31: a) Principle of the light-induced PE2 DNA2 56 immobilization using direct laser writing 
(DLW); b) Photoenolization of 56, induced by laser light absorption, and subsequent [4+2] 
cycloaddition with maleimide moiety bound to the surface. 
Subsequently, PE2- DNA2 56 functionalized surfaces were washed in order to remove 
the non-reacted starting material 56 and analyzed by ToF-SIMS. Figure 3.32a depicts the 
resulted image of measured PO2
- signal, which represents a characteristic mass fragment of 
DNA.[233] Ten squares with high PO2
- signal intensity corresponding to the written pattern were 
observed. However, despite the multi-step washing procedure, a relatively high background 
PO2
- signal has been detected, probably stemming from non-specific attachment of 56 due to 
the electrostatic interactions between positively charged amino groups on the surface and 
negatively charged DNA backbone. To avoid this, the writing and washing conditions were 
optimized in the follow up experiments. In order to assess the hybridization ability of the 
immobilized oligonucleotides, the modified surfaces were incubated in a 3.00 µM 
Cy®3-cDNA2 solution in TE-Mg buffer for 16 hours. The surfaces were washed with ultrapure 
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water (MQ water), TETBS buffer and again in MQ water, rinsed with fresh MQ water and dried 
under a stream of nitrogen. 
 
 
Figure 3.32: a) ToF-SIMS image of PO2- ion of PE2-DNA2 56 immobilized on maleimide 
functionalized glass surface via DLW; b) fluorescence image of hybridized Cy®3-cDNA2 squares, 
written by employing the laser power of 2 - 16 mW. 
The fluorescence detection of hybridized oligonucleotides was performed by 
fluorescence microscopy and as it can be seen from Figure 3.32b, the fluorescence image of 
eight clearly distinguishable and regular squares can be observed, confirming the high 
hybridization rate of complementary fluorescent DNA to immobilized oligonucleotides. It 
should be noted that the fluorescence intensity increases with the increase in the laser power. 
This is a consequence of more PE2 moieties being activated at higher power, leading to higher 
yield of reaction with the surface maleimide groups. However, at the laser power above 8 mW, 
a decrease of fluorescence intensity was observed indicating the possible DNA damage and 
lower density of immobilized DNA. In order to optimize the DLW procedure, different 
conditions were tested and are summarized in the following paragraphs.  
 
Results and Discussion 
89 
 
3.3.4.2 Optimization of the DLW Procedure: Dose and Resolution Tests 
In order to establish the best writing conditions, dose tests were performed. For this 
purpose, a group of 2D lines was written using a 10.0 µM PE2-DNA2 56, dissolved in 0.5×SSC 
buffer (pH 7.0)/DMSO (3:2, v/v) mixture and scanning speed of 100 µm s-1. Three fields 
(100×100 µm) of lines were constructed by 1-fold, 2-fold and 4-fold scanning repetition. 
Throughout the line pattern, the laser power was linearly increased from 0 to 20 mW from the 
bottommost to the topmost line. From the left line to the right line of each field the value of the 
vertical axis (z position) was increased resulting in the focal point position being inside the 
glass substrate for the leftmost line and above the surface inside the DNA solution for the 
rightmost line. Thus incorrect detection of the glass interface can be compensated. For the 
visualization of the written DNA pattern the surface was washed (10 min in 2×SSC + 0.2% 
SDS (2×), 10 min in 2×SSC, 15 min in 0.1×SSC + 0.1% SDS and 10 min in MQ water) and 
subsequently incubated in 200 nM Cy®3-cDNA2 dissolved in TETBS/TE-Mg (1:1, v/v) buffer 
mixture at ambient temperature for 16 h. The excess of complementary oligonucleotide was 
removed by washing with MQ water, TETBS and again with MQ water.  
 
Figure 3.33: Fluorescence images of hybridized Cy®3-cDNA2 of 2D line fields constructed by 1-fold, 
2-fold and 4-fold scanning repetition; z position change from left to the right, laser power increasing 
linearly from bottom to top from 0 to 20 mW. 
Subsequently, the surface was dried under a stream of nitrogen and analyzed by 
fluorescence microscopy (Figure 3.33).4 As expected, no lines could be observed for the focal 
point position far from the interface and for low laser powers and the most intense lines were 
observed for the 4-fold scanned field (right image in Figure 3.33). Unfortunately, the employed 
hybridization conditions resulted in DNA aggregates formation. To find the most suitable 
hybridization conditions, hybridization at different concentrations of Cy®3-cDNA2 and 
                                                 
4Fluorescence measurements were performed by Patrick Müller, Institute of Applied Physics, Karlsruhe Institute 
of Technology (KIT). 
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incubation times in combination with various washing and surface blocking procedures were 
performed (not shown). Finally, the best results could be obtained using the conditions below: 
 
Concentration of 56 in  
0.5×SSC(pH 7.0)/DMSO (3:2, v/v): 
 
10 µM 
Writing speed: 100 µm s-1 
Scan number: 4-fold 
Laser power: 6 mW 
Washing steps after DLW: 10 min in 2×SSC + 0.2% SDS  (2×) 
10 min in 2×SSC 
15 min in 0.1×SSC + 0.1% SDS 
10 min in MQ water 
Blocking before hybridization: 45 in (5×SSC, 0.1% SDS, 1% BSA) at 42°C, than 
rinsing with MQ water 
Hybridization: 200 nM Cy®3-cDNA2 or 200 nM Cy®5-cDNA3 in 
TETBS buffer, 1.5 h at RT 
Washing steps after hybridization: 5 min in 2×SSC + 0.2% SDS  (2×) 
10 min in 0.1×SSC + 0.1% SDS 
5 min in 2×SSC  
5 min in MQ water 
Employing the optimized reaction conditions resolution tests were performed in order 
to determine the resolution limit for the given DLW system. In such an experiment, line arrays 
were fabricated with varying line distance, ranging from 1.00 µm to 0.400 µm (from bottom to 
the top). Additionally, the laser power was varied from 0.40 mW to 24 mW (from left to the 
right). Around the line array a frame and text labels were written by 1-fold scan using a writing 
speed of 100 µm s-1. After the laser writing was performed, the sample was treated using 
optimized blocking, hybridization and washing steps and analyzed by fluorescence microscopy 
(Figure 3.34). 
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Figure 3.34: Fluorescence images of Cy®3-cDNA2 hybridised to PE2-DNA2 immobilized onto the 2D 
line array written by DLW using 4-fold scanning repetition and the speed of 100 µm s-1. Laser power 
was increased from left to the right: 0.4 mW, 0.8 mW, 2 mW, 4 mW, 8 mW, 16 mW and 24 mW. 
Zoomed section is the column, written using 4mW laser power and different distances between the line 
segments (image on the right).   
As it can be seen from Figure 3.34, strongly fluorescent images are obtained for regions 
written using 4 and 8 mW laser power, and no fluorescent signals are detected in the areas 
without immobilized DNA, demonstrating that precise and well defined patterns can be 
prepared using our strategy. Weaker fluorescence signal are observed at the lower and higher 
laser power, confirming our hypotheses that this is due to the low activation level of the 
photoenol containing DNA, or its damage, respectively. When the segment written with 4mW 
laser power is magnified, clearly defined, 0.478 ± 0.047 nm wide lines (this was determined 
using ImageJ software using the fluorescence intensity profile across the lines) can be observed 
up to the line distance of 0.60 µm. The arrays with smaller line distance could not be resolved 
by the employed confocal optical microscope. Further investigations by e.g. Atomic Force 
Microscopy (AFM) would be conceivable, but were not performed at this point. Rather, a more 
challenging issue of highly resolved, multi-sequence array fabrication was addressed and it is 
presented in the following section. . 
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3.3.4.3  DLW for Multi-DNA Array Preparation 
The simplest multi-DNA array was designed using two different DNA sequences. For 
this purposes additional 22mer oligonucleotide sequence DNA3 was functionalized with PE2 
moiety (procedure described in Section 3.1.3) and employed in DLW experiments. The 
fabrication of two-sequence array was performed in three writing steps. First, a 100×100 µm 
polymer frame (Figure 3.35) was written using a solution of polymerization reagents 
tetraphotoenol 83 and maleimide containing methacrylate derivative 84 in 
γ-butyrolacton/acetophenone mixture, synthesized by Dr. A. S. Quick.[229] 
 
 
 
Figure 3.35: Microscopic of 100x100 µm image of polymer frame written by DLW utilizing 83 and 84 
as polymerization reagents. 
Such polymer frame is visible by an employed CCD camera and is used as a reference 
point for the later spatial control of the writing position. In the next step, first DNA sequence, 
PE2-DNA2 56, is written within the polymer frame using the optimized, but slightly changed, 
reaction conditions (higher concentration of the PE2-DNA2 56 solution (30.0 µM instead of 
10.0 µM) and a slower writing speed (50 µm s-1instead of 100 µm s-1) were employed. A 
reference point relative to the left lower corner of the polymer frame was fixed as a starting 
point of the laser writing position and a 2D line array consisting of four columns of three line 
segments with different line spacing (8.00 µm, 6.00 µm and 4.00 µm, from bottom to top) was 
fabricated (Figure 3.36). Additionally, a 2×2 checkerboard pattern with 10×10 µm squares was 
written on the right hand side of the frame. Following this step, a third writing step was 
performed to immobilize the second sequence PE2-DNA3 57. This was done only after 
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previously defined writing start point has been localized employing a 3D piezo stage and CCD 
camera. 
The line pattern of the second sequence was programmed in such way to be written 
between the lines of the first sequence. Finally, multi DNA array was washed, surfaces blocked 
and immobilized DNA was allowed to hybridize with corresponding complementary DNA 
sequences, Cy®3-cDNA2 and Cy®5-cDNA3, labeled with two different flourophores. 
(Figure 3.36). 
 
 
Figure 3.36: Top: fluorescence images of the two DNA sequence patterns for Cy®3 (left), Cy®5 (right) 
and merged signals (middle). Bottom: magnification of the four lower line segments of the merged 
image image and fluorescence intensity profiles along the green line for Cy®3 lines (left) and for Cy®5 
(right) lines to illustrate the regularity of the line pattern. Cy®3 (λex = 550 nm, λem = 570 nm; Cy®5 
(λex = 649 nm, λem = 666 nm).   
Strong, clearly distinguishable fluorescent signals could be detected for different 
sequences and the quality of the lateral resolution is additionally confirmed by the intensity 
profile along the patterned structure (Figure 3.36, bottom left and right). It should be noted, that 
the lines of the second DNA sequences are slightly shifted to the right due to the limitations of 
employed piezo stage during the writing procedure. However, larger structures such as 3×3 
(10×10 µm) or 2×2 (45×45 µm) checkerboard pattern could be reproduced in exact agreement 
with the programmed design (Figure 3.37). 
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Figure 3.37: Fluorescence images of a) 3×3 (10x10 µm)  and b) 2×2 (45x45µm) checkerboard pattern 
containing two different sequences hybridized with corresponding Cy®5 and Cy®3 complementary 
DNA. Merged patterns are shown in the middle. Laser power : 6 mW, writing speed 50 µm s-1. 
In addition, high and well defined fluorescent regions confirm, that fabrication of 
multiplex DNA using light-induced cycloaddition and DLW is not only possible, but it results 
in functional surfaces as confirmed with high level of DNA hybridization and well-resolved 
patterns, which can be readjusted to the needs of a particular application. We were also 
interested in exploring if other species, in particular protein, could be immobilized onto such 
patterns through DNA directed immobilization. But prior to this experiments, the hybridization 
limits of DNA arrays was studied by incubating DNA2 patterns with different amounts of 
Cy®3-cDNA2 solutions (1.00 pM, 100 pM, 1.00 nM and 1.00 µM). This is important as some of 
the species, which might be used for array preparation through DDI are present in small 
amounts and this strategy might not be suitable if not enough DNA on the surface is available 
for hybridization.  
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Figure 3.38: Fluorescence images of PE2-DNA2 56 containing surfaces incubated with Cy®3-cDNA2 
of different concentrations (1.00 pM, 100 pM, 1.00 nM and 1.00 µM). 
Figure 3.38 shows the results of the hybridization study, clearly indicating that the best 
fluorescence signal intensity can be obtained when 1.00 nM Cy®3-cDNA2 is used and higher 
concentration lead to a decreased intensity due to the crowding effects. It should be noted his 
results are by no means to be taken as a strict rule, since the hybridization ability will depend 
on the size and charge of the DNA conjugate (as seen in the next paragraph). However, it can 
be considered as a concentration guide to determine the concentration range for hybridization 
onto the DLW array patterns.  
In order to test the applicability of two sequence arrays for the DNA directed 
immobilization of proteins, HRP-cDNA2 conjugate (synthesized using the procedure reported 
by Kukolka et al.[234]) was hybridized onto the surface of the 2×2 (45×45 µm) checkerboard 
pattern containing both DNA2 and DNA3 sequences by incubating the pattern in 100 nM 
HRP-cDNA2 solution in PBS buffer at ambient temperature for 2 h. The hybridization was also 
attempted using 1.00 nM solution, however as noted earlier, the hybridization ability depends 
on the properties of DNA conjugate and in case of HRP, the optimum solution concentration 
was found to be 100 nM. After extensive washing, the hybridized pattern was analyzed by ToF-
SIMS, focusing on the detection of the iron content. Namely, HRP contains heme cofactor, 
which might be expected to give distinct iron signal. However, no iron could be detected, most 
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probably due to the low concentration of the protein on the surface and the hindrance of the 
heme by the protein shell. 
 
 
Figure 3.39: ToF-SIMS image of PO3- ion of 2×2 checkerboard pattern containing PE2-DNA2 (1) and 
PE2-DNA3 (2) after hybridization with HRP-cDNA2. 
However, we have obtained phosphate ion signals (PO3
-), which were more intense in 
the square patterns containing PE2-DNA2. This means that the higher DNA content is present 
in this region, indicating the presence of complementary sequence containing HPR moiety 
(Figure 3.39). We have additionally tried to label immobilized HRP with heavy iodine 
according to the published procedures, but this was not successful in our hands and additional 
experiments were not performed due to the time constrains. In addition, another protein, widely 
used streptavidin (STV) was hybridized onto two-pattern array using 100 nM STV-cDNA2[234] 
solution. To prove that STV is bound onto array, we employed the strong biotin binding affinity 
of this protein (association constant ca. 1015 dm3 mol-1)[235] and exposed the STV bound surface 
to fluorophore labeled biotin (300 nM solution of Atto550-biotin). As a control, PE2-DNA2 
array without STV-cDNA2 conjugate was incubated with Atto550-biotin to ensure that there is 
no unspecific binding on labeled biotin to DNA surface. As it can be seen in Figure 3.40, only 
the pattern, to which STV is hybridized, showed high fluorescence intensity stemming from the 
bound biotin, proving that the protein is successfully hybridized and capable of undergoing the 
binding event with biotin.  
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Figure 3.40: Fluorescence images of Atto550-biotin bound to a) two sequence pattern containing 
immobilized STV-cDNA2 (squares labeled 1) and b) STV free surface. (Atto550: λex = 554 nm, 
λem = 576 nm). 
Low fluorescence intensity can be observed in control regions containing DNA only 
(but not in the surrounding empty area) most probably due to the electrostatic interaction of 
cationic fluorophore Atto550 and anionic oligonucleotide backbone. This issues can be 
resolved in the future by use of other labeling fluorophores and more intense washing steps.  
In conclusion, distinct patterns of photoenol containing oligonucleotides were 
successful created by use of photoactivation ability of direct laser writing and following 
reaction with the maleimide modified glass surface. Both line array and checkered pattern 
arrays were designed using single and multi-DNA sequences. Hybridization studies have 
shown, that immobilized DNA is fully functional and can be used for subsequent DNA directed 
immobilization of different species. This was confirmed by successful hybridization of DNA 
containing small molecules (fluorophores) and proteins ( HRP and STV). In addition, a clearly 
defined and highly resolved (lines within the line pattern were still clearly resolved at 600 nm 
interline distance) patterns can be programmed and written opening new possibilities for 
surface structuring for application in biosensing and material design.  
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4 Summary and Outlook 
 
Within this thesis, DNA was covalently coupled to the protein and different surfaces 
using novel light-induced strategies based on photoenol and tetrazole chemistry. To enable 
light-induced cycloaddition, oligonucleotides were first functionalized with photo-activatable 
groups: 2,5-dimethylbenzophenone (PE1) and 2-methoxy-6-methylbenzaldehyde (PE2) for 
Diels-Alder cycloaddition and tetrazole (Tz,) for NITEC using phosphoramidite, 
H-phosphonate and amide coupling methods. Further, the ability of modified oligonucleotides 
to undergo light-induced reactions was studied in details using model dienophile, Do-TEG-Mal. 
Reactions with PE1-DNA1 (performed in aqueous solutions due to the DNA stability and 
solubility requirements) were not successful as the presence of protic solvents favors 
reketonization of PE1 group.[122] In contrast, PE2-DNA2 and Tz-DNA2 could successfully be 
converted to desired cycloadducts in high yields. However, side products were detected when 
the reaction with Tz-DNA2 was performed, although their amount could be decreased by 
addition of the larger amount of dienophile (15.0 eq). Detailed ESI-MS and HPLC studies also 
showed that the light-induced reaction of PE2-DNA2 is faster (completed after 10 min) than of 
tetrazole-DNA, in which the side products are not eliminated by either the excess of dienophile 
or prolonged irradiation time. 
Taking into account the reaction kinetics and the absence of the side products, 
PE2-DNA2 was further used for coupling to the protein horseradish peroxidase (HRP). 
Resulting conjugate retained inherent functions of both the DNA and HRP as confirmed by 
DNA hybridization and Amplex®Red peroxidase activity assay. In addition, to extend the 
application of the light-triggered reactions to surface biofunctionalization, the modification of 
copper nanoparticles (Cu NPs), which have excellent electronic and catalytic properties and a 
huge potential for design of electronic and biosensing devices, with DNA was attempted. For 
this purpose, two different bi-functional linkers containing maleimide for light-induced 
cycloaddition, and dopamine and nitrilotriacetic acid (NTA), respectively, were prepared for 
stabilization of Cu NPs. Although initial coupling results with PE2-DNA2 and dopamine-
maleimide coated Cu NPs were promising, control reactions indicated that there is a strong, 
non-specific binding of DNA to the NP surface. On the other hand, CuNPs containing NTA 
bound maleimide were not stable enough to perform light triggered coupling. However, further 
studies should be conducted to afford stable Cu-NTA-Mal NPs, and these should involve the 
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optimization of the solvent composition and introduction of polyethylene glycol unite to NTA-
Mal linker in order to improve the solubility and decrease the steric hindering of surface 
functional groups.  
Finally, the light-induced Diels-Alder cycloaddition was successfully employed for the 
controlled immobilization of PE2-DNA2 onto maleimide functionalized silicon and glass 
surfaces. Initial experiments, performed utilizing a shadow mask, resulted in a DNA wave 
pattern with line thickness of 200 µm after irradiation with 320 nm light. However, much 
improved resolution and significant increase in the pattern variety was achieved by use of Direct 
Laser Writing (DLW) technique combined with multiphoton-induced cycloaddition. Fully 
functional line patterns containing multiple DNA sequences with the resolution of 600 nm were 
structured and successfully hybridized with fluorophore labeled complementary strands. This 
indicated that DNA directed immobilization on patterned surface can be performed, which was 
additionally confirmed by immobilization of DNA-HRP and DNA-streptavidin (STV) protein 
conjugates. Successful immobilization was confirmed either indirectly through monitoring of 
the phosphate signal by TOF-SIMS or by use of the fluorescent protein binding substrates. 
Further experiments, which were not performed due to the time constrains, should focus on the 
simultaneous immobilization of multiple functional proteins such as cell receptor proteins and 
design of i.e. ordered cell patterns either for the cell studies or the growth of artificial tissues.  
In conclusion, it has been shown for the first time that light-induced Diels-Alder 
cycloaddition, based on the photoenol chemistry can be used not only for the preparation of 
DNA-protein conjugates, but also for the precise structuring of DNA on various surfaces. 
Remarkable resolution and variety of patterns can be achieved by combination of the light-
induced reactions and direct laser writing technology, which might open new avenues for use 
of DNA surfaces in bionanotechnology, in particular design of cell arrays and preparation of 
bio-inspired materials.  
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5 Experimental Part 
 
5.1 Materials and Methods 
 
5.1.1 Chemicals 
Triethylene glycol (≥99%, Sigma-Aldrich), anhydrous N,N-dimethylformamide (DMF, 
≥99.8%, Sigma-Aldrich), dichloromethane (DCM, ≥99.8%, VWR), 1-hydroxybenzotriazole 
hydrate (HOBt, ≥97%, Sigma Aldrich),  N,N′-dicyclohexylcarbodiimide (DCC, 99%, Sigma-
Aldrich), N-hydroxysuccinimide (NHS, 98%, Sigma-Aldrich), methanol (MeOH, 99.8%, 
VWR), phosphorous acid (H3PO3, 99%, Sigma-Aldrich), anhydrous pyridine (99.8%, Sigma-
Aldrich), trimethylacetyl chloride (99%, Sigma-Aldrich), acetonitrile (MeCN, 99.9%, VWR), 
anhydrous acetonitrile (MeCN, 99.8%, Sigma-Aldrich), triethylamine (NEt3, ≥99%, Sigma-
Aldrich), 4-(N-maleimidomethyl)cyclohexane-1-carboxylic acid 3-sulfo-N-
hydroxysuccinimide ester sodium salt (sulfo-SMCC, powder, Sigma-Aldrich), horseradish 
peroxidase (HRP, type VI-A, Sigma-Aldrich), oxidizing solution (0.02 M iodine in 
THF/pyridine/water (7:2:1), Link Technologies), oligonucleotides DNA1, DNA2, 
NH2-DNA2 and NH2-DNA3 on solid support, cDNA2, 6-FAM-cDNA2, Cy®3-cDNA2, 
Cy®5-cDNA3, SH-cDNA2 and Cy®3-DNA4 as purified lyophilized solid (Sigma-Aldrich, for 
sequences refer to Table 5.1) were used as received. Protein marker, Precision Plus Protein™ 
Dual Xtra Standards, was purchased from Bio-Rad. DNA marker, O'Range Ruler 10 bp DNA 
Ladder, was purchased from ThermoFisher Scientific. Ultrapure water produced with a Milli-
Q Advantage A10 system was used in all experiments. Triethyl ammonium bicarbonate buffer 
(TEAB buffer, 2 M, pH 7.5) was prepared by bubbling of gaseous CO2 into 2 M aqueous 
solution of triethylamine until the pH of this solution reaches pH 7.5. Gel filtration NAP5 and 
NAP10 columns and Vivaspin sample concentrators were purchased from GE Healthcare 
(Germany). 
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DNA sequences  
 
Table 5.1: Sequences and extinction coefficients of used oligonucleotides. 
Name Sequence (5'-3') and 5'-modification ε 
[L*mol-1*cm-1] 
DNA1 5'-GGTGAAGAGATC-3' 127600 
DNA2 5'-GTGGAAAGTGGCAATCGTGAAG-3' 228100 
NH2-DNA2 5'-[AminoC6T]-
GTGGAAAGTGGCAATCGTGAAG-3' 
228100 
NH2-DNA3 5'-[AminoC6T]-
GGTCCGGTCATAAAGCGATAAG-3' 
225100 
cDNA2 5'-CTTCACGATTGCCACTTTCCAC-3' 191700 
6-FAM-
cDNA2 
5'-[6FAM]-CTTCACGATTGCCACTTTCCAC-3' 191700 
Cy®3-
cDNA2 
5'-[Cyanine3]-CTTCACGATTGCCACTTTCCAC-3' 191700 
Cy5®-
cDNA3 
5'-[Cyanine5]-CTTATCGCTTTATGACCGGACC-3'  
Cy®3-DNA4 5'-[Cyanine3]CCTGCTTATGTTTCCGATGTGC-3' 193400 
SH-cDNA2 5'-[ThiC6]CTTCACGATTGCCACTTTCCAC-3' 191700 
 
 
Buffers 
 
Table 5.2: Buffers and the corresponding recipes. 
Buffer Composition 
5×TBE 450 mM Tris/HCl, 450 mM Borsäure, 10 mM EDTA, pH 8-8.3 
1×PBS 16.7 mM KH2PO4, 83.3 mM K2HPO4, 150 mM NaCl, pH 7.3 
TETBS 20 mM Tris/HCl, 150 mM NaCl, 5 mM EDTA-Na2∙2H2O,  
0.05% Tween-20, pH 7.5 
DNA loading 
buffer(6×) 
10 mM Tris, 60 mM EDTA, 0.03% bromophenol blue, 0.03% 
xylene cyanol, 60% glycerin, pH 7.6 
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Nanoparticle loading 
buffer (6×) 
10 mM Tris, 60 mM EDTA, 60% glycerin, pH 7.6 
SDS loading buffer 
(4×) 
50 mM Tris, 8% SDS, 40% glycin, 20% mercaptoethanol, 
5mg/mL bromophenol blue 
Stacking gel buffer 0.5 M Tris, pH 6.8 
Separating gel buffer 1.5 M Tris, pH 8.8 
PAGE running buffer 25 mM Tris, 192 mM glycin 
SDS running buffer 25 mM Tris, 250 mM glycin, 0.1% SDS 
20×SSC 3 M NaCl, 0.3 M trisodium citrate 
Glycin-NaOH buffer add 50 mM NaOH to 50 mM glycin until pH reach 8.5 
Anion exchange buffer 
A 
20 mM Tris/HCl, pH 8.3 or 6.3 
Anion exchange buffer 
B 
20 mM Tris/HCl, 1 M NaCl, pH 8.3 or 6.3 
HPLC elution buffer 0.1 M NH4OAc 
 
5.1.2 Instruments and Methods 
 
Nuclear magnetic resonance spectroscopy (NMR) 
 
NMR spectroscopy was performed using following instruments: 
1H-NMR (250 MHz), 13C-NMR (63 MHz): Bruker AC 250 
1H-NMR (300 MHz), 13C-NMR (75 MHz): Bruker AVANCE 300 
1H-NMR (400 MHz), 31P-NMR (100MHz), 13C-NMR (100 MHz): Bruker AVANCE 400 
1H-NMR (500 MHz), 13C-NMR (126 MHz): Bruker AVANCE DRX 500 
Samples were dissolved in CDCl3, DMSO-d
6, methanol-d4 or CD3CN. The δ-scale is referenced 
to tetramethylsilane (TMS) or phosphoric acid as the internal standards. The chemical shift δ is 
expressed in "ppm" and the coupling constant J is in "Hz".  
 
Mass Spectrometry (MS) 
The mass of the compounds was measured by Fast Atom Bombardment Mass 
Spectrometry (FAB-MS) or Electron Ionization Mass Spectrometry (EI-MS) using Finnigan 
MAT95 mass spectrometer. Analyses of oligonucleotides were performed by Matrix-Assisted 
Laser Desorption Ionization - Time of Flight Mass Spectrometry (MALDI-TOF) using 
Autoflex III SmartBeam™ (Nd:YAG laser (355 nm) with a repetition rate of 200 Hz) 
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spectrometer from Bruker Daltonics in the linear negative mode; used matrix: a 9:1 mixture of 
saturated 3-hydroxypicolinic acid and 0.44 M diammonium hydrogen citrate. Fragments can be 
identified according to their mass-to-charge ratios (m/z), and the intensity of the signals 
represents the relative abundance of the ions. The most intense signal is the base peak, which 
is assigned an abundance of 100%.  
EI-MS: abbreviation for the molecular ion [M+]. 
FAB-MS: abbreviation for the protonated molecular ion [M+H]+. 
MALDI-TOF: abbreviation for the molecular ion [M]. 
 
Electrospray Ionization Mass Spectrometry (ESI-MS)5  
Mass spectra were recorded on a Q Exactive (Orbitrap) mass spectrometer 
(ThermoFisher Scientific, San Jose, CA, USA) equipped with an HESI II probe. The instrument 
was calibrated in the m/z range 74 − 1822 using premixed calibration solutions (Thermo 
Scientific). A constant spray voltage of 2.9 kV and a dimensionless sheath gas of 10 were 
applied. The capillary temperature and the S-lens RF level were set to 320 °C and 68.0, 
respectively. The oligonucleotide samples were dissolved with a concentration of 10 µM in a 
mixture of water/acetonitrile (3:1, v/v) containing 0.5 % acetic acid and infused with a flow of 
30 μL·min-1. 
 
Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS)6 
Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS) was conducted with a 
TOF.SIMS5 instrument (ION-TOF GmbH, Münster, Germany), equipped with a Bi cluster 
liquid metal primary ion source and a non-linear time-of-flight analyzer. The Bi source was 
operated in the bunched mode providing 0.7 ns Bi3
+ ion pulses at 25 keV energy and a lateral 
resolution of approximately 4 µm. The short pulse length allowed high mass resolution to 
analyze the complex mass spectra of the immobilized organic layers. Images larger than the 
maximum deflection range of the primary ion gun of 500×500 µm2 were obtained using the 
manipulator stage scan mode. Primary ion doses were kept below 1011 ions·m−2 (static SIMS 
limit). Spectra were calibrated on the CH−, CH2
−, CH3
−, or on the C+, CH+, CH2
+, and CH3
+ 
peaks. 
 
                                                 
5 ESI-MS measurements were conducted by Dr. Michael Kaupp, Institute for Technical and Polymer Chemistry, 
Karlsruhe Institute of Technology (KIT). 
6 ToF-SIMS measurements were conducted by Dr. Alexander Welle and Doris Abt, Institute for Technical 
Chemistry and Polymer Chemistry, Karlsruhe Institute of Technology (KIT). 
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Fourier Transform Infrared Spectroscopy (FTIR) 
Fourier transform infrared spectra (FTIR) were recorded using Bruker "IFS-88" or 
Bruker ALPHA. For the sample preparation diffusive reflectance infrared Fourier transform 
(DRIFT) and attenuated total reflection (ATR) techniques were used. The absorption bands of 
functional groups in IR spectra are expressed in wavenumbers ṽ (cm-1). 
 
UV-Vis Spectroscopy 
UV-Vis spectra were recorded on a Cary 300 Scan spectrophotometer (Varian Inc., 
Germany) and on a Cary 100 (Agilent Technologies) in the wavelength region 200−800 nm 
respectively.  
 
Fluorescence microscopy 
Fluorescence microscopy was performed using Axiovert 200M (Carl Zeiss) inverted 
microscope with Plan-Neofluar objective (magnification/numeric aperture 10x/0.16).  
For confocal fluorescence microscopy7 a commercial laser scanning microscope (Zeiss LSM 
510 Meta) was employed. As excitation sources, a DPSS laser at 561 nm wavelength (Cyanine3 
dye) and a helium-neon gas laser at 633 nm wavelength (Cyanine5 dye) were used. The sample 
was imaged through a 63x objective lens with a numerical aperture of 1.4. 
 
High-Performance Liquid Chromatography (HPLC) 
High-performance liquid chromatography (HPLC) was performed using HPLC system 
1200 series of Agilent Technologies with degasser (G1322A), autosampler (G1329A), 
thermostated column compartment (G1316A), quaternary pump (G1311A), diode-array 
detector (G1315D), fraction collector (G1364C) and Zorbax Eclipse XDB-C18 column 
(dimensions 4.6×150 mm) from Agilent. Following purification conditions were used: eluent A 
0.1 M NH4OAc, eluent B acetonitrile, gradient 0−100% B over 40 min (Table 5.3), flowrate 
1 mL/min, UV/Vis detection at 260 nm and 280 nm. Purification was verified by MS (MALDI-
TOF). 
 
                                                 
7 Confocal fluorescence microscopy was conducted by Patrick Müller, Institute of Applied Physics, Karlsruhe 
Institute of Technology (KIT). 
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Table 5.3: Standard gradient for the purification of oligonucleotides by HPLC. Eluent A: 0.1 M 
ammonium acetate, eluent B: acetonitrile. 
t / min 0 10 15 20 25 32 40 45 
B / % 0 5 10 15 30 80 100 0 
 
Fast Protein Liquid Chromatography (FPLC) 
Protein purifications were performed on a GE Healthcare Äkta Explorer 900 FPLC 
System with a pump: P-900, detectors: Monitor UV-900 and Monitor pH/C-900, fraction 
collector: Frac-950 and MonoQ 5/50 GL anion exchange column (GE Healthcare, Germany). 
Used purification conditions: buffer A: 20 mM Tris, pH 8.3; buffer B: 20 mM Tris, 1 M NaCl, 
pH 8.3; gradient: linear increase of buffer B to 100 % in 30 minutes, flowrate: 1 mL/min, 
UV/Vis detection at 260 nm and 403 nm for the Äkta Explorer 900 FPLC System. Also another 
system was used: GE Healthcare Äkta pure 25 with HiTrap Q HP (5 mL) column. Used 
purification conditions: buffer A: 20 mM Tris, pH 6.3; buffer B: 20 mM Tris, 1 M NaCl, pH 6.3 
respectively; gradient: linear increase of buffer B to 100% in 28 minutes, flowrate: 5 mL/min, 
UV-Vis detection at 260 nm and 403 nm. 
 
Polyacrylamide Gel Electrophoresis (PAGE)  
PAGE characterization was performed by using a Mini-Protean® Tetra System, which 
was connected to PowerPac™ voltage source (BioRad, Germany). Native PAGE was used for 
the separation of DNA according to their size. 12 mL of 21% PA gel solution was prepared 
following the recipe from the Table 5.4. After polymerization of the gel solution, the glass 
plates were put into an electrophoresis system (Bio-Rad). Subsequently 1 µL of loading buffer 
(6×) was added to 5 µL of DNA sample and loaded into the wells. Gels were run in 1×TBE 
buffer at 100 V. 
 
Table 5.4: Recipe for 21% PA gel. 
Gel component Volume 
water 1.6 mL 
5×TBE 2 mL 
30% acrylamide and bis-acrylamide, solution 37.5:1 8.4 mL 
ammonium persulfate solution (10% in water) 0.1 mL 
tetramethylethylenediamine (TEMED) 0.004 mL 
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For the characterization of proteins and protein-DNA conjugates SDS-PAGE and non-
denaturing PAGE consisting of stacking and separating gels were used. The recipes of 12% 
SDS- and 12.5% non-denaturing PA gels are listed in the Table 5.5 and Table 5.6 respectively. 
For the SDS-PAGE sample preparation 4 µL of SDS loading buffer (4×) were mixed with 
12 µL Protein sample and heated for 5 minutes at 95°C. Then the samples were loaded into the 
wells and the gel was run for 30 minutes at 80 V and 1 hour at 100 V in SDS running buffer. 
For the mass reference 1 µL of the standard protein marker was added in one of the wells.  
 
Table 5.5: Recipe for SDS-PA gel. 
Gel component SDS-Stacking gel (5%) 
Volume 
SDS-Separating gel (12%) 
Volume 
water 2.20 mL 3.30 mL 
30% acrylamide and bis-
acrylamide, solution 37.5:1 
0.67 mL      4.00 mL 
0.5 M Tris/HCl, pH 6.8 1.00 mL - 
1.5 M Tris/HCl, pH 8.8 - 2.50 mL 
10% SDS solution in water 0.04 mL 0.10 mL 
10% ammonium persulfate 
solution in water 
0.04 mL 0.10 mL 
TEMED 0.004 mL 0.004 mL 
 
For the non-denaturing PAGE sample preparation 1 µL of loading buffer (6×) was added to 
5 µL of protein-DNA conjugate sample and loaded into the wells. The gel was run for 
30 minutes at 100 V and 1.5 hours at 120 V in PAGE running buffer. For the mass reference 
1 µL of the standard protein marker was added in one of the wells. 
 
Table 5.6: Recipe for non-denaturing PA gel. 
Gel component Stacking gel (5%) 
Volume 
Separating gel (12%) 
Volume 
water 2.40 mL 4.00 mL 
30% acrylamide and bis-
acrylamide, solution 37.5:1 
0.561 mL      5.00 mL 
0.5 M Tris/HCl, pH 6.8 0.428 mL - 
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1.5 M Tris/HCl, pH 8.8 - 3.00 mL 
10% ammonium persulfate 
solution in water 
0.034 mL 0.06 mL 
TEMED 0.0034 mL 0.006 mL 
 
When the gel running was completed, the gel was transferred into a staining chamber. To 
prepare the staining solution for ssDNA or dsDNA was prepared by dissolving 3 µL SYBR 
gold or ethidium bromide in 30 mL 1×TBE buffer. Bio-Rad Silver staining kit was used for 
protein staining. The images of the stained gels were taken under UV-irradiation by using a 
Bio-Rad Gel Doc™ XR imaging system. 
 
Agarose Gel Electrophoresis 
Agarose gel was prepared by dissolving certain amount of agarose in 0.5×TBE buffer 
in a microwave oven. After cooling down the solution slightly it was casted in an 
electrophoresis system. After the formation of polymerized gel, 0.5×TBE buffer was added to 
the chamber. Then 3 µl of nanoparticle loading buffer (6×) was added to 15 μL samples and 
loaded into the wells. Gels were run at 100 V. 
 
Setup for Photo-Induced Reactions 
 
 
 
Figure 5.1: Drawing of the cusom-built photoreactor employed in the current study. 
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The samples to be irradiated were crimped air-tight in headspace vials (20 mm, VWR, 
Germany) using SBR seals (VWR, Germany) with PTFE inner liner. The photoreactions were 
performed in a custom-built photoreactor (Figure 5.1), consisting of a metal disk which revolves 
at a distance of 40-50 mm around a compact low-pressure fluorescent lamp with λmax = 320 nm 
± 30 nm (36 W, Arimed B6, Cosmedico GmbH, Germany) (Figure 5.2). 
 
 
 
Figure 5.2: Emission spectrum of the employed compact low-pressure fluorescent lamp (36 w, 
Arimed B6, λmax = 320 ± 30 nm). 
For spatially controlled surface immobilization of PE2-DNA2 maleimide functionalized 
surfaces were mounted into sample holders with mask before being immersed with the reaction 
solution. 
 
Direct Laser Writing8 
The home-built direct laser writing setup is based on a tunable Titanium Sapphire 
oscillator (Coherent Chameleon Ultra II) delivering 150 fs pulses at a center wavelength of 700 
nm. The beam intensity is controlled by an acousto-optical modulator (AA Optic-Electronic). 
The laser beam is focused through an oil immersion objective lens with a numerical aperture of 
1.4 (Leica  HCX  PL  APO  100x/1.4-0.7 OILCS). The sample is held by a 3D piezo stage 
(Physik Instrumente (PI) GmbH und Co. KG) that allows for its relative translation with respect 
to the laser beam focus. An additional CCD camera is used for monitoring the writing process 
and sample alignment. 
 
                                                 
8 DLW was conducted by Patrick Müller, Institute of Applied Physics, and Dr. Alexander Quick, Institute for 
Technical Chemistry and Polymer Chemistry, Karlsruhe Institute of Technology (KIT). 
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5.2 Syntheses 
 
The syntheses of the compounds N-(2-(2,2-dimethylbenzo[d][1,3]dioxol-5-yl)ethyl)-3-
(2-(2-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethoxy)ethoxy)ethoxy)propan-amide[236] 64, 
4-maleimidobutyric acid[205] 77, dopamine-triethylene glycol methyl ether[236] 72 and di-tert-
butyl 2,2'-((6-(((benzyloxy)carbonyl)amino)-1-(tert-butoxy)-1-oxohexan-2-yl)azanediyl) 
diacetate[237] 76 was performed by Dr. Ishtiaq Ahmed, Centre for Functional Nanostructures, 
Institute for Biological Interfaces, Karlsruhe Institute of Technology (KIT), according to the 
literature procedures. 
   
Syntheses of oligonucleotide modifiers. 
 
2-(2-(2-Azidoethoxy)ethoxy)ethan-1-ol 43 
 
 
A solution of 15.2 g (101 mmol, 1 eq.) triethylene glycol and 10.8 mL (7.89 g, 
77.9 mmol, 0.770 eq.) triethylamine in 100 mL THF was cooled to 0°C. Methanesulfonyl 
chloride 2.82 mL (4.17 g, 36.4 mmol, 0.360 eq.) was added dropwise and the reaction mixture 
was brought under stirring to the ambient temperature overnight. Solvents were removed and 
the residue was re-dissolved in 100 mL EtOH. Sodium azide 4.67 g (71.9 mmol, 0.710 eq.) was 
added and the reaction mixture was heated to 95°C under reflux overnight. After cooling to 
ambient temperature solvent was removed under reduced pressure and the residue was re-
dissolved in 150 mL diethyl ether, washed three times with saturated NaCl solution. The 
organic layer was dried over sodium sulfate and the solvent was removed under reduced 
pressure. The crude product was purified by silica gel chromatography, CH/EtOAc (3:1, 2:1, 
(v/v), EtOAc), yielding 4.66 g (26.6 mmol, 26 %) of a yellow oil. 
 
1H-NMR (250 MHz, CDCl3):  
δ (ppm) = 3.39 (t, 3J = 5.2 Hz, 2H, CH2N3), 3.59 − 3.75 (m, 10 H, 5×CH2). 
 
2-(2-(2-aminoethoxy)ethoxy)ethan-1-ol 44 
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In a 100 mL three necked round bottom flask 1.50 g (8.56 mmol, 1.00 eq.) 2-(2-(2-
azidoethoxy)ethoxy)ethan-1-ol 43 was dissolved in 50 mL EtOAc under inert atmosphere. 
Subsequently 200 mg Pd(OH)2/C (10%) were added and the flask was flushed with hydrogen. 
The reaction mixture was stirred under hydrogen atmosphere at ambient temperature overnight. 
The mixture was filtered over celite in a sintered funnel to remove palladium and charcoal and 
the celite was washed with several portions of EtOAc. The solvent was removed under reduced 
pressure and 1.20 g (8.04 mmol, 94%) of amino terminated triethylene glycol 44 was obtained 
as a brown oil.  
1H-NMR (250 MHz, CD3CN):  
δ (ppm) = 2.72 − 2.81 (m, 2H, CH2NH2), 3.47 − 3.58 (m, 10 H, 5×CH2). 
 
2-(2-(2-Hydroxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate 35 
  
 
 
 
A solution of 10.0 g (66.6 mmol, 1 eq.) triethylene glycol and 4.62 mL (3.37 g, 
33.3 mmol, 0.500 eq.) triethylamine in 100 mL DCM was cooled to 0°C. A solution of 3.17 g 
(16.7 mmol, 0.250 eq.) 4-toluenesulfonyl chloride in 20 mL DCM was added dropwise and the 
reaction mixture was brought under stirring to the ambient temperature overnight. The reaction 
mixture was washed with saturated sodium bicarbonate solution 100 mL and the organic layer 
was dried over sodium sulfate. The solvent was removed under reduced pressure and the crude 
product was purified by silica gel chromatography, CH/EtOAc (2:1, 1:1, (v/v), EtOAc), 
Rf = 0.10 (CH/EtOAc, 1:1, v/v), yielding 6.20 g (20.4 mmol, 21%) of a colorless oil. 
1H-NMR (250 MHz, CDCl3):  
δ (ppm) = 2.43 (s, 3 H, CH3), 3.53 − 3.59 (m, 6 H, 3×CH2), 3.66 − 3.71 (m, 4 H, 2×CH2), 4.15 
(t, 3J = 4.7 Hz, 2H, CH2OS), 7.33 (d,
 3J = 8.1 Hz, 2 H, 2×Ar-H), 7.78 (d, 3J = 8.3 Hz, 2 H, 2×Ar-
H). 
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2-Methoxy-6-methylbenzaldehyde 39[126a] 
 
 
 
 
A suspension of 5.00 g (36.7 mmol, 1.00 eq.) 2,3-dimethylanisole, 9.15 g (36.7 mmol, 
1.00 eq.) copper(II) sulfate pentahydrate and 29.6 g (110 mmol, 3.00 eq.) potassium 
peroxydisulfate in 250 mL acetonitrile/water (1:1, v/v) was heated 20 min under reflux 
(reaction control by thin layer chromatography). The reaction mixture was cooled down to the 
ambient temperature and the non-dissolved copper salt was removed by filtration. DCM 
(100 mL) was added and the phases were separated. The aqueous phase was extracted two times 
with DCM (100 mL) and the combined organic layers were dried over sodium sulfate. After 
removal of solvent under reduced pressure, the crude product was purified by flash column 
chromatography (CH/EtOAc, (5:1, 4:1 (v/v))), Rf = 0.54 (CH/EtOAc (2:1, v/v)) yielding 3.32 g 
(22.1 mmol, 60 %) of a yellow oil.  
1H-NMR (250 MHz, CDCl3):  
δ (ppm) = 2.57 (s, 3 H, CaromCH3), 3.90 (s, 3 H, CaromOCH3), 6.82 (t, 3J = 7.8 Hz, 2 H, 2×Ar-
H), 7.38 (t, 3J = 7.8 Hz, 1 H, Ar-H), 10.65 (s, 1 H, CHO). 
 
2-Hydroxy-6-methylbenzaldehyde 40 
 
 
 
 
A solution of 3.32 g (22.1 mmol, 1.00 eq.) 2-methoxy-6-methylbenzaldehyde 39 in 
50 mL anhydrous DCM was cooled down to 0 °C. AlCl3 8.85 g (66.4 mmol, 3.00 eq.) was 
added and the reaction mixture was stirred at ambient temperature overnight. The reaction was 
quenched with water and the phases were separated. The aqueous layer was extracted three 
times with DCM (100 mL). The combined organic layers were dried over sodium sulfate and 
the solvent was removed under reduced pressure. The crude product was purified by flash 
column chromatography (CH/EtOAc (100/1, v/v), Rf = 0.24 (CH/EtOAc (80:1, v/v) yielding 
1.60 g (11.7 mmol, 53 %) of a yellow solid.  
1H-NMR (300 MHz, CDCl3):  
Experimental Part  
113 
 
δ (ppm) = 2.61 (s, 3 H, CH3), 6.71 (d, 3J = 7.4 Hz, 1 H, Ar-H), 6.82 (d, 3J = 8.5 Hz, 1 H, Ar-
H), 7.38 (t, 3J =  8.1 Hz, 1 H, Ar-H), 10.33 (s, 1 H, CHO), 11.92 (s, 1 H, CaromOH). 
 
Methyl 4-((2-formyl-3-methylphenoxy)methyl)benzoate 42 
 
 
 
 
 
 
 
A solution of 1.00 g (7.34 mmol, 1.00 eq.) 2-hydroxy-6-methylbenzaldehyde 40, 1.72 g 
(7.49 mmol, 1.02 eq.) of methyl-4-(bromomethyl)-benzoate, 1.50 g (11.0 mmol, 1.50 eq.) 
K2CO3 and 29.0 mg (110 µmol, 0.0150 eq.) 18-crown-6 in 80 mL anhydrous acetone was 
stirred at 40 °C overnight. The reaction mixture was cooled to the ambient temperature, non-
dissolved salt was filtered and the solvent was removed under reduced pressure. The residue 
was re-dissolved in 100 mL DCM/water (1:1, v/v) and acidified with 1 M HCl to  pH 1. The 
aqueous layer was extracted three times with DCM (150 mL). The combined organic layers 
were dried over sodium sulfate and the solvent was removed under reduced pressure. The crude 
product was recrystallized from hexane/EtOAc (7:1, v/v) yielding 2.10 g (7.38 mmol, 100%) 
of a pale yellow solid.  
1H-NMR (400 MHz, CDCl3):  
δ (ppm) = 2.58 (s, 3 H, CaromCH3), 3.92 (s, 3 H, COOCH3), 5.21 (s, 2 H, CH2), 6.84 (t, 
3J = 7.4 Hz, 2 H, 2×Ar-H), 7.36 (t, 3J = 7.9 Hz, 1 H, Ar-H), 7.49 (dt, 3J = 8.5 Hz, 2 H, 2×Ar-
H), 8.06 (dt, 3J = 8.4 Hz, 4J = 1.8 Hz, 2 H, 2×Ar-H),  10.75 (s, 1 H, CHO). 
 MS (EI, 70 eV), m/z (%): 284 (32) [M+], 149 (100), 121 (18). 
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4-((2-Formyl-3-methylphenoxy)methyl)benzoic acid 30 
 
 
 
 
 
 
 
A solution of 900 mg (22.5 mmol, 4.00 eq.) NaOH in 10 mL MeOH was added to a 
solution of 1.60 g (5.63 mmol, 1.00 eq.) methyl-4-((2-formyl-3-methylphenoxy)-
methyl)benzoate 42 in 100 mL DCM. The reaction mixture was stirred at ambient temperature 
overnight. Solvents were removed under reduced pressure and the residue was re-dissolved in 
100 mL DCM/water (1:1, v/v). The organic phase was extracted three times with water and the 
combined aqueous layers were acidified with 1 M HCl to pH 3. The aqueous layer was extracted 
tree times with DCM (150 mL). The combined organic layers were dried over sodium sulfate 
and the solvent was removed under reduced pressure yielding 1.15 g (4.25 mmol, 76 %) of a 
yellow solid.  
1H-NMR (250 MHz, CDCl3):  
δ (ppm) = 2.52 (s, 3 H, CH3), 5.39 (s, 2 H, CH2), 6.90 (dt, 3J = 7.6 Hz, 1 H, Ar-H), 7.14 (d, 
3J = 8.4 Hz, 1 H, Ar-H), 7.46 (t, 3J = 8.3 Hz, 1 H, Ar-H), 7.68 (d, 3J = 8.5 Hz, 2 H, 2×Ar-H), 
8.09 (dt, 3J = 8.5 Hz, 4J = 1.8 Hz, 2 H, 2×Ar-H), 10.74 (s, 1 H, CHO).  
MS (EI, 70 eV), m/z (%): 270 (36) [M+], 135 (100). 
 
4-((2-Formyl-3-methylphenoxy)methyl)-N-(2-(2-(2-
hydroxyethoxy)ethoxy)ethyl)benzamide 37 
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The synthesis was performed under inert conditions using the literature procedure.[157] 
The solution of 100 mg (370 µmol, 1.00 eq.) 4-((2-formyl-3-methylphenoxy)methyl)benzoic 
acid 30 and 51.0 mg (377 µmol, 1.02 eq.) HOBt in 10 mL dry DMF was stirred for 10 minutes 
at room temperature. 78.0 mg (377 µmol, 1.02 eq.) DCC in 5 mL dry DMF were added and the 
solution was stirred for another 10 minutes, before 43.0 mg (377 µmol, 1.02 eq.) NHS in 10 mL 
dry DMF were added dropwise over a period of 30 minutes. The reaction was continued for 
2 hours. The resulting NHS ester was added dropwise to a stirred solution of 61.0 mg 
(407 µmol, 1.10 eq.) 2-(2-(2-aminoethoxy)ethoxy)ethan-1-ol 44 in 10 mL dry DMF over a 
period of 45 minutes. The reaction mixture was stirred for 48 h at room temperature. The urea 
side product was removed by filtration and the crude product was transferred to chloroform. 
The organic solution was washed three times with saturated NaCl solution and deionized water. 
The organic phase was dried over Na2SO4 and the solvent removed under reduced pressure. 
The crude product was purified by silica gel chromatography, CH/EtOAc (3:1, 1:1, 1:2 (v/v), 
MeOH), Rf = 0.14 (EtOAc), yielding 69.8 mg (174 µmol, 47 %) of a yellow solid. 
1H-NMR (300 MHz, CDCl3):  
δ (ppm) = 2.56 (s, 3 H, CH3), 3.56 – 3.59 (m, 2 H, NHCH2),  3.65 – 3.68 (m, 10 H, 5×CH2), 
5.17 (s, 2 H, CaromCH2OCarom), 6.83 (t, 
3J = 8.0 Hz, 2 H, 2×Ar-H), 7.34 (t, 3J = 8.0 Hz, 1 H, Ar-
H), 7.46 (d, 3J = 8.2 Hz, 2 H, 2×Ar-H), 7.84 (d, 3J = 8.2 Hz, 2 H, 2×Ar-H), 10.71 (s, 1 H, CHO).  
13C-NMR (100 MHz, CDCl3):  
δ = 21.40 (CH3), 39.71 (NHCH2), 61.47 (CH2OH), 70.02 (4×CH2), 110.31 (C-Ar), 123.52 
(Cquart, CaromCHO), 124.56 (C-Ar), 127.00 (2×C-Ar), 127.47 (2×C-Ar), 134.19 (Cquart, 
CaromCONH), 134.40 (C-Ar), 139.63 (Cquart, CaromCH2OCarom), 142.17 (Cquart, CaromCH3), 
161.89 (Cquart, CaromOCH2), 167.09 (Cquart, CONH), 192.09 (Cquart, CHO). 
IR (ATR Platinum):  
ῦ = 3456 (w, ν (O-H)), 3319 (w, ν (N-H)), 2890 (w, ν (C-H)), 1688 (m, ν (C-N), ν (C=O)), 
1644 (m, ν (NHC=O), ν (C=C)), 1537 (m, ν (C-H)), 1271 (s, ν (C-O)). 
HR-MS (FAB, matrix: 3-NBA), m/z [M+H]+ calculated for C22H28O6N1 402.1911; found, 
402.1912. 
 
(4-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)-2,5-dimethylphenyl)(phenyl)methanone 36 
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A solution of 620 mg (2.74 mmol, 1.00 eq.) (4-hydroxy-2,5-
dimethylphenyl)(phenyl)methanone 31, 1.00 g (3.29 mmol, 1.20 eq.) of 2-(2-(2-
hydroxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate 35, 1.14 g (8.21 mmol, 3.00 eq.) 
K2CO3, 7.00 mg (82.0 µmol, 0.0300 eq.) LiBr and 22.0 mg (82.0 µmol, 0.0300 eq.) 18-crown-
6 in 80 mL anhydrous acetonitrile was heated under reflux overnight. The reaction mixture was 
cooled to the ambient temperature, non-dissolved salt was filtered and washed with acetone. 
The solvents were removed under reduced pressure. The crude product was purified by silica 
gel chromatography, CH/EtOAc (1:1, 1:2, 1:3 (v/v)), Rf = 0.15 (CH/EtOAc, 1:1, v/v), yielding 
851 mg (2.37 mmol, 87 %) of a colorless oil. 
 
1H-NMR (400 MHz, CDCl3):  
δ (ppm) = 2.17 (s, 3 H, CH3), 2.36 (s, 3 H, CH3), 2.49 (br, 1 H, OH), 3.62 (t, 3J = 4.9 Hz, 2 H, 
CH2),   3.69 – 3.77 (m, 6 H, 3×CH2),  3.91 (t, 3J = 4.9 Hz, 2 H, CH2), 4.20 (t, 3J = 4.6 Hz, 2 H, 
CH2), 6.71 (s, 1 H, Ar-H), 7.15 (s, 1 H, Ar-H), 7.43 (t, 
3J = 7.8 Hz, 2 H, 2×Ar-H), 7.55 (tt, 
3J = 7.4 Hz, 4J = 1.2 Hz 1 H, Ar-H), 7.75 (d, 3J = 7.1 Hz, 2 H, 2×Ar-H). 
13C-NMR (100 MHz, CDCl3):  
δ = 15.69 (CH3), 20.55 (CH3), 61.73 (CH2OH), 67.65 (CaromOCH2), 69.70 (CH2), 70.41 (CH2), 
70.97 (CH2), 72.46 (CH2), 113.56 (C-Ar), 123.35 (Cquart, CaromCH3), 128.22 (2×C-Ar), 129.96 
(2×C-Ar), 130.30 (Cquart, CCO), 132.43 (C-Ar), 132.48 (C-Ar), 137.65 (Cquart, CaromCH3), 
138.72 (Cquart, CCO), 158.51 (Cquart, CaromO), 197.99 (Cquart, CO).  
MS (FAB, matrix: 3-NBA), m/z (%): 359 (80) [M+H]+, 105 (100). 
 
4-((2-Tosylhydrazono)methyl)benzoic acid 60 
 
 
 
 
 
 
A mixture of 6.56 g (43.7 mmol, 1.00 eq.) 4-formylbenzoic acid and 8.14 g (43.7 mmol, 
1.00 eq.)  p-toluenesulfonyl hydrazide in 100 mL ethanol was heated under reflux for 30 min. 
The reaction mixture was diluted with 100 mL water and the precipitate was filtered off. The 
Experimental Part  
117 
 
solid was washed with 100 mL aqueous EtOH and dried under reduced pressure to give 11.3 g 
(35.3 mmol, 81%) of a colorless solid. 
1H-NMR (250 MHz, DMSO-d6):  
δ (ppm) = 2.35 (s, 3 H, CH3), 7.40 (d, 3J = 8.1 Hz, 2 H, 2×Ar-H), 7.66 (d, 3J = 8.4 Hz, 2 H, 
2×Ar-H), 7.76 (d, 3J = 8.3 Hz, 2 H, 2×Ar-H), 7.93 (d, 3J = 8.3 Hz, 2 H, 2×Ar-H), 7.96 (s, 1 H, 
NCH), 11.69 (s, 1 H, NH).  
 
4-(2-(4-Methoxyphenyl)-2H-tetrazol-5-yl)benzoic acid 24 
 
 
 
 
 
In a 250 ml round bottom flask 4.00 g (32.5 mmol, 1.00 eq.) of p-anisidine were 
dissolved in a mixture of concentrated HCl (8.46 mL), H2O (26.9 mL) and EtOH (26.9 mL) 
and cooled to 0°C. A cooled solution of 2.24 g (32.5 mmol, 1.00 eq.) NaNO2 in 13.5 mL H2O 
was added dropwise and stirred for 10 min at 0 °C. Formed diazonium salt solution was added 
dropwise to a solution of 10.3 g (32.5 mmol, 1.00 eq.) 4-((2-tosylhydrazono)methyl)benzoic 
acid 60 in 200 mL pyridine at the temperature between -10 °C and -5 °C over a period of 
45 min. After complete addition, the solution was stirred at 0 °C for 30 min and at the ambient 
temperature overnight. The turbid solution was poured into a 10% aqueous HCl solution (500 
mL), the precipitate was filtered off, washed with 500 mL EtOH and dried under reduced 
pressure to give 6.00 g (20.3 mmol, 62%) of a purple solid. 
1H-NMR (250 MHz, DMSO-d6):  
δ (ppm) = 3.86 (s, 3 H, CH3), 7.21 (dt, 3J = 9.1 Hz, 4J = 2.2 Hz, 2 H, 2×Ar-H), 8.06 (dt, 
3J = 9.1 Hz, 4J = 2.2 Hz, 2 H, 2×Ar-H), 8.13 (dt, 3J = 8.5 Hz, 4J = 1.8 Hz, 2 H, 2×Ar-H), 8.25 
(dt, 3J = 8.5 Hz, 4J = 1.8 Hz, 2 H, 2×Ar-H), 13.26 (br, 1 H, COOH). 
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2,5-Dioxopyrrolidin-1-yl 4-((2-formyl-3-methylphenoxy)methyl)benzoate 55 
 
 
 
 
  
 
 
 
In a 50 mL two necked round bottom flask 100 mg (369 µmol, 1.00 eq.) 4-((2-formyl-
3-methylphenoxy)methyl)benzoic acid 30 and 51.1 mg (440 µmol, 1.20 eq.) NHS were 
dissolved in 20 mL anhydrous THF under inert atmosphere. The reaction mixture was cooled 
to 0 °C and 91.6 mg (444 µmol, 1.20 eq.) DCC were added. The stirring was continued at 
ambient temperature overnight. After the filtration of DCU salt solvent was removed under 
reduced pressure and the crude product was purified by flush column chromatography 
DCM/MeOH (DCM, 99.5:0.5, 99:1 (v/v)), Rf = 0.56 (DCM/MeOH, 98:2, v/v), yielding 130 mg 
(353 µmol, 96 %) of a pale yellow solid. 
1H-NMR (500 MHz, CDCl3):  
δ (ppm) = 2.59 (s, 3 H, CH3), 2.91 (br, 4 H, 2×CH2), 5.26 (s, 2 H, CH2), 6.82 − 6.86 (m, 2 H, 
2×Ar-H), 7.36 (t, 3J = 8.0 Hz, 1 H, Ar-H), 7.57 (d, 3J = 8.2 Hz, 2 H, 2×Ar-H), 8.16 (d, 
3J = 8.2 Hz, 2 H, 2×Ar-H), 10.76 (s, 1 H, CHO).   
13C-NMR (126 MHz, CDCl3):  
δ = 21.44 (CH3), 25.65 (2×CH2), 69.56 (CH2), 110.23 (C-Ar), 123.64 (Cquart, CaromCHO), 
124.84 (C-Ar), 127.02 (2×C-Ar), 130.99 (2×C-Ar), 134.39 (C-Ar), 142.37 (Cquart, CaromCH3), 
143.73 (Cquart, CaromCH2), 161.47 (Cquart, CaromO), 161.57 (Cquart, CaromCOO), 169.16 (2×Cquart, 
2×CON), 191.79 (Cquart, CHO).        
IR (ATR Platinum):  
ῦ = 1763 (w, ν (C=O)), 1730 (w, ν (C=ON), ν (C=OO), 1685 (w, ν (C-N), ν (N-O)), 1575 (w, 
ν (C=C)), 1236 (w, ν (C-O)). 
HR-MS (EI, 70 eV), m/z [M+] calculated for C20H17O6N1 367.1050; found, 367.1052. 
 
 
 
 
Experimental Part  
119 
 
2,5-Dioxopyrrolidin-1-yl 4-(2-(4-methoxyphenyl)-2H-tetrazol-5-yl)benzoate 62 
  
 
 
 
 
 
 
In a 50 mL two necked round bottom flask 100 mg (338 µmol, 1.00 eq.) 4-(2-(4-
methoxyphenyl)-2H-tetrazol-5-yl)benzoic acid 24 and 47.0 mg (405 µmol, 1.20 eq.) NHS were 
dissolved in 20 mL anhydrous THF under inert atmosphere. The reaction mixture was cooled 
to 0 °C and 84.0 mg (405 µmol, 1.20 eq.) DCC were added. The stirring was continued at 
ambient temperature overnight. After the filtration of DCU salt solvent was removed under 
reduced pressure and the crude product was purified by flush column chromatography 
DCM/MeOH (DCM, 99.5:0.5, 99:1 (v/v)), Rf = 0.58 (DCM/MeOH, 98:2, v/v), yielding 110 mg 
(279 µmol, 83 %) of a pink solid.  
1H-NMR (500 MHz, CDCl3):  
δ (ppm) = 2.94 (br, 4 H, 2×CH2), 3.90 (s, 3 H, CH3), 7.07 (d, 3J = 8.7 Hz, 2 H, 2×Ar-H), 8.11 
(d, 3J = 8.7 Hz, 2 H, 2×Ar-H), 8.29 (d, 3J = 8.1 Hz, 2 H, 2×Ar-H), 8.40 (d, 3J = 8.1 Hz, 2 H, 
2×Ar-H).     
13C-NMR (126 MHz, CDCl3):  
δ = 25.69 (2×CH2), 55.69 (CH3), 114.76 (2×C-Ar), 121.50 (2×C-Ar), 126.54 (Cquart, CaromN), 
127.21 (2×C-Ar), 130.21 (Cquart, CaromCOO), 131.20 (2×C-Ar), 133.26 (Cquart, CaromCN), 160.77 
(Cquart, CaromCO), 161.39 (Cquart, CaromCN), 163.63 (Cquart, COO), 169.11 (Cquart, 2×CON).  
IR (ATR Platinum):  
ῦ = 2940 (vw, ν (C-H)), 1765 (m, ν (C=O)), 1730 (m, ν (C=N), ν (N=N), ν (C=C)), (w, ν 
(C=ON), ν (C=OO), 1512 (m, ν (C=C)), 1200 (w, ν (C-O)). 
HR-MS (FAB, matrix: 3-NBA), m/z [M+H]+ calculated for C19H16O5N5 394.1146; found, 
394.1144. 
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2-(2-(2-(4-((2-Formyl-3-methylphenoxy)methyl)benzamido)ethoxy)ethoxy)ethyl 
phosphonate thriethylammonium salt 49 
 
Compound 49 was synthesized under inert conditions according to a reported method 
with slight modification.[47] 4-((2-Formyl-3-methylphenoxy)methyl)-N-(2-(2-(2-hydroxy-
ethoxy)ethoxy)ethyl)benzamide 37 120 mg (299 µmol, 1.00 eq.) was dissolved in a solution of 
1 M phosphorous acid in anhydrous pyridine (681 mg, 8.31 mmol, 27.7 eq. of H3PO3 dissolved 
in 9.80 ml pyridine). Pivaloyl chloride 202 µL (1.64 mmol, 5.50 eq.) was added dropwise to 
the reaction mixture. The solution became briefly opaque and was stirred for a further 2 hours. 
Once complete (TLC control), the reaction mixture was quenched by addition of TEAB buffer 
(8.40 mL, 2 M, pH 7.7) and was then extracted twice with DCM. The organic layers were 
combined and dried over Na2SO4. The solvents were removed under reduced pressure to give 
the product 49 as a yellow thick oil, which was used in the next step without further purification. 
31P-NMR (100 MHz, CD3CN): δ (ppm) = 3.78 (s, 1 P). 
 
2-(2-(2-(4-Benzoyl-2,5-dimethylphenoxy)ethoxy)ethoxy)ethyl phosphonate 
triethyammonium salt 51 
 
 
 
 
 
 
Compound 51 was synthesized under inert conditions according to a reported method 
with slight modification.[47] (4-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)-2,5-
dimethylphenyl)(phenyl)methanone 36 61.0 mg (170 µmol, 1.00 eq.) was dissolved in a 
solution of 1 M phosphorous acid in anhydrous pyridine (388 mg, 4.73 mmol, 27.7 eq. of H3PO3 
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dissolved in 5.57 ml pyridine). Pivaloyl chloride 115 µL (936 µmol, 5.50 eq.) was added 
dropwise to the reaction mixture. The solution became briefly opaque and was stirred for a 
further 30 minutes. Once complete, the reaction mixture was quenched by addition of TEAB 
buffer (3.88 mL, 2 M, pH 7.7) and was then extracted twice with DCM. The organic layers were 
combined and dried over Na2SO4. The solvents were removed under reduced pressure to give 
the product 51 as a pale yellow semi-solid, which was used in the next step without further 
purification. 
31P-NMR (100 MHz, CD3CN): δ (ppm) = 3.47 (s, 1 P). 
 
2-(2-(2-(4-Benzoyl-2,5-dimethylphenoxy)ethoxy)ethoxy)ethyl (2-cyanoethyl) 
diisopropylphosphoramidite 46 
 
 
Compound 46 was synthesized under inert conditions using the procedure described by 
Ligeour and co-workers.[238] DIPEA 199 µL (1.17 mmol, 2.00 eq.) and 2-cyanoethyl N,N-
diisopropylchlorophosphoramidite 196 µL (879 µmol, 1.50 eq.) were added to a solution of 
21.0 mg (586 µmol, 1.00 eq.) (4-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)-2,5-
dimethylphenyl)(phenyl)methanone 36 in 3 mL of anhydrous CH2Cl2 and stirred 2 h at ambient 
temperature. The reaction mixture was washed with saturated NaHCO3 solution and dried over 
Na2SO4. The solvents were removed under reduced pressure to give the product 46 as a 
colorless semi-solid, which was used in the next step without further purification.  
31P-NMR (100 MHz, CD3CN): δ = 11.8; 18.2; 149.2. 
 
Nanoparticle Linker Syntheses 
 
4-Maleimidobutyroyl chloride 78 
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4-Maleimidobutyric acid (1.10 g, 6.01 mmol) was dissolved in benzene (10 mL) and 
thionyl chloride (1.00 mL) was added. The reaction mixture was refluxed for 2 h at 70°C. 
Subsequently, the benzene and non-reacted thionyl chloride were removed under reduced 
pressure yielding 1.10 g (5.46 mmol, 99%) of a white powder. 
1H-NMR (250 MHz, CDCl3):  
δ (ppm) = 1.98 (quint, 3J = 6.9 Hz, 2 H, CH2), 2.92 (t, 3J = 7.2 Hz, 2 H, CH2), 3.59 (t, 
3J = 6.7 Hz, 2 H, CH2), 6.72 (s, 2 H, 2×CH).    
 
2,2'-((5-(((Benzyloxy)carbonyl)amino)-1-carboxypentyl)azanediyl)diacetic acid 75 
 
      
 
 
 
In a 100 mL round bottom flask 6.96 g (50.1 mmol, 2.81 eq.) bromoacetic acid were 
dissolved in 15 mL of 2 M NaOH solution and cooled to 0 °C. Under vigorous stirring the 
solution of 5.00 g (17.8 mmol, 1.00 eq.) N(γ)-benzyloxycarbonyl-L-lysine in 15.0 mL of 2 m 
NaOH was added dropwise at 0 °C. After 2 h, the ice bath was removed and the reaction 
mixture was stirred at ambient temperature overnight. The solution was heated to 50 °C for 2 h. 
The reaction mixture was cooled to the ambient temperature and 48 mL of 1 M HCl solution 
was added. Formed crystals were filtered and re-dissolved in 1 M NaOH solution. The product 
precipitated out by the dropwise addition of 1 M NaOH solution and was collected by filtration 
yielding 3.54 g (8.93 mmol, 50%) of a white solid.  
1H-NMR (250 MHz, DMSO-d6):  
δ (ppm) = 1.32 – 1.44 (m, 4 H, 2×CH2), 1.47 – 1.69 (m, 2 H, CH2), 2.92 – 3.00 (m, 2 H, 
CH2NH), 3.31 (t, 
3J = 7.3 Hz, 1 H, NCHCH2),  3.46 (dd, 4 H, (HOCOCH2)2N), 4.99 (s, 2 H, 
CaromCH2OCONH), 7.27 – 7.36 (m, 5 H, 5×Ar-H). 
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Di-tert-butyl 2,2'-((6-amino-1-(tert-butoxy)-1-oxohexan-2-yl)azanediyl)diacetate 79 
 
 
 
 
 
 
In a 100 mL three necked round bottom flask 2.00 g (3.54 mmol, 1.00 eq.) di-tert-butyl 
2,2'-((6-(((benzyloxy)carbonyl)amino)-1-(tert-butoxy)-1-oxohexan-2-yl)azanediyl) 
diacetate 76 was dissolved in 50 mL MeOH under inert atmosphere. Subsequently 200 mg 
Pd/C (10%) were added and the flask was flushed with hydrogen. The reaction mixture was 
completed after 5 h as monitored by TLC (CH/EtOAc (2:1, v/v)) and visualized by UV and 
ninhydrin staining. The mixture was filtered over celite in a sintered funnel to remove palladium 
and charcoal and the celite was washed with several portions of MeOH. The solvent was 
removed under reduced pressure and 1.45 g (3.37 mmol, 95%) of the compound 79 were 
obtained as a yellow oil. 
1H-NMR (400 MHz, CDCl3):  
δ (ppm) = 1.07 – 1.27 (m, 2 H, CH2), 1.44 (s, 18 H, ((CH3)3COCOCH2)2N), 1.45 (s, 9 H,  
(CH3)3COCOCHN), 1.47 – 1.54 (m, 2 H, CH2), 1.56 – 1.70 (m, 2 H, CH2), 2.67 (t, 3J = 6.6 Hz, 
2 H, CH2), 3.30 (t, 
3J = 7.4 Hz, 1 H, NCHCH2),  3.45 (s, 2 H, (CH3)3COCOCH2N), 3.47 (d, 
2 H, (CH3)3COCOCH2N). 
 
Di-tert-butyl 2,2'-((1-(tert-butoxy)-6-(4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-
yl)butanamido)-1-oxohexan-2-yl)azanediyl)diacetate 80 
 
 
 
 
 
 
 
In a 100 mL two necked round bottom flask 870 mg (2.02 mmol, 1.00 eq.) di-tert-butyl 
2,2'-((6-amino-1-(tert-butoxy)-1-oxohexan-2-yl)azanediyl)diacetate 79 and 0.559 mL 
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(408 mg, 4.03 mmol, 2.00 eq.) triethylamine were dissolved in 50 mL anhydrous DCM under 
inert atmosphere. The reaction mixture was cooled to 0 °C and the solution of 1.22 g 
(6.05 mmol, 3.00 eq.) 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)butanoyl chloride 78 in 
20.0 mL of anhydrous DCM was added dropwise at 0 °C. The reaction mixture was warmed to 
the ambient temperature under stirring overnight. The solvent was removed under reduced 
pressure and the crude product was purified by flash column chromatography DCM/MeOH 
(DCM, 99:1, 99:2 (v/v)), Rf = 0.75 (DCM/MeOH, 9:1, v/v), yielding 1.01 g (1.69 mmol, 84 %) 
of a yellow oil. 
1H-NMR (400 MHz, CDCl3):  
δ (ppm) = 1.44 (s, 18 H, 6×CH3), 1.45 (s, 9 H, 3×CH3), 1.47 − 1.58 (m, 4 H, 2×CH2), 
1.59 − 1.66 (m, 2 H, CH2), 1.93 (quint, 3J = 7.0 Hz, 2 H, CH2), 2.17 (t, 3J = 7.3 Hz, 2 H, CH2), 
3.15 − 3.25 (m, 2 H, CH2), 3.29 (t, 3J = 6.8 Hz, 1 H, CH), 3.42 (s, 2 H, CH2), 3.45 (s, 2 H, CH2), 
3.55 (t, 3J = 6.7 Hz, 2 H, CH2), 6.68 (s, 2 H, 2×CH).       
13C-NMR (100 MHz, CDCl3):  
δ = 22.87 (CH2), 24.81 (CH2), 28.10 (6×CH3), 28.19 (3×CH3), 28.38 (CH2), 29.79 (CH2), 33.56 
(CH2), 37.30 (CH2), 39.22 (CH2), 53.89 (2×CH2), 64.85 (CH), 80.73 (Cquart, 2×(OC(CH3)3), 
81.12 (Cquart, OC(CH3)3), 134.08 (Cquart, 2×CHCON), 170.74 (Cquart, 2×CH2COO), 170.84 
(Cquart, CHCOO), 171.79 (Cquart, CONH), 172.42 (Cquart, 2×CON).          
IR (ATR Platinum):  
ῦ = 2975 (w, ν (C-H), ν (N-H)), 1704 (s, ν (C=O), ν (C=C), δ (N-H)), 1365 (m, δs (C-H)), 1138 
(s, ν (C-O)).  
HR-MS (FAB, matrix: 3-NBA), m/z [M+H]+ calculated for C30H50O9N3 596.3542; found, 
596.3543. 
 
2,2'-((1-Carboxy-5-(4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-
yl)butanamido)pentyl)azanediyl)diacetic acid 81 
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In a 25 mL round bottom flask 100 mg (168 µmol, 1 eq.) di-tert-butyl 2,2'-((1-(tert-
butoxy)-6-(4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)butanamido)-1-oxohexan-2-
yl)azanediyl)diacetate 80 were dissolved in 5 mL DCM and the solution was cooled to 0 °C. 
Subsequently 1.00 mL TFA was added and the reaction mixture was stirred 3 h at the ambient 
temperature. The solvent was removed under reduced pressure and the rest of TFA was co-
evaporated three times (30 mL) with toluene yielding 70.7 mg (165 µmol, 98%) of a yellow 
oil. 
1H-NMR (400 MHz, DMSO-d6):  
δ (ppm) = 1.35 − 1.39 (m, 4 H, 2×CH2), 1.46 − 1.62 (m, 2 H, CH2), 1.69 (t, 3J = 7.2 Hz, 2 H, 
CH2), 2.02 (t, 
3J = 7.5 Hz, 2 H, CH2), 2.93 − 2.98 (m, 2 H, CH2), 3.36 − 3.42 (m, 5 H, 2×CH2, 
CH), 3.57 − 3.60 (m, 2 H, CH2), 6.70 (s, 2 H, 2×CH2).          
13C-NMR (100 MHz, DMSO-d6):  
δ = 24.12 (CH2), 28.75 (CH2), 32.54 (CH2), 36.35 (CH2), 36.82 (2×CH2), 38.26 (CH2), 52.44 
(CH2), 53.18 (CH2), 63.82 (CH), 134.39 (Cquart, 2×CHCON), 170.91 (Cquart, 2×CH2COOH), 
170.99 (Cquart, 2×CON), 172.37 (Cquart, CONH), 173.11 (Cquart, CHCOOH).           
IR (ATR Platinum):  
ῦ = 3085 (w, ν (O-H)),  2938 (w, ν (C-H), ν (N-H)), 1698 (s, ν (C=O), ν (C=C), δ (N-H)), 1407 
(m, δs (C-H)), 1141 (s, ν (C-O)).  
HR-MS (FAB, matrix: 3-NBA), m/z [M+H]+ calculated for C18H26O9N3 428.1664; found, 
428.1662. 
 
5.3 DNA Modification 
 
Phosphoramidite Method 
The synthesis of the PE1-DNA1 48 was performed on an Expedite 7/99 Synthesizer 
from PerSeptive Biosystems in a group of Prof. Dr. Hans-Achim Wagenknecht at the Institute 
for Organic Chemistry, Karlsruhe Institute of Technology (KIT) under the supervision of 
Claudia Stubinitzky using standard phosphoramidite coupling protocol (Table 5.7). Reagents 
and CPG (0.100 µmol) were purchased from ABI and Glen Research. The commercially 
available (Proligo) phosphoramidites of the natural DNA bases and the synthesized 
photoenol(1) phosphoramidite 46 were dissolved under inert atmosphere in absolute 
acetonitrile (67.0 mM and 100 mM respectively). The coupling reagents and the building blocks 
were conveyed in a pulsed mode with 16 µL per pulse. The coupling protocol contains the 
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information about the conveyed substance, the pulse number and the duration of single steps in 
seconds. The time period of 0 s represents the minimum time of a single step. Used coupling 
reagents: 
 Dblk: 3% dichloroacetic acid in DCM 
 Wsh: acetonitrile 
 Act: 450 mM tetrazole in acetonitrile 
 Caps: acetic anhydride in THF/pyridine (Cap A) and N-methylimidazole in 
THF/pyridine (Cap B) 
 Ox: iodine in water/THF/pyridine 
 
  
Table 5.7: Standard coupling protocol for natural bases with thymine (T) as example. 
Coding Function Mode 
Amount 
/Arg1 
Time (s) 
/Arg2 
$Deblocking     
144 Index Fract. Coll. NA 1 0 
0 Default WAIT 0 1.5 
141 Trityl Mon. On/Off NA 1 1 
16 Dblk PULSE 10 0 
16 Dblk PULSE 50 49 
38 Diverted Wsh A PULSE 40 0 
141 Trityl Mon. On/Off NA 0 1 
38 Diverted Wsh A PULSE 40 0 
144 Index Fract. Coll. NA 2 0 
$Coupling     
1 Wsh PULSE 5 0 
2 Act PULSE 5 0 
21 T+Act PULSE 5 0 
21 T+Act PULSE 2 16 
2 Act PULSE 3 24 
1 Wsh PULSE 7 56 
1 Wsh PULSE 8 0 
$Capping     
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12 Wsh A PULSE 20 0 
13 Caps PULSE 8 0 
12 Wsh A PULSE 6 15 
12 Wsh A PULSE 14 0 
$Oxidizing     
15 Ox PULSE 15 0 
12 Wsh A PULSE 15 0 
$Capping     
13 Caps PULSE 7 0 
12 Wsh A PULSE 30 0 
 
For the photoenol(1) phosphoramidite 46 the coupling time was enhanced from 96 s to 560 s. 
Table 5.8 shows the modified section "$Coupling" of standard protocol. 
  
Table 5.8: Coupling protocol for the photoenol phosphoramidite 46. 
$Coupling     
1 Wsh PULSE 5 0 
2 Act PULSE 5 0 
22 46+Act PULSE 5 0 
22 46+Act PULSE 2 120 
2 Act PULSE 4 240 
1 Wsh PULSE 7 200 
1 Wsh PULSE 8 0 
 
The synthesized PE1-DNA1 48 was cleaved from the resin and deprotected by incubation with 
25% aqueous ammonia solution at 60 °C for 3 h. The resin was filtered off, washed with de-
ionized water and the solvents were removed in vacuum concentrator. The crude 
PE1-DNA1 48 was re-dissolved in de-ionized water (500 µL) and purified by HPLC. Product 
fraction was collected and the solvent was removed in vacuum concentrator. After re-dissolving 
in de-ionized water (1.50 mL), PE1-DNA1 48 was quantified by the absorbance at 260 nm on 
a Cary 300 Scan spectrophotometer and analyzed by MALDI-TOF (Table 5.9) and gel 
electrophoresis (21% PA gel, 30 min at 100 V, 50 min at 120 V in TBE running buffer. 
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Table 5.9: MALDI-TOF MS results for the photoenol modified oligonucleotide PE1-DNA1 48, 
theoretical and found values in [g/mol]. 
 [M]theo [g/mol] [M]found [g/mol] 
PE1-DNA1 48 4154 4153 
 
H-Posphonate Method 
For the photoenol modification of DNA (205 nmol) H-phosphonates 51 and 49 were 
used following the procedure below.  
The commercial dimethoxytrityl (DMT) protected oligonucleotide (1.00 eq.) on controlled pore 
glass (CPG) solid support was deprotected with dichloroacetic acid (3% in DCM). The reaction 
completion was followed by color change from orange-yellow to colorless. The solid support 
was washed several times with acetonitrile, dried and transferred to a previously silanized flask. 
The H-phosphonate  (350 eq.) was dissolved in anhydrous CH3CN/pyridine (1:1, v/v) 
(360 mM) under inert atmosphere and added to the CPG. Pivaloyl chloride (100 eq., 100 mM in 
anhydrous CH3CN/pyridine (1:1, v/v)) was added and the reaction mixture was stirred at 39 °C 
for 16 hours. The reaction solution was removed by centrifugation and the solid support washed 
five times with CH3CN (5 mL). After treatment with standard DNA synthesis oxidizing 
solution (500 µL) for 10 minutes in case of modification with photoenol 51 and for 3 minutes, 
when photoenol 49 was used, the CPG was washed five times with CH3CN (5 mL). The PE-
modified sequence was deprotected and cleaved from the solid support by incubation with 
750 µL 25% ammonia solution at 55 °C for 5 hours. The supernatant was collected and the 
solvents removed in vacuum concentrator. Photoenol modified oligonucleotide was dissolved 
in water and purified by reversed phase HPLC. The main fractions were collected, concentrated 
in vacuum concentrator, quantified by the absorbance at 260 nm on a Cary 300 Scan 
spectrophotometer and characterized by MALDI-TOF (Table 5.10) and PA gel electrophoresis 
(21% PA gel, 30 min at 100 V, 50 min at 120 V in TBE running buffer. 
 
Table 5.10: MALDI-TOF MS results for the photoenol modified oligonucleotides; theoretical and found 
values in [g/mol]. 
 [M]theo [g/mol] [M]found [g/mol] 
PE1-DNA1 48 4154 4156 
PE2-DNA1 53 4197 4196 
PE2-DNA2 54 7356 7354 
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Amide Coupling via Active Ester (NHS ester) Method. 
The commercial dimethoxytrityl (DMT) protected NH2-DNA2 (or NH2-DNA3) 
(175.3 nmol, 1.00 eq. (or 177.6 nmol, 1.00 eq.)) on controlled pore glass (CPG) solid support 
was deprotected with dichloroacetic acid (3% in DCM). The reaction completion was followed 
by color change from orange-yellow to colorless. The solid support was washed five times 
(5 mL) with acetonitrile, dried and transferred to an Eppendorf® Safe-Lock tube. In another 
tube 20.0 mg (54.4 µmol, 310 eq.) NHS ester 55 were dissolved in 300 µL anhydrous DMF 
under inert atmosphere and added to the CPG. Subsequently, 10 µL (7.60 µg, 58.8 nmol, 
0.335 eq.) DIPEA were added and the reaction mixture was incubated at 40 °C for 2 h. The 
reaction solution was removed by centrifugation and the solid support washed five times with 
DMF (5 mL) and three times with acetonitrile (3 mL). The PE-modified sequence was 
deprotected and cleaved from the solid support by incubation with 750 µL 25% ammonia 
solution at 55 °C for 5 hours. The supernatant was collected and the solvents removed in 
vacuum concentrator. Photoenol modified oligonucleotide was dissolved in water and purified 
by reversed phase HPLC. The main fractions were collected, concentrated in vacuum 
concentrator, quantified by the absorbance at 260 nm on a Cary 300 Scan spectrophotometer 
and characterized by MALDI-TOF (Table 5.11) and PA gel electrophoresis 21% PA gel, 
30 min at 100 V, 50 min at 120 V in TBE running buffer. 
For the modification of NH2-DNA2 with tetrazole moiety same procedure as described 
above with slight modification was used. For the coupling step 40.0 mg (102 µmol, 580 eq.) 
NHS ester 62 were dissolved in 700 µL anhydrous DMF under inert atmosphere and added to 
the CPG. Subsequently, 10 µL (7.60 µg, 58.8 nmol, 0.335 eq.) DIPEA were added and the 
reaction mixture was incubated at ambient temperature for 2 h. After purification the product 
was quantified by the absorbance at 260 nm on a Cary 300 Scan spectrophotometer and 
characterized by MALDI-TOF (Table 5.11) and PA gel electrophoresis 21% PA gel, 30 min at 
100 V, 50 min at 120 V in TBE running buffer. 
 
Table 5.11: MALDI-TOF MS results for the photoenol/tetrazole modified amino terminated 
oligonucleotides; theoretical and found values in [g/mol]. 
 [M]theo [g/mol] [M]found [g/mol] 
PE2-DNA2 56 7323 7324 
PE2-DNA3 57 7243 7232 
Tz-DNA2 63 7349 7349 
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5.4 Photoreactions 
 
Photo-Induced Cycloaddition between Photoenol Modified Oligonucleotides 
PE2-DNA1 53 and PE2-DNA2 54 and Dienophile 64 
For the initial photo-induced cycloaddition reactions between photoenol modified 
oligonucleotide and maleimide linker 64 the following procedure was used. The mixture of 
2.00 nmol PE-DNA and 2.00 nmol dienophile 64 in 1.00 mL H2O/CH3CN (1:1, v/v) was placed 
into the headspace vial, which was crimped air-tight as described above, degassed by purging 
with argon for 15 minutes and subsequently irradiated for 16 hours in the photoreactor at 
λmax = 320 nm. After the irradiation the solvents were removed under reduced pressure, the 
residue re-dissolved in water and purified by reversed phase HPLC. The collected fractions 
were characterized by MALDI-TOF (Table 5.12) and native PAGE (21% PA gel, 30 min at 
100 V, 50 min at 120 V in TBE running buffer. 
 
Table 5.12: MALDI-TOF MS results for the photo-cycloadducts 66 und 67; theoretical and found 
values in [g/mol]. 
 [M]theo [g/mol] [M]found [g/mol] 
Cycloadduct 67 7832 7838 
Cycloadduct 66 4673 4675 
 
Photo-Induced Cycloaddition between Photoenol-/Tetrazole Modified Oligonucleotides 
PE2-DNA2  56/Tz-DNA2 63 and Dienophile 64. 
For the photo-induced cycloaddition reactions between photoenol/tetrazole modified 
oligonucleotides and maleimide linker 64 and for the control experiments the following 
procedure was used. Different amounts of dienophile 64 (5 eq., 15 eq. and 100 eq.) were tested. 
The mixture of 2.00 nmol modified DNA and a certain amount of dienophile 64 (5 eq., 15 eq. 
or 100 eq.) in 500 µL H2O/DMSO (3:2, v/v) was placed into the headspace vial, which was 
crimped air-tight as described above, deoxygenated by purging with argon for 15 minutes and 
subsequently irradiated for 2 hours in the photoreactor at λmax = 320 nm. After irradiation the 
reaction mixture was passed through NAP-5 and NAP-10 columns and eluted with water in 
order to remove DMSO and the excess of 64. The solution was concentrated under reduced 
pressure and the residue re-dissolved in water (300 µL) and purified by reversed phase HPLC. 
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The collected fractions were characterized by MALDI-TOF (Table 5.13) and native PAGE 
21% PA gel, 30 min at 100 V, 50 min at 120 V in TBE running buffer. 
 
Table 5.13: MALDI-TOF MS results for the photo-cycloadducts 68 and 69, theoretical and found 
values in [g/mol]. 
 [M]theo [g/mol] [M]found [g/mol] 
Cycloadduct 68 7796 7794 
Cycloadduct 69 7794 7792 
 
Photo-Induced Cycloaddition between Photoenol Modified Oligonucleotide 
PE2-DNA2 54 and HRP-Mal. 
Photo-Induced Cycloaddition between Photoenol Modified Oligonucleotide 
PE2-DNA2 54 and HRP-Mal as well as the control reactions were performed using the 
following procedure. First HRP was functionalized with maleimide group in the coupling 
reaction with sulfo-SMCC. Sulfo-SMCC (2.00 mg, 4.58 µmol, 138 eq.) was dissolved in 
100 µL DMF and added to 200 µL HRP solution (33.2 nmol, 1.00 eq., 166 µM in PBS buffer, 
pH 6.0) and incubated for 1 hour at room temperature. The excess sulfo-SMCC was removed 
by filtration of the reaction mixture through NAP-5 and NAP-10 columns. The buffer was 
exchanged using PBS buffer pH 7.1 as eluent.  
For the photoreaction a mixture of 2.00 nmol PE2-DNA2 54 and 2.20 nmol of fresh 
prepared HRP-Mal in 500 µL of PBS/CH3CN solution (3:2, v/v) was placed into the headspace 
vial, which was crimped air-tight as described above, degassed by purging with nitrogen for 
15 minutes and subsequently irradiated for 16 hours in the photoreactor at λmax = 320 nm 
(± 30 nm, 36 W, Arimed B6, Cosmedico GmbH, Germany). The reaction mixture was filtered 
through NAP-5 and NAP-10 columns to exchange the buffer to 20 mM Tris/HCl pH 8.3, 
concentrated by using 5 kDa Vivaspin and purified by anion exchange chromatography using 
MonoQ 5/50 GL column (buffer A: 20 mM Tris, buffer B: 20 mM Tris, 1 M NaCl; gradient: 
linear increase of buffer B to 100 % in 30 minutes, flowrate: 1 mL/min). The concentration and 
buffer exchange to PBS of collected fractions were carried out by using 5 kDa Vivaspin, the 
characterization of product fraction was performed by native PAGE 12.5% PA gel, 30 min at 
80 V, 90 min at 100 V in Tris/glycin running buffer. 
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Stability Test for HRP under Irradiation at λmax = 320 nm (± 30 nm). 
For the stability tests, a solution of native HRP (2.00 nmol) in a mixture of PBS/CH3CN 
(3:2) (500 mL) was placed into the headspace vials, which was crimped air-tight as described 
above, degassed by purging with nitrogen for 15 minutes and subsequently irradiated in the 
photoreactor at λmax = 320 nm (± 30 nm) for 16 hours. In order to remove acetonitrile from the 
reaction mixture the solution was passed through NAP-5 and NAP-10 and eluted with PBS. 
Subsequently, the solution was concentrated by using 5 kDa Vivaspin and analyzed by SDS-
PAGE (12.5% SDS-PA gel, 30 min at 80 V, 1 h at 100 V in SDS/Tris/glycin running buffer. 
 
Peroxidase Activity Tests for HRP and HRP-DNA2 Conjugate (Amplex®Red Assay). 
Peroxidase activity tests for HRP and HRP-DNA2 conjugate were performed in black 
96 well microtiterplates using a Synergy microplate reader (BioTek) to record the fluorescence 
signals of resorufin (λex = 530 nm, λem = 590 nm, sensitivity = 70), which was formed by the 
oxidation of Amplex Red. The mixture of 2 pmol (0.500 µL, 3.74 µM) HRP or 2 pmol 
(0.800 µL, 2.57 µM) HRP-DNA2 in sodium phosphate buffer (pH 6.0) and 1 nmol (5.00 µL, 
200 µM) H2O2 was added to the wells (5 wells per sample). To each sample 5 nmol (10.0 µL, 
0.500 mM) Amplex®Red were added and the final volume of each sample was adjusted to 
100 µL with sodium phosphate buffer (pH 6.0). The measurements were done over a time 
period of 1 h for every sample. 
 
5.4.1 Kinetic Study of the Photo-Induced Cycloaddition Reaction. 
 
General procedure 
A solution of photoenol/tetrazole modified oligonucleotide (24 nmol, 1.00 eq.) and 64 
(120 nmol, 5.00 eq. or 360 nmol, 15.0 eq.) in 3.00 mL of water/DMSO mixture (3:2, (v/v)) was 
placed in a headspace vial (Pyrex, diameter 20 mm, VWR, Germany) in the dark. The vial was 
crimped air-tight using SBR seal (VWR, Germany) with PTFE inner liner and the solution was 
deoxygenated by purging with argon for 15 minutes. Subsequently, the reaction mixture was 
aliquoted in 5 different headspace vials (500 µL in each; the vials were flushed with argon and 
crimped air-tight) in a glove box and irradiated for 0 min, 15 min, 30 min, 1 h and 3 h by 
revolving around a compact low-pressure fluorescent lamp with λmax = 320 nm  at a distance of 
40-50 mm in a custom-built photoreactor. Each reaction mixture was passed through NAP-5 
and NAP-10 columns and eluted with water in order to remove DMSO and the excess of 64. 
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Solvent was removed in vacuum concentrator and the residues were re-dissolved in 200 µL 
water. One part of the solution (100 µL) was analyzed by reversed phase HPLC. The other 
100 µL of each sample were mixed with 100 µL of a mixture acetonitrile/water (1:1, (v/v)) and 
1% AcOH, filtered with syringe filter (GHP Acrodisc® 13 mm syringe filter with 0.2 µm GHP 
membrane from PALL Life Sciences) and analyzed by ESI-MS.  
 
Irradiation of Tz-DNA2 63 and 100 eq. of dienophile 64.  
A solution of Tz-DNA2 63 (9.00 nmol, 1.00 eq.) and 64 (900 nmol, 100 eq.) in 1.50 mL 
of water/DMSO mixture (3:2, (v/v)) was placed in a headspace vial (Pyrex, diameter 20 mm, 
VWR, Germany) in the dark. The vial was crimped air-tight using SBR seal (VWR, Germany) 
with PTFE inner liner and the solution was deoxygenated by purging with argon for 15 minutes. 
Subsequently, the reaction mixture was aliquoted in 3 different headspace vials (500 µL in 
each; the vials were flushed with argon and crimped air-tight) in a glove box and irradiated for 
1 h, 5 h and 24 h by revolving around a compact low-pressure fluorescent lamp with 
λmax = 320 nm at a distance of 40-50 mm in a custom-built photoreactor. Each reaction mixture 
was passed through NAP-5 and NAP-10 columns and eluted with water in order to remove 
DMSO and the excess of 64. Solvent was removed in vacuum concentrator and the residues 
were re-dissolved in 200 µL water. One part of the solution (100 µL) was analyzed by reversed 
phase HPLC. The other 100 µL of each sample were mixed with 100 µL of a mixture 
acetonitrile/water (1:1, (v/v)) and 1% AcOH, filtered with syringe filter (GHP Acrodisc® 
13 mm syringe filter with 0.2 µm GHP membrane from PALL Life Sciences) and analyzed by 
ESI-MS. 
 
The Detailed Time Resolution of the Photo-Induced Cycloaddition Reaction between the 
Photoenol/Tetrazole Modified Oligonucleotides and the Dienophile 64. 
A solution of photoenol/tetrazole modified oligonucleotide (16.0 nmol, 1.00 eq.) and 64 
(80.0 nmol, 5.00 eq. or 240 nmol, 15.0 eq.) in 4.00 mL of water/DMSO mixture (3:2, (v/v)) 
was placed in a headspace vial (Pyrex, diameter 20 mm, VWR, Germany) in the dark. The vial 
was crimped air-tight using SBR seal (VWR, Germany) with PTFE inner liner and the solution 
was deoxygenated by purging with argon for 15 minutes. Subsequently, the reaction mixture 
was aliquoted in 7 different headspace vials (500 µL in each; the vials were flushed with argon 
and crimped air-tight) in a glove box and irradiated for 0 min, 1 min, 5 min, 10 min, 15 min, 
1 h and 5 h by revolving around a compact low-pressure fluorescent lamp with 
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λmax = 320 nm  at a distance of 40-50 mm in a custom-built photoreactor. Each reaction mixture 
was passed through NAP-5 and NAP-10 columns and eluted with water in order to remove 
DMSO and the excess of 64. Solvent was removed in vacuum concentrator and the residues 
were re-dissolved in 100 µL water. Each sample was mixed with 100 µL of a mixture 
acetonitrile/water (1:1, (v/v)) and 1% AcOH, filtered with syringe filter (GHP Acrodisc® 
13 mm syringe filter with 0.2 µm GHP membrane from PALL Life Sciences) and analyzed by 
ESI-MS.  
 
5.4.2 Spatially Controlled Immobilization of PE2-DNA2 54 on Maleimide 
Functionalized Silicon Wafers. 
For the spatially controlled immobilization of PE2-DNA2 54, maleimide functionalized 
silicon wafer9 was mounted into the sample holder with a shadow mask and placed into the 
PE2-DNA2 54 solution (1.75 µM, 4.00 mL) in PBS/CH3CN (1:1, v/v). The vial was crimped 
air-tight using SBR seals with PTFE inner liner. The solution was deoxygenated by purging 
with argon for 15 min and subsequently irradiated for 5 h by revolving around a compact low-
pressure fluorescent lamp with λmax = 320 nm  at a distance of 40-50 mm in a custom-built 
photoreactor. After irradiation, the mask was removed. The surface was rinsed with de-ionized 
water and sonicated in water for 10 s, in order to remove any possibly physisorbed material. 
The surface was subsequently washed with PBS buffer, MQ water, DMF, DMSO, again with 
MQ water and finally dried under a nitrogen stream. The surface was then analyzed by ToF-
SIMS. For the control experiment the same procedure as described above was applied for the 
non-modified DNA2.  
 
Hybridization of immobilized PE2-DNA2 54 with complementary Cy®3 labeled cDNA2.   
The surface with immobilized PE2-DNA2 54 was covered with a 50 µM solution of 
complementary DNA2 labeled with Cy®3 dye (λExc=550 nm, λEm=570 nm) in TETBS buffer 
(pH = 7.5) and incubated in the dark at ambient temperature overnight. The surface was then 
washed several times with MQ water, TETBS buffer and again with MQ water, dried under a 
nitrogen stream and analyzed by fluorescence microscopy. For the control experiment, the 
surface with immobilized PE2-DNA2 was covered with non-complementary DNA4 labeled 
with Cy®3 dye using the same procedure as described above. 
                                                 
9 The functionalization of silicon wafers with maleimide moiety was conducted by Doris Abt, Institute for 
Technical Chemistry and Polymer Chemistry, Karlsruhe Institute of Technology (KIT), using the procedure 
described by Yameen et al. 
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5.4.3 Direct Laser Writing (DLW). 
 
Cleaning and Functionalization of Glass Surfaces with Maleimide Moiety. 
 
Substrate Preparation. 
High precision microscope cover glasses (22×22 mm, 170±5µm, No. 1.5H) were 
cleaned with acetone wetted KimTech wipes, placed into the slides holder and heated in a 
solution of 40.0 mL 25% ammonia solution, 40.0 mL 30% H2O2 and 200 mL MQ water (1:1:5, 
v/v/v) in a glass chamber at 150 °C for 1 h. Each glass was thoroughly rinsed with MQ water, 
EtOH, MQ water and finally dried under a nitrogen stream. Glasses were placed on a glass Petri 
dish and exposed to oxygen plasma (300 W) for 5 min just before silanization. 
 
APTES Functionalized Glass Substrates. 
Silanization solution was prepared by mixing 93.005% MeOH (235 mL), 5% MQ water 
(12.5 mL), 0.005% glacial acetic acid (12.0 µL) and 1% APTES (2.50 mL). Plasma activated 
glasses were shacked in the silanization solution at ambient temperature for 1 h and finally 
thoroughly rinsed with EtOH and MQ water. The glass substrates were subsequently annealed 
at 100 °C for 1 h, kept under vacuum for 2 h and stored under inert atmosphere before 
maleimide functionalization. 
 
Maleimide Functionalized Glass Substrates. 
The APTES functionalized glass substrates were separately immersed in 55.0 mM 
CH2Cl2 solution of triethylamine (12.0 mL) in Falcon® 50 mL centrifuge tubes. Equal volume 
(12.0 mL) of a 50.0 mM solution of 4-maleimidobutyroyl chloride 78 in anhydrous CH2Cl2 was 
added under inert atmosphere and the reaction was proceed at ambient temperature overnight. 
Maleimide functionalized substrates were thoroughly rinsed with CH2Cl2 and MeOH and 
additionally kept in MeOH overnight, in order to remove the quaternary triethylammonium  
salt. The substrates were rinsed with MeOH, dried under a nitrogen stream and stored under 
inert atmosphere at ambient temperature. 
 
Dose and Resolution Tests 
The maleimide functionalized glass slide was mounted in the DLW sample holder and 
a droplet of an immersion oil was placed on one glass side. The sample was placed into the 
DLW setup and a droplet of a freshly prepared, filtered (GHP Acrodisc® 13 mm syringe filter 
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with 0.2 µm GHP membrane from PALL Life Sciences) 10.0 µM solution of PE2-DNA2 56 in 
0.5×SSC (pH 7.0)/DMSO (3:2, v/v) was placed on maleimide functionalized glass side. On the 
same surface dose and resolution test were performed in the 100×100 µm2 squares respectively. 
For the dose tests 2 µm long lines were written with the scanning speed of 100 µm s-1 and a 
scan number of 4 by linear increasing of laser power from 0 mW (bottom) to 20 mW (top) and 
variation of the laser focus position (z position) at the interface from -z (left) to +z (right). For 
the resolution tests a pattern of 6×7 segments with 10 µm long lines and different distances 
between the lines were written by variation of the laser power from left to right (0.4 mW, 
0.8 mW, 2 mW, 4 mW, 8 mW, 16 mW, 24 mW) and decrease of the line distance from bottom 
to top (1 µm, 0.8 µm, 0.7 µm, 0.6 µm, 0.5 µm, 0.4 µm). Sample development was performed 
by immersing the sample in 2×SSC, 0.2% SDS (20 mL, 10 min), after short sonication (5 s) the 
sample was immersed into 2×SSC (20 mL, 10 min), then into 0.1×SSC, 0.1% SDS (20 mL, 10 
min) and finally rinsed thoroughly with MQ water and dried under a stream of nitrogen.  
 
Hybridization of immobilized PE2-DNA2 56 with complementary Cy®3-cDNA2.   
The surface with immobilized PE2-DNA2 56 was blocked with BSA prior to 
hybridization. The sample was immersed in a solution of 5×SSC/SDS/BSA 
(98.9% / 0.1% / 1%) and incubated in a water bath at 43 °C for 1 h. Subsequently, the sample 
was rinsed thoroughly with MQ water and placed in TETBS buffer. A solution of 
Cy®3-cDNA2 in TETBS buffer was heated to 95 °C for 5 min and added to the sample, so that 
the final concentration was 200 nM. The sample was incubated in the dark at ambient 
temperature for 1.5 h, washed by immersing in 2×SSC, 0.2% SDS (20 mL, 5 min), 2×SSC 
(20 mL, 5 min), in 0.1×SSC, 0.1% SDS (20 mL, 10 min) and finally rinsed thoroughly with 
MQ water and dried under a stream of nitrogen. 
 
Writing of Two Different DNA Sequences. 
In order to perform the writing of two different DNA sequences, a 3D polymer frame 
(100×100 µm2) as a visual reference object was written with tetraphotoenol photoresist. The 
tetraphotoenol was synthesized by Dr. Alexander Quick, Institute for Technical Chemistry and 
Polymer Chemistry, Karlsruhe Institute of Technology (KIT) using the previously reported 
procedure.[229] The maleimide functionalized glass slide was mounted in the DLW sample 
holder and a droplet of an immersion oil was placed on one glass side. The sample was placed 
into the DLW setup and a droplet of a tetraphotoenol photoresist (27.3 mM in γ-
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butyrolactone/acetophenone (1:1, v/v)) was placed on maleimide functionalized glass side. The 
frame was written with the scanning speed of 10 µm s-1 and 12.0 mW laser power. Sample 
development was performed by immersing the sample in acetone for several minutes. The 
sample was rinsed with acetone and MQ water, dried under a stream of nitrogen, mounted in 
the DLW sample holder and a droplet of an immersion oil was placed on one glass side. A 
droplet of a freshly prepared, filtered (GHP Acrodisc® 13 mm syringe filter with 0.2 µm GHP 
membrane from PALL Life Sciences) 30.0 µM solution of PE2-DNA2 56 in 
0.5×SSC (pH 7.0)/DMSO (3:2, v/v) was placed on maleimide functionalized glass side. A 
pattern of line segments and checkerboard pattern were written with the scanning speed of 
50 µm s-1, 4 scans and 6 mW laser power. Subsequently, the sample was developed by 
immersing in 2×SSC, 0.2% SDS (20 mL, 10 min), sonicated for 5 s, immersed into 2×SSC 
(20 mL, 10 min), then into 0.1×SSC, 0.1% SDS (20 mL, 10 min) and finally rinsed thoroughly 
with MQ water and dried under a stream of nitrogen. Then the sample was mounted in the DLW 
sample holder and again the immersion oil was dripped on one glass side. The sample was 
placed into the DLW setup and a droplet of a freshly prepared, filtered 30.0 µM solution of 
PE2-DNA3 57 in 0.5×SSC (pH 7.0)/DMSO (3:2, v/v) was placed on maleimide functionalized 
glass side. The sample was positioned according to the previous writing settings and the patterns 
were completed with the second sequence. The sample was developed as described before. 
 
Hybridization of immobilized PE2-DNA2 56 and PE2-DNA3 57 with complementary 
Cy®3-cDNA2 and Cy®5-cDNA3.   
The surface with immobilized PE2-DNA2 56 and PE2-DNA3 57 was blocked with 
BSA prior to hybridization. The sample was immersed in a solution of 5×SSC/SDS/BSA 
(98.9% / 0.1% / 1%) and incubated in a water bath at 43 °C for 1 h. Subsequently, the sample 
was rinsed thoroughly with MQ water and placed in TETBS buffer. A solution of 
Cy®3-cDNA2 and Cy®5-cDNA3 in TETBS buffer was heated to 95 °C for 5 min and added 
to the sample, so that the final concentration was 200 nM. The sample was incubated in the dark 
at ambient temperature for 1.5 h. The sample was washed by immersing in 2×SSC, 0.2% SDS 
(20 mL, 5 min), 2×SSC (20 mL, 5 min), in 0.1×SSC, 0.1% SDS (20 mL, 10 min) and finally 
rinsed thoroughly with MQ water and dried under a stream of nitrogen.  
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5.4.4 Synthesis of Do-TEG-Mal 71 Coated Copper Nanoparticles. 
Dopamine-maleimide coated copper nanoparticles were synthesized employing a 
literature procedure.[236] A solution of 29.0 mg (125 µmol, 0.500 eq.) Do-TEG-Mal 71 and 
39.0 mg (125 µmol, 0.500 eq.) dopamine-triethylene glycol methyl ether 72 (as an inert linker) 
in 4.00 mL CH3CN/H2O (1:1, v/v) was heated under inert atmosphere to 80 °C. CuCl2∙2H2O 
(42.0 mg, 250 µmol, 1.00 eq.) was dissolved in 1.00 mL CH3CN/H2O (1:1, v/v) and added 
dropwise to the dopamine linkers solution. The reaction mixture was stirred at 80 °C for 10 h. 
Synthesized nanoparticles were analyzed by UV-Vis spectroscopy. 
 
Synthesis of NTA 75 Coated Copper Nanoparticles. 
A typical synthesis was performed under inert atmosphere in order to avoid moisture 
and oxygen during the reaction. In a 25 mL two necked round bottom flask CuCl2∙2H2O 
(17.0 mg, 100 µmol, 1.00 eq.) and NTA75 (33.7 mg, 85.0 µmol, 0.850 eq.) were dissolved in 
5.00 mL diethylene glycol and heated to 100 °C. In another 5 mL round bottom flask 2.50 mL 
diethylene glycol were heated to 100 °C and at this temperature 18.9 mg (500 µmol, 5.00 eq.) 
NaBH4 were added. The solution was added dropwise to the copper solution under vigorous 
stirring. The solution color turned from blue-green to brownish black due to the formation of 
copper nanoparticles. After slow cooling to ambient temperature, the as-prepared nanoparticles 
were collected by centrifugation and washed three times by centrifugation in a 1:1 mixture of 
EtOH and isopropanol. The washed nanoparticles were re-dispersed in isopropanol and 
analyzed by UV-Vis spectroscopy. Different copper/linker rations were tested in order to 
investigate the stability of copper nanoparticles (Table 5.14).  
 
Table 5.14: Reactant amounts used for the synthesis of CuNPs. 
CuCl2∙2H2O NTA Linker NaBH4 Stability 
1.00 eq. 0.680 eq. 8.00 eq. - 
1.00 eq. 1.00 eq. 4.00 eq. - 
1.00 eq. 0.100 eq. 8.00 eq. 2 h 
1.00 eq. 0.150 eq. 8.00 eq. 2 h 
1.00 eq. 0.200 eq. 8.00 eq. 7 days 
1.00 eq. 0.400 eq. 8.00 eq. - 
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Synthesis of NTA-Mal 81 Coated Copper Nanoparticles. 
In a 25 mL two necked round bottom flask CuCl2∙2H2O (21.3 mg, 125 µmol, 1.00 eq.) 
and NTA-Mal 81 (10.7 mg, 24.9 µmol, 0.200 eq.) were dissolved in 5.00 mL diethylene glycol 
and heated to 100 °C. In another 5 mL round bottom flask 2.50 mL diethylene glycol were 
heated to 100 °C and at this temperature 37.8 mg (999 µmol, 8.00 eq.) NaBH4 were added. The 
solution was added dropwise to the copper solution under vigorous stirring. The solution color 
turned from blue-green to brownish black due to the formation of copper nanoparticles. After 
slow cooling to ambient temperature, the as-prepared nanoparticles were collected by 
centrifugation and washed three times by centrifugation from a 1:1 mixture of EtOH and 
DMSO. The washed nanoparticles were re-dispersed in DMSO and analyzed by UV-Vis 
spectroscopy. 
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